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Abstract 
Considering the importance of nitrogen-rich heterocycles in drug discovery, a novel strategy 
towards heterocycle synthesis was envisioned using cyanamide chemistry. Synthesis which 
involve mild conditions, avoids multi-step sequence and non-toxic reagents are desirable for 
generation of large combinatorial libraries of drug molecules. We envisaged that the NCN 
linkage of the cyanamide as well as the concomitant use of the nucleo-and electrophilic centres 
of the cyanamide could provide a novel synthetic route towards nitrogen heterocycles.  
The first part (Ch-2) constitute the bulk of the thesis and it focuses on the generation of 
cyanamide ion and its cyclisative capture with a 1,3-dipole – nitrile oxide in situ. The 
cycloadduct -1,2,4-oxadiazol-5(4H)-imine was obtained in good yields, which was further 
transformed into pharmacologically important cores like oxadiazolone and amidines. A library 
of the different heterocyclic cores was generated, which tolerated a wide variety of functiona l 
groups in good to excellent yields. 
In the second part (Ch-3), we developed a novel protocol for the synthesis of 1,2,4-triazol-3-
imine via a formal 1,3-dipolar cycloaddition of in situ generated nitrile imines and cyanamide 
ion. Further hydrolysis furnished with 1,2,4-triazol-3-one, which is an important core from 
medicinal chemistry point of view.   
The concomitant generation and reaction of two reactive species- 1,3-dipoles and cyanamide 
ion was achieved in a single pot in situ to provide a route towards novel and pharmaceutica l ly 
important heterocyclic cores. The present work provides a platform for the development of 
cyanamide derivatives as a ‘single-reagent—diverse-scaffolds’ strategy for time efficient 
library delivery of structurally diverse molecules. 
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sometimes leads to success. However, accidental observations can 
disclose new horizons, far off the original target and sometimes 
more valuable. The luck chance might lurk just outside the 
experimenter’s door, but the door is not always open. Opening it  
brings serendipity – acceptance of Fortuna's gift."  
 
"The solution of one problem usually generates a bevy of new ones. The inexperienced young 
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"Playfulness is an incentive for the scientist and a driving force of 
progress" 
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(in his autobiography – ‘The Adventure Playground of Mechanisms and Novel Reactions’) 
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Chapter 1 
Introduction to Heterocycles and Cyanamides 
 
1.1 Heterocycles 
The IUPAC Gold Book describes heterocyclic compounds as: ‘Cyclic compounds having as 
ring members atoms of at least two different elements, e.g. quinoline, 1,2-thiazole, 
bicyclo[3.3.1]tetrasiloxane’.1  
Another classical reference book, the Encyclopaedia Britannica, describes a heterocyclic 
compound as: ‘Any of a major class of organic chemical compounds characterized by the fact 
that some or all of the atoms in their molecules are joined in rings containing at least one atom 
of an element other than carbon (C), most frequently oxygen, nitrogen, or sulfur’.2  However, 
many other atoms can form the stable covalent bonds necessary for ring construction includ ing 
phosphorus, arsenic, antimony, silicon, selenium, tellurium, boron, and germanium.3  
Heterocyclic compounds are commonly found as 3 to 8 membered rings, although five and six-
membered rings are more prominent in nature.4 The five-membered heterocycles studied 
generally include ─ containing (i) one-heteroatom (pyrrole, furan, thiophene), (ii) two-
heteroatoms (pyrazole, imidazole, oxazole, thiazole) (iii) three-heteroatoms (oxadiazo le, 
triazole, tetrazole) (Figure 1.1). Fused heterocycles like indole, benzimidazole, benzoxazo le , 
indoles etc. are also widely distributed/studied.5   
 
Figure 1.1 Some common five-membered heterocycles 
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Around 133,326 different heterocyclic ring systems had been reported upto 1984,4 with many 
more being added since then. Moreover, with possibility to decorate these core ring systems 
via substitution with different functionalities, millions of heterocyclic compounds have been 
synthesised till date. A recent analysis of the organic compounds registered in Chemical 
Abstracts revealed that as of June 2007, there were 24,282,284 compounds containing cyclic 
structures, with heterocyclic systems making up many of these compounds.6 As Rolf Huisgen 
had said, ‘The number of organic compounds is potentially infinite. Nowhere does one feel 
confronted with this profusion to a higher extent than in heterocyclic chemistry’,7 highlighting 
the increasing role of heterocyclic molecules in organic chemicals.  
The history of heterocyclic chemistry can be dated back to 1800s, in step with the development 
of organic chemistry.8 The early heterocyclic compounds were mostly isolated from natural 
resources, some of the notable historic examples being: 
• Uric acid (1776, by Scheele from human bladder stones),  
• Alloxan (1818, by Brugnatelli on oxidation of uric acid),  
• Quinoline and Pyrrole (1834, by Runge from coal distillates, called coal tar),  
• Melamine (1834, by Liebig by synthesis),  
• Pyridine (1849, by Anderson by pyrolysis of bones),  
• Indole (1866, by Baeyer from degradation of indigo, synthesised by Friedlander in 
1906),  
• Furan (1870, from wood and cellulose destructive distillation) 
• Chlorophyll (1936, isolation by Treibs) 
The plant kingdom forms a rich source of many nitrogen heterocyclic compounds, most 
common being the alkaloids (alkali in nature). Natural products like morphine, quinine, 
camptothecin, vinblastine nicotine, reserpine are some of the important alkaloids isolated from 
plant sources.9  
Porphins (four pyrrole units linked in a cycle by four sp2 carbons) and their derivatives known 
as porphyrins are an important class of natural heterocyclic molecules, which play an important 
role in the respiratory system of both plants and animals. Two of the most important porphyrins 
include- the iron (II) complex heme which when associated with the protein globin is found in 
blood as the oxygen-carrying hemoglobin, and chlorophyll, which is a magnesium complex 
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involved in photosynthesis (Figure 1.2). One of the vitamins (B12, cyanocobalamine) also 
contains a modified porphin ring, which is complexed to cobalt. 
 
Figure 1.2 Porphyrin containing natural molecules: chlorophyll-a and heme 
The genetic material DNA, the basis of life comprising of nucleic acids (4) having heterocyclic 
bases – pyrimidines: cytosine, thymine and uracil and purines: adenine and guanine are 
important building blocks of life (Figure 1.3).9   
Figure 1.3 Nucleic acids with purine and pyrimidine heterocycles 
Examples of heterocyclic core also appear in several amino acids and neurotransmitters. For 
example, the essential amino acids: proline (5, pyrrolidine), tryptophan (6, indole), histid ine 
(7, imidazole) are important amino acids in life, whereas the neurotransmitters serotonin and 
histamine are important in the modulation of the body’s   and biochemical processes; whereas 
melatonin (10) is involved in the regulation of circadian rhythms (sleep patterns).  
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Figure 1.4 Heterocyclic structures found in amino acids and neurotransmitters 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Heterocycles found in vitamins and cofactors 
Heterocyclic molecules are also important constituents of vitamins, co-enzymes and 
antibiotics. Thiazolium ring is prominent in vitamin B1 (11), and its co-enzyme form plays an 
important role in the decarboxylation of α-keto-acids. Vitamin B5 (12, nicotinic acid amide) 
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and Vitamin B6 (13, pyridoxal) are pyridine-based molecules, whereas the co-enzymes NAD 
(14) and FAD (15) are important biochemical catalysts for the physiological processes in the 
body (Figure 1.5). 
1.2 Heterocycles in Drug Discovery 
Heterocycles are common structural scaffolds in marketed drugs and in medicinal chemistry 
targets in the drug discovery process. Over 80% of top small molecule drugs by US retail sales 
in 2010 contained at least one heterocyclic fragment in their structures.10 In fact, heterocyclic 
moieties are present in the structures of all top 10 brand name small molecule drugs.10 The 
importance of nitrogen containing heterocycles can be estimated from the fact that 
approximately 60% of all unique small molecule drugs approved by US-FDA contain at least 
one nitrogen atom.11 
One of the reasons for the widespread use of heterocyclic compounds is that their structures 
can be subtly manipulated to achieve a required modification in function. Some of the drug 
properties that can be modulated by a strategic inclusion of heterocyclic moiety into the 
molecule include: 1) potency and selectivity through bioisosteric replacements, 2) lipophilic ity, 
3) polarity, and 4) aqueous solubility.10 
Figure 1.6 Some top-selling drugs containing heterocyclic cores 
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Heterocyclic groups acts as bioisosteres for different functional groups, for example the use of 
tetrazole ring system is used as a mimic of a carboxylic acid functional group12 as it is similar 
in terms of acidity and steric requirement. The tetrazole group is found to be superior in terms 
of metabolic stability, bioavailability and greater charge distribution.12  
 
Scheme 1.1 Retrosynthetic scheme for omeprazole 
One of the important biological interactions involve the hydrogen bonding of the drugs with 
the target proteins, which can be achieved via heterocyclic rings. 13 They also provide good 
chelation properties (for e g. the binding of the heterocyclic component of the HIV-1 integrase 
inhibitor Raltegravir to Mg2+ and Mn2+ which are important cofactors of the integrase enzyme 
provides its activity).14 Heterocycles are also used to reduce the lipophilicity of the drug 
compounds, as they contain lower ClogP values. In addition, they can modulate the polarity 
and aqueous solubility of compounds, hence playing an important role in the drug discovery 
process. Several drugs known in the market contain a nitrogen heterocycle.9 Some of the top-
selling drugs15 including atorvastatin (cholesterol- lowering), omeprazole, clopidogre l, 
olanzapine, celecoxib and cimetidine are illustrated in Figure 1.6. The retrosynthetic analys is 
of omeprazole is shown in Scheme 1.1. 2-thiobenzimidazole (16b) and 4-methoxy-3,5-
dimethyl-2-chloromethyl pyridine (16c) react to give 16a which when oxidized gives 
omeprazole (16). 
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1.3 Heterocycles in Materials chemistry 
Heterocylces also find application in material science and have been widely used for 
constructing polymeric material,16 and  smart materials.  In particular the 5-membered and 6-
membered nitrogen heterocycles have been recently explored as an efficient light emitting 
source and have also been used to build high performance electron-transport materials (ETMs) 
with high electron mobilities, high triplet energy levels and low electron injunction barriers.17,18 
OLEDs (Organic light emitting diodes) have become one of the most sought after research area 
in the light-emission field, due to their potential applications in flat panel displays, solid-state 
lighting, and back-lighting sources for liquid display.19 
Figure 1.7 Heterocyclic molecules in light emitting materials20 
Among the 5-membered N-heterocycles, due to electron-deficient nature of the 1,2,4-
oxadiazoles, 1,3,4 oxadiazoles and 1,2,4-triazole rings, their use as an electron transport layer 
and hole-blocking material in multi- layer type electroluminescent cells has been 
demonstrated17,18,20,21 (Figure 1.7). Heterocyclic molecules have also found application in 
liquid crystals which finds applications in displays, optoelectronic devices and as sensors due 
to their special properties (Figure 1.8).17 Heterocycles on alkylation find use as ionic liquids 
which aggregate electrostatically. Imidazolium salts in particular are used to extract metal ions 
from aqueous solutions, dissolve carbohydrates, create polyelectrolyte brushes on surface, coat 
metal nanoparticles and create oriented liquid crystals.22 
Polymers of nitrogen heterocyles like 1,2,4-triazole and 1,2,4-oxadiazole have found use in 
data storage, electrolyte membrane fuel cells and solar cells. Pyrrole-imidazole polyamides 
have been used as sequence-selective DNA probes and their conjugation with fluoropho res 
have found application in biological imaging.23,24 Imidazole and imidazolium based polymers 
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form hydrogels- a form of responsive polymer which swells nearly 200 times the origina l 
volume and found applications in drug release, sensors and artificial muscles.22 
 
 
 
 
 
 
Figure 1.8 Benzothiadiazole-based liquid crystal containing different heterocyclic 
substituents17 
1.4 Heterocycles in Catalysis 
In early 2000s Berber and Macmillan introduced heterocycles like proline and imidazolidinone 
as organocatalysts for various asymmetric transformations. Organocatalysts have advantages 
over traditional metal-based chiral catalysts25 – a) generally insensitive to oxygen and moisture 
in the atmosphere, thus avoiding the need for special reaction vessels or ultra-dry reagents and 
solvents; b) non-toxic and environment friendly; c) easy availability from natural sources as 
single enantiomers, hence making it cheap to prepare in large quantities.  
Organocatalysis has its basis on 5-6 different generic activation modes, and its classifica t ion 
has evolved since its discovery. Different activation modes like – iminium catalysis, enamine 
catalysis, SOMO (single occupied molecular orbitals) and counter anion catalysis operate on 
covalent interactions, whereas activation modes like hydrogen bonding, phase transfer catalysis 
and Bronsted acid involve non-covalent interactions. 
One of the early examples of proline-catalysed reaction was the inter-molecular cross aldol 
reaction,26 where the proline (27) formed a nucleophilic enamine on condensation with an 
aldehyde (26) and reacted with a ketone (25) to form a cross aldol product (28) in good yields 
(Scheme 1.2a). 
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Scheme 1.2 Reactions catalysed by proline and imidazolidinone-based organocatalysts 
Enamine catalysis is considered bifunctional catalysis, as the amine-containing catalyst 
(proline) reacts with ketone to form a nucleophilic enamine, and simultaneously engages with 
an electrophilic reaction partner through either hydrogen bonding or electrostatic interaction. 2 7  
(Scheme 1.3). The products are formed through α-functionalisation of carbonyl compounds 
and involves HOMO activation. The enamine intermediate as the primary catalytic species was 
identified recently by NMR and X-ray spectroscopy28 in 2010, which also revealed the 
secondary catalytic species: an oxazolidinone acting as a bridge between aldehyde and enamine 
(Scheme 1.3). 
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Scheme 1.3 Mechanistic scheme for aldol reaction – evidence of primary and secondary 
intermediates 
Iminium catalysis was the first organocatalytic activation mode to be designed and used as a 
general strategy for asymmetric organic synthesis.25 They are applicable for transformations 
traditionally catalysed by lewis acids expected to emulate equilibrium dynamics and п-orbital 
electronics inherent to Lewis acid catalysis (lowering activation energy of LUMO). 
Condensation of a chiral secondary amine with an enal forms the iminium ion, the LUMO 
orbital of which is lowered in energy such that it can now interact with suitable coupling 
partners through either pericyclic reactions or by conjugate addition26 (Scheme 1.2b and 1.2c).  
The first highly enantioselective organocatalytic Diels–Alder reaction using a chiral 
organocatalyst was reported by Macmillan in 2000.29 The activated iminium ion, formed 
through condensation of the imidazolidinone (31) and an α,β-unsaturated aldehyde, reacted 
with various dienes to give [4+2] cycloadducts in excellent yields and enantioselectivit ies 
(Scheme 1.2b). The dimethyl substitution of the imidazolidinone catalyst keeps the bulk of the 
iminium ion in a position so as to form a п-п stacking of the benzyl group with alkene unit, 
blocking the top face of the alkene and leading to a high facial selectivity.  
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Figure 1.9 Orientation of imidazolidinone catalyst responsible for enantioselectivity 
Another example of an iminium-enamine catalysis is the Jorgensen epoxidation of α,β-
unsaturated aldehydes by hydrogen peroxide catalysed by diarylprolinol derivative.30 (Scheme 
1.2c). The first step is the formation of the iminium ion intermediate by reaction of the α,β-
unsaturated aldehyde with the chiral amine. In the next step, the peroxide adds as a nucleophile 
to the electrophilic α-carbon atom leading to an enamine intermediate. The formation of the 
epoxide then takes place by attack of the nucleophilic enamine carbon atom to the electrophilic 
peroxygen atom, followed by hydrolysis of the iminium intermediate. 
 
 
Scheme 1.4 Mechanism of the Jorgensen epoxidation of α,β-unsaturated aldehydes 
While it goes through the enamine/iminium intermediate route, the secondary intermed ia te 
peroxyhydrate has been implicated in accelerating of the reaction by functioning as a phase 
transfer catalyst. Similar to the methyl groups in imidazolidinone, it was found that the silyl 
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group in the prolinol derivative was responsible for the enantioselectivity by discrimina ting 
between the two planar faces of the electrophile.31 Other organocatalytic transformations such 
as 1,3-dipolar cycloadditions, Friedel–Crafts alkylations, α-chlorinations, α-fluorinations, and 
intramolecular Michael reactions have been carried out using these catalysts.26 
 
Heterocyclic molecules has also been explored as chelating ligand with transition metals which 
in turn act as catalysts for a variety of reactions.32–35Among these, N-heterocyclic carbenes 
(NHC) derived from imidazole, pyrazole and triazole have found use as ligands for metals, 
their complexation and coordination chemistry being very similar to organophosphanes.36,3 7  
They are σ bond donors and bind strongly to the metals. They have been found to be versatile 
in their applications e g. palladium-NHC complexes have found use as catalysts in Heck, Stille, 
Sonagashira coupling, aryl amination, etc.38–41 Although considered ‘phosphine-mimics’ there 
have been increasing evidence that NHC─metal catalysts surpass their phosphane congeners 
in both activity and scope of application.42 The most convincing and best studied example so 
far has been olefin metathesis, for which ruthenium-NHC catalysts were exploited. It was found 
that the organophosphanes─ubiquitous standard ligands in organometallic chemistry gave 
poorer catalytic performance than NHC ligands in structurally analogous catalysts. The NHC- 
ruthenium complexes gave rise to the second generation Grubb’s catalyst. Further replacement 
of a phosphine ligand from the second generation Grubb’s catalyst with a heterocyclic molecule 
like pyridine led to a million-fold increase in the initiation rate.43 This fast-initiating catalyst 
has found use as initiators for ring opening metathesis polymerisation (ROMP),44 and are 
called third-generation Grubb’s catalyst.43,45 
1.5 Heterocycles in Pesticides and Agrochemicals 
Ever since the discovery of synthetic agrochemicals in the late 1940s like DDT - 1,1-bis(p-
chlorophenyl)-2,2,2-trichloroethane) and parathion as powerful insecticides, many synthet ic 
compounds were found to be of commercial values, heterocycles being prominent among them. 
Various 5- and 6─membered heterocyclic ring containing molecules were discovered as 
effective insecticides, fungicides as well as herbicides8 (Figure 1.9). They act through inhibit ion 
of various target enzymes/ion channels leading to their pesticidal activity, for eg. The 
insecticide fipronil (38) which is a pyrazole derivative, acts by disrupting the central nervous 
system of the insects, specifically by blocking chloride ion passage in the system. Some 
representative examples are found in Figure 1.10. 
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Figure 1.10 Five-membered heterocyclic molecules in pesticides 
1.6 Heterocycle Synthesis 
The synthesis of the most commonly studied 5- and 6- membered heterocyclic rings could be 
broadly divided into two major categories:8,46 
• Intramolecular cyclisation  
• Cycloaddition reactions  
1.6.1 Synthesis of heterocycles by intramolecular cyclisation:  
Intramolecular cyclisations involving carbonyl groups, aza-wittig reactions, C-C coupling are 
some of the commonly employed routes towards heterocycle synthesis. 
Carbonyl group condensations: 
The primary knowledge that the carbonyl groups in aldehydes and ketones are electrophilic 
and receptive to addition of nucleophiles like substituted amines, water, alcohols and thiols  has 
led to the synthetic route towards a large number of five and six-membered heterocyclic rings 
like pyrroles, thiophene, furan, pyridazones, etc.8  
Heterocycles with two heteroatoms can be synthesised from 1,3-dicarbonyl and β-halocarbonyl 
compounds by its reaction with different nitrogen nucleophiles (Scheme 1.5). The nucleophilic 
attack of hydrazine, hydroxylamine or amidine on 1,3-diketone (39) leads to the formation of 
pyrazoles (40), isoxazoles (41) and pyrimidine (42) rings respectively. Similarly, the reaction 
of β-bromoketone (43) with amidine and thioamide generates imidazole (44) and thiazole (45) 
ring respectively (Scheme 1.5).46  
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Scheme 1.5 Synthesis of heterocycles by carbonyl condensation 
 
Figure 1.11 Some heterocycle containing drugs synthesised through a key carbonyl 
condensation step 
Intramolecular aza-wittig reaction: 
The traditional Wittig reaction involves the reaction of ylides (carbanionic structures stabilised 
by positively charged phosphonium ion) with carbonyl compounds to form the C-C double 
bonds. An aza-wittig reaction involves the replacement of carbanionic center with a nitrogen 
anion forming an iminophosporane, which when reacted with the carbonyl compound forms 
the C=N bond. Intramolecular aza-Wittig process has been adapted to form a great variety of 
heterocyclic compounds.47 A chain containing ester/amide carbonyl groups and 
iminophosporane at the terminal ends give rise to heterocyclic rings like 1,3-oxazoles (50, 
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Scheme 1.6), isoquinolines, quinazolines, diazepin-2-ones among others. A large number of 
natural compounds48,49 have been synthesised till date, which involve aza-Wittig reaction as 
the key step (Figure 1.12). 
 
Scheme 1.6 Synthesis of 1,3-oxazoles by aza-Wittig intramolecular reaction 
Figure 1.12 Natural products synthesised using aza-Wittig reactions as the key step49 
Cyclisations involving C-C bond formations: 
The intramolecular C-C coupling reactions (eg. Heck, Suzuki, Stille reactions) catalysed by 
transition metals have found applications in synthesis of heterocycles.50 One of the examples 
include the synthesis of indole by Heck intramolecular coupling of an olefinic group and halide 
catalysed by Palladium diacetate. The synthesis by Sundberg51 proceeded at room temperature 
to give the product (56) in 96% yield (Scheme 1.7).  
Similar transition metal-catalysed intramolecular reactions of C-C unsaturated compounds 
tethered with NH, OH, C=O and C=N groups are known to form a wide range of heterocyclic 
rings. Alkenes, allenes and alkynes have been utilised as carbon-carbon unsaturated compound, 
and a wide variety of transition-metal complexes, such as palladium, platinum, gold, copper, 
titanium, tungsten, and organolanthanides have been used as catalysts.50 
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Scheme 1.7 Synthesis of indole ring by intramolecular Heck-coupling 
Ring-closing metathesis (RCM) involving an intramolecular interaction between two alkene 
groups has recently found application in the formation of 5- and 6-membered heterocyclic 
rings, mainly in the total synthesis of natural products.50 One of the examples include the 
synthesis of a pyrrolizidine alkaloid, pyrrolam A52 (58, Scheme 1.8).  
 
Scheme 1.8 Synthesis of Pyrrolam A by ring closing metathesis (RCM) 
1.6.2 Synthesis of Heterocycles by Cycloaddition 
The reactions in which "two or more unsaturated molecules (2 п electron systems) combine 
with the formation of a cyclic adduct (2 new σ bonds and two less п bonds) can be considered 
a cycloaddition reaction.”53 Cycloaddition reactions can be classified according to the number 
of п components (denoted in brackets) involved in the two reacting molecules: for eg. [4+2] 
cycloaddition involving 4 and 2 п component systems in the form of diene and dienophile to 
form a 6-membered ring, more commonly called as Diels-Alder reaction (Scheme 1.9). 
Similarly, [3+2] and [2+2+1] cycloaddition form 5 membered rings, [2+2] cycloaddit ion 
forming four-membered rings, and other higher order cycloadditions like [5+2], [4+3], [4+4], 
[6+2], [6+4] to form large-membered heterocyclic molecules.54  
The transition state of the Diels-Alder reaction has delocalised 6 п-electrons, giving it an 
aromatic character leading to a stable cycloadduct (Scheme 1.9). Figure 1.13 depicts the energy 
level diagram and the frontier molecular orbital (FMO) interactions of the diene and dienophile 
(lactic anhydride).53   
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Scheme 1.9 [4+2] Diels-Alder cycloaddition reaction 
The HOMO (Highest occupied molecular orbital) of the diene has one node in the center 
leading to a matching symmetry with the LUMO (Lowest unoccupied molecular orbital) of the 
dienophile. Dienes react readily with electrophiles because their HOMOs are relatively high in 
energy. Dienophiles having electron withdrawing groups like carbonyl or nitro lower their 
LUMO energy leading to better overlap in the transition state with the higher lying diene 
HOMO. The most common cycloaddition observed thus, is between an electron rich diene 
(High HOMO) and electron-deficient dienophile (low LUMO)55 (Figure 1.14) 
 
Figure 1.13 FMO of Diels-Alder cycloaddition of diene and cyclic anhydride 
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Figure 1.14 Orbital overlap of FMO of diene and dienophile 
 
Scheme 1.10 Dimerization of cyclopentadiene leading to endo product 
In a Diels-Alder cycloaddition, exo product is more stable, but the kinetic endo product is 
formed preferably (Scheme 1.10). Apart from the frontier orbitals interaction, the bonding 
interaction at the back of the dienes (shown by red arrows, figure 1.15) forming the п-bond 
leads to lowering of the transition state energy, and makes the formation of the endo product 
more favourable. In case of dienophiles with electron withdrawing groups (eg. carbonyl), a 
bonding interaction between the carbonyl groups and the developing п-bond at the back of the 
diene, lowers the energy of transition state leading to endo product. 
 
Figure 1.15 Orbital interactions leading to preferential endo product formation in the 
dimerization of cyclopentadiene 
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The regioselectivity of the Diels-Alder cycloaddition depends on the coefficients of the p-
orbitals of dienes and dienophiles with the largest orbital coefficients bonding together. The 
coefficients are calculated through computational calculations, which shows a distortion in the 
LUMO of the dienophiles (larger orbital coefficient on the β-carbon) leading to a maximum 
overlap with the end of diene having larger orbital coefficients (Scheme 1.11). 
 
Scheme 1.11 Regioselectivity in Diels-Alder cycloaddition  
Hetero-Diels-Alder Cycloaddition 
Hetero-Diels-Alder reaction involve either hetero-diene or hetero-substituted alkenes which 
undergo cycloaddition. A Diels-Alder reaction usually proceeds by the overlap of the LUMO  
of the dienophile and the HOMO of the diene. However, due to the electron-withdrawing nature 
of the hetero-substituted diene, the reduction in the activity of the hetero-diene is compensated 
by the introduction of electron-donating groups on the alkenes. This results in the ‘inverse 
electronic demand’, as now the HOMO of the alkene overlaps the LUMO of the hetero-diene.  
For example tetrahydropyridine derivatives are readily formed by the Diels-Alder 
cycloaddition of 1-azadiene (62) with activated alkenes.56 The two carbonyl groups in the 
maleic anhydride (63) activate the dienophile to give the product 64 (Scheme 1.12a). 
The other two examples involve the use of a hetero-substituted dienophile like a diazo 
compound (66) or nitroso compound (68), which undergo cycloaddition with a diene (65) to 
provide pyridazine (67) or 1,2-oxazine (69) as the product respectively (Scheme 1.12b, 1.12c).4 
The hetero-Diels-Alder reaction has been applied extensively in natural product synthesis.57,58 
Hetero-Diels-Alder and 1,3-dipolar cycloaddition are the  most common studied cycloaddit ions 
for the synthesis of 5- and 6-membered heterocycles.8  
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Scheme 1.12 Hetero-Diels-Alder cycloaddition of hetero/dienes with hetero-substituted 
alkenes 
1,3- Dipolar cycloaddition 
The origin of the concept of 1,3-dipolar cycloadditions can be traced back to a review article 
published on the chemistry of diazoalkanes by Rolf Huisgen in 1955.59 The possible resonance 
structures of CH2N2 lead Huisgen to realise that it could be extended to a series of similar 
structures, in which elements of carbon, nitrogen and oxygen could be permuted. Such 
permutation lead to 18 different 1,3-dipoles of either the propargylic-allenylic or of allyl type 
based on the valence-bond theory.60 A 1,3-dipole is a neutral species that has a princip le 
canonical resonance form which can be represented by a separation of charge over three atoms.  
The structures of 1,3-dipoles reported till now are illustrated in Figure 1.16. 
In this group of reactions, a 1,3-dipole undergoes a [3+2] cycloaddition with a saturated bond 
forming a 5-membered heterocyclic ring (Scheme 1.13). The pioneering work of Huisgen on 
1,3-dipolar cycloadditions resulted in 94 full papers, 109 communications and 28 review 
articles (as of 1994) as mentioned in Huisgen’s autobiography.61 On present day, more than 
1240 references related to 1,3-DC can be found by Scifinder search. It has had a highest impact 
on heterocyclic chemistry as it offers a powerful tool for the construction of 5-membered 
heterocycles, finding applications in various scientific disciplines including, synthetic organic 
22 | P a g e  
 
chemistry, dendrimer and polymer chemistry,62,63 material sciences,64 bio-conjugation,65,66 and 
medicinal chemistry.49,67 
 
Scheme 1.13 Typical representation of a 1,3-dipolar cycloaddition reaction 
Given their importance in organic chemistry,49 numerous theoretical studies have been 
undertaken to rationalise the reactivity and selectivity of 1,3-dipolar cycloaddition reactions.  
Even though centuries has passed since their first description, there is still an ongoing debate 
on whether 1,3-diplar cycloaddition reactions have a concerted or a stepwise mechanism. 
Huisgen argued in favour of a concerted process (sometimes can be asynchronous) based on 
kinetic and stereochemical results, along with substituent and solvent effects.68,69  
The lack of rate difference between alkene and alkyne dipolarophiles and the lack of solvent 
effect on the reaction, led Firestone to postulate a stepwise syn-diradical mechanism.7 0  
Firestone argued that first one σ-bond is formed preferentially and then the resultant diradical 
intermediate cyclises prior to bond rotation and thus retain the observed stereochemistry. In 
2008, Houk et al. carried quantum chemical calculations to compare concerted vs stepwise 
transition states and concluded that concerted pathways are favoured over stepwise.7 1  
Although, some cases do exist where stepwise mechanisms precede over the concerted 
pathways. 
Many theories for the mechanism of 1,3-dipolar cycloaddition have been proposed recently 
based on computational studies such as the Transition state distortion theory71 and unified 
reaction valley approach (URVA).72 The transition state distortion theory suggests that a 
significant distortion of the 1,3-dipole geometry would be needed to achieve the TS geometry 
of maximum overlap. Calculations of the distortion energies and the bond angle change of 
dipoles and dipolarophiles revealed that the majority of the transition state distortion energy 
(∼80%) arised from deformation of the 1,3-dipole due to angle change, whereas the 
dipolarohile account for 20% of the total distortion energy. Whereas the URVA studies suggest 
that the mechanism is determined early in the van der Waals range where the mutual orientation 
of the reactants decides on charge transfer, charge polarization, the formation of radicaloid 
centers and the asynchronicity of bond formation. 
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Figure 1.16 Structures of the 1,3-dipoles – propargyl-allenyl type and allyl type 
Early examples of Husigen 1,3-dipolar cycloaddition 
Some of the earliest examples of 1,3-dipolar cycloaddition involve nitrile imines, nitrile ylides 
and azomethine ylides as the 1,3-dipoles. Huisgen carried out the reactions of the 1,3-dipoles 
with suitable dipolarophiles like alkene, alkyne, imine, carbonyl (C=O), thiocarbonyl (C=S) 
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and nitriles to form the corresponding five membered heterocycles.60,73 The cycloaddition of 
nitrile imine derived from 70 with various dipolarophiles is depicted in Scheme 1.14. With 
alkenes and alkynes, nitrile imine forms pyrazoline (72) and pyraozle (73). It forms 
oxadiazoline (76), thiadiazoline (78) and triazole (80) with benzaldeyde, thiocarbonyl 
compounds and nitriles respectively. 
Scheme 1.14 1,3-dipolar cycloadditions of nitrile imine with various dipolarophiles 
Similarly, nitrile oxides have been generated in situ and reacted with dipolarophiles like alkene, 
alkynes to give isoxazoline and isoxazole respectively. Cycloadditions with C=O and C=S and 
C=N and C≡N dipolarophiles gave dioxazole, 1,4,2 oxathiazole, 1,2,4-oxadiazoline and 1,2,4-
oxadiazole respectively.60 A direct application of the dipolar cycloaddition is well-represented 
in the synthesis of the anti-inflammatory drug Celecoxib (containing pyrazole), which was 
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obtained by a cycloaddition between a nitrile imine and an enamine.74 The regioselective issues 
in its synthesis by carbonyl condensation route was overcome in this case. 
FMO of [3+2] cycloaddition 
While the debate was ongoing if the cycloadditions were concerted or followed a diradical 
mechanism, FMO (Frontier Molecular Orbital) theory provided a rationale for the observed 
reactivity and regioselectivity. In the FMO approach, the energies of the highest occupied and 
lowest unoccupied molecular orbitals (HOMO and LUMO) of the 1,3-dipoles and the 
dipolarophiles were calculated, together with the molecular orbital (MO) coefficients of the 
reacting centers.  
HO orbital energies are derived from ionization potential data obtained by photoelec tron 
spectroscopy, the value if which is negative of the orbital energy (Koopman’s theorem). LU 
orbital energy is the negative of electron affinity of molecule, and are also calculated from the 
reduction potential, charge transfer energies or sometimes UV spectral data.75  
Sustmann suggested that as the two addends start to approach each other, their orbitals (HOMO 
and LUMO) begin to interact and orbitals of suitable symmetry are formed.76 The stabilisa t ion 
of the MO is a direct function of the energy gap between the two frontier orbitals: lesser the 
energy gap, more the stabilisation. The energy gap of the interactions [HOMO(1,3-
dipole)/LUMO(dipolarophile) and LUMO(1,3-dipole)/HOMO(dipolarophile)] are compared, 
and the FMO interaction corresponding to the lower value is presumed to play the dominant 
role (Figure 1.17). 
Figure 1.17 FMO interaction of 1,3-dipoles with dipolarophiles76 
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First order perturbation theory was used to predict the effect of the substituents on the orbital 
energies. Electron-withdrawing substituents lower the energy and electron-donating 
substituents increase the energy. An analysis of the energy diagrams of the FMO indicated that 
the reactivity increased as the dipole HOMO was raised and dipole LUMO was lowered. 
Based on dominant FMO interaction and the direction of charge transfer, Sustmann classified 
1,3-dipolar cycloaddition into three types76 (Figure 1.18): 
Type 1: HO controlled  
In Type I, the smallest FMO gap exists between dipole HOMO and dipolarophile LUMO. 
Nucleophilic dipoles (like diazomethanes, nitrile imines, nitrones, azides and other ylides) with 
high lying HOMO orbitals and electrophilic dipolarophiles with low lying LUMO are involved 
in the cycloaddition leading to a cycloadduct. Thus electron-donating groups on dipole and 
electron-withdrawing groups on dipolarophile lead to an increase in reactivity by lowering the 
energy gap between the two frontier orbitals. 
Type 2: HO-LU controlled 
In Type II, the FMO gaps are equivalent between dipole HOMO-dipolarophile LUMO and vice 
versa. A dipole of this class is referred to as a HOMO-LUMO controlled dipole or an 
ambiphilic dipole, which includes nitrile imide, nitrone, carbonyl oxide, nitrile oxide, and 
azide. Increase in either frontier orbital energies will accelerate the reaction. For example, 
azides react with various electron-rich and electron-poor dipolarophile with similar 
reactivities.77 
Type 3: LU controlled 
In Type III, smallest FMO gap exists between dipole LUMO and dipolarophile HOMO. 
Electrophilic dipoles like ozone and dipolarophiles containing electron-donating groups bring 
the gap closer. Substituents which lower the dipole LU energy or raise the dipolarophile HO 
energy accelerate LU controlled reactions. 
The above classification is based on the simplified FMO model which only takes the frontier 
orbital energies into account, but a complete perturbation expression involves other factors like 
repulsion factors (closed shell and coulomb constants) and charge transfer stabilisation. 7 8  
However, the use of only frontier orbitals have been well supported by experimental results.  
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Figure 1.18 Classfication of 1,3-dipolar cycloaddition according to the FMO inetractions 
The regioselectivity in cycloaddition is dependent on the terminal coefficients of the frontier 
orbitals.75,78 The CNDO/2 calculated frontier orbital coefficients indicate that the HOMO of 
almost all 1,3-dipoles have larger values at the anionic terminus ‘c’ whereas, LUMO has the 
largest values at the neutral terminus ‘a’ (Figure 1.19). Exceptions include nitrile ylides and 
symmetrical dipoles. The preferred regio-isomer would be the one in which the atoms with the 
larger terminal coefficients (a-d and c-e) of the frontier orbitals interact. Case (a) would be 
more stabilised than case (b), resulting in stronger interaction and leading to cycloaddit ion 
products (Figure 1.19).                                              
 
Figure 1.19 Schematic representation of greater stabilisation of transition state (a) than (b) 
due to different coefficient magnitudes 
In the dipole-HOMO controlled cycloadditions, products with substituent remote from the 
anionic terminus ‘c’ are obtained (4-substituted) in case of electron deficient and conjugated 
dipolarophiles (larger coefficient at unsubstituted carbon ‘d’ in LUMO). Whereas in case of 
electron-rich dipolarophiles (larger coefficient at substituted carbon ‘e’), 5-substituted products 
are obtained (Scheme 1.15a and 1.15 b; Figure 1.20) 
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Scheme 1.15 Regio-selective products formed in 1,3-dipolar cycloaddition78 
 
Figure 1.20 FMO interactions and the role of orbital coefficients in imparting regio-
selectivity  
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Larger coefficients for the neutral terminus ‘a’ being present in the LUMO-dipole, 5-
substituted products are obtained in dipole-LUMO controlled cycloaddition for all 
dipolarophiles (electron-rich, conjugated and electron-deficient which have larger coefficients 
at unsubstituted carbon ‘d’) (Figure 1.20). 
Hence, all 1,3-dipoles react with electron-rich dipolarophiles to give 5-substituted products, 
whereas for conjugated and electron-deficient dipolarophiles, the regiochemistry depends on 
the dominant frontier orbital interaction (dipole-HO or dipole-LU controlled) (Scheme 1.15a, 
1.15b and 1.15c) 
Azide-alkyne Huisgen cycloaddition 
A 1,3-dipolar cycloaddition between an azide and a terminal/internal alkyne to give a 1,2,3-
triazole, called the Huisgen azide-alkyne cycloaddition was one of the earliest examples of the 
use of azide as a 1,3-dipole. The reaction, first realised by Huisgen,79 gave a mixture of 1,4-
substituted and 1,5-subsitituted triazoles after heating the starting materials neat at 98 oC for 
18 h  (Scheme 1.16). Since the difference in HOMO-LUMO energy levels for both azides and 
alkynes are of similar magnitude, both dipole-HOMO- and dipole-LUMO-controlled pathways 
operate in these cycloadditions leading to a mixture of regioisomeric 1,2,3-triazole products. 
 
 
Scheme 1.16 Cu(I) and Ru(II) catalysed azide-alkyne click reactions 
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Copper-catalysed Azide-Alkyne Cycloaddition (CuAAC) 
A notable variant of the Huisgen cycloaddition was the Cu(I) catalysed variant in which the 
organic azides and terminal alkynes are united to afford 1,4-regioisomers of 1,2,3-triazoles as 
sole products (Scheme 1.10). This reaction was first reported in 2002 independently by Morten 
Meldal80 and K. Barry Sharpless group.81 The reaction goes through a stepwise mechanism and 
is termed as Copper (I)-catalysed Azide-alkyne Cycloaddition (CuAAC). Although Cu(I) such 
as cuprous iodide and cuprous bromide have been used, the most common method involves the 
in situ generation of Cu(I) by using a mixture of copper (II) sulfate and a reducing agent like 
sodium ascorbate in water.82 It is considered one of the best click reactions,83 with an enormous 
rate acceleration of 107 to 108 compared to un-catalysed 1,3-dipolar cycloaddition. It succeeds 
over a broad temperature range, insensitive to aqueous conditions and a pH range over 4 to 12, 
and tolerates a broad range of functional groups. Pure products are often isolated by simple 
filtration without the need for column chromatography.  
After the introduction of CuAAC in 2002, numerous advances in this reaction have taken place 
and have found application in bioconjugation66 (labelling), material science84 (polymers, 
dendrimers) and drug discovery.67,85,86 
The mechanism for the CuAAC had been elusive until recently owing to the challenges 
involved in the direct study of copper catalysis. The first mechanism proposed by Sharpless et 
al. involved a mononuclear copper complex as the reactive intermediate.81 Over a period of 
time, different experimental as well as theoretical studies pointed towards possible involvement 
of poly nuclear copper (I) intermediates in the reaction.87–89 In 2013, Fokin et al. reported a 
direct evidence of a dinuclear copper intermediate (III) through calorimetry and crossover 
experiments90 (Scheme 1.17). 
Through the heat-flow calorimetry experiments performed on a representative cycloaddit ion 
process, they found that monomeric copper acetylide complexes were not reactive towards 
azide unless an exogenous copper catalyst was added. Further involvement of the role of two 
copper atoms was proved through cross-over experiments with an isotopically enriched 
exogenous copper source.  
A catalytic cycle of CuAAC was proposed90 - activation of σ-bound copper acetylides (I) (both 
terminal and formally internal) by a weak and reversible п-interaction with a copper centre. 
The σ-bound copper acetylide II bearing a п-bound copper reversibly co-ordinates the azide, 
forming the complex III (Scheme 1.17) 
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Scheme 1.17 Fokin’s proposed catalytic model for CuAAC with two copper atoms90 
Nucleophilic attack at N-3 of the azide by the β-carbon of the acetylide forms the first covalent 
C-N bond which leads to an unusual 6-membered copper metallacycle IV. Ring contraction to 
a triazolyl-copper derivative V is followed by protonolysis which delivers the triazole product 
and closes the catalytic cycle (Scheme 1.17). 
The dinuclear complex of п, σ -bis copper acetylide II was qualified as a non-isolable and 
highly interactive intermediate by Fokin and group. Although in 2015, Bertrand and 
colleagues91 were successful in isolating the intermediate (1Cu2a; Scheme1.18) by stabiliz ing 
it with cyclic (alkyl)(amino) carbenes (CAACs) ligand. They also isolated the mononuc lear 
copper (I) intermediate (1Cua; Scheme 1.18) and an unprecedented bis-metallated triazole 
complex (2Cu2a) as key intermediate in CuAAC (Scheme 1.18). 
 
The isolation of the mononuclear complex and experimental kinetic studies indicate that both 
mono and di nuclear complexes promote the cycloaddition, although the di nuclear complex 
1Cu2a is the kinetically favoured pathway. The treatment of azide with all the three complexes, 
found an acceleration in the rate of reaction with both di-nuclear complexes as compared to the 
mono-nuclear complex. Although the reactions promoted by 1Cu2a and 2Cu2a proceed at the 
same rate, a short initiation period is observed with 1Cu2a, which is concomitant with the 
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formation of 2Cu2a; after the initiation period, the concentration of 2Cu2a remains constant over 
the course of the catalytic reaction, indicating that 2Cu2a is the resting state of the catalytic cycle 
(Scheme 1.18). 
 
Scheme 1.18 Bertrand’s mono and bis-copper pathways for CuAAC91  
The use of the ligand as well as the use of trifluoromethane sulfonate anion as the counter ion 
was responsible in forming a stable and isolable complex of both 1Cu2a and 2Cu2a. The alkyne 
serves as the proton source for the demetallation of 2Cu2, which regenerates the п,σ-bis(copper) 
acetylide of type 1Cu2, leaving out complexes of type 1Cu from the catalytic cycle. Thus, the 
regioselective formation of 1,4-disubstituted triazole was attributed to the mechanism 
involving the role of 2 copper atoms working in tandem.  
Ruthenium-catalysed Azide-alkyne Cycloaddition (RuAAC) 
The 1,5-regioisomer of 1,2,3-triazole was obtained as the sole product when ruthenium (II) was 
used as a catalyst, giving rise to the term ruthenium-catalysed azide-alkyne cycloaddit ion 
(RuAAC)92 (Scheme 1.10). As a result of the pioneering work of Fokin and colleagues, it was 
found that [Cp*RuCl] complexes, such as Cp*RuCl(PPh3)2, Cp*RuCl(COD) and 
Cp*RuCl(NBD), were among the most effective catalysts. The catalytic activity of the 
ruthenium complexes, was attributed to the pentamethyl cyclopentadienyl ligands owing to 
their ability to stabilise the higher formal oxidation states of the metal centre. The complexes 
also promote the cycloaddition reactions of organic azides with internal alkynes, providing 
access to fully-substituted 1,2,3-triazoles, which was not observed with copper catalysts.  
33 | P a g e  
 
Unlike CuAAC, where copper acetylides were involved, the neutral [Cp*RuCl] was found to 
be the catalytically active species in RuAAC with no detection of ruthenium acetylides in the 
reaction. The chloride ion is found to have a prominent role as ruthenium catalysts with Br and 
I species were less active and the [Cp*Ru]+ cationic complexes were completely inactive. 
The mechanism92 of the RuAAC is depicted in Scheme 1.19. The displacement of the spectator 
ligands in 1Ru (step A) by azide and alkyne produces the activated complex 2Rua, which is 
converted, via the oxidative coupling of an alkyne and an azide (step B), to the ruthenacyc le 
3Ru. This step controls the regioselectivity, in which the new carbon-nitrogen bond is formed 
between the more electronegative (and less sterically demanding) carbon of the alkyne and the 
terminal electrophilic nitrogen of the azide. 
Alkynes with a H-bond donor group (propargylic alcohols and amines) provided exclusive 
regioselectivity owing to the strong H-bond between alcohol/amine and the Cl- ligand on 
ruthenium. The new bond always formed between the β carbon of the alkyne and the termina l 
N2 of the azide. 
 
Scheme 1.19 Proposed catalytic cycle for RuAAC92 
DFT studies were carried out to ascertain the energy of different possible activated complexes 
of ruthenium with azide and alkyne (Figure 1.21). Out of the four different possible complexes 
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2Rua, 2Rub, 2Ruc, 2Rud, DFT calculations favoured 2Rua, with the azide co-ordinated to the 
metal through the proximal nitrogen (N-1) and the alkyne through the β-carbon. The 
nucleophilic attack of the alkyne on the terminal nitrogen of the azide (oxidative coupling) 
leads to the ruthenacycle 3Ru.   
 
Figure 1.21 Structures and computed energies of activated complexes92 
The metallacycle intermediate 3Ru then undergoes a rate-determining reductive elimina tion 
(step C) releasing the aromatic triazole product and regenerating the catalyst (step D) or the 
activated complex 2Rua. Extensive studies by Fokin et al.92 indicate that the regioselectivity in 
RuAAC is determined by the oxidative coupling step, involving nucleophilic attack of the 
activated alkyne at the electrophilic terminal nitrogen of the azide. 
In situ 1,3-dipolar cycloadditions 
Dipolar cycloadditions of the 1,3-dipoles with in situ generated dipolarophile have been of 
recent interest. In the development of novel synthetic methods for high through put synthes is, 
protocols which are reliable, efficient, precludes the use of too many reagents and generate 
inoffensive byproducts are quintessential.67 In this regard an efficient coupling technology of 
in situ generated short lived reactive species utilizing single reagent are the best bargain. In this 
respect, a series of aryne click reactions have been developed with dipoles like nitrile oxides, 
nitrile imines and azides to give benzisoxazoles (85), 1H-indazoles (86) and benzisoxazo les 
(87) respectively (Scheme 1.20).93 Both arynes and the 1,3-dipoles are generated in a single-
pot using fluoride ion sources like CsF and TBAF, which on cycloaddition yield the 
cycloadducts 85-87. 
Thus, cycloadditions particularly 1,3-dipolar cycloadditions provide a great synthetic route 
towards various 5-membered heterocycles. 
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Scheme 1.20 1,3-dipolar cycloaddition of in situ generated arynes and various 1,3-dipoles 
 
1.7 Cyanamides- Chemical History 
Cyanamide was first obtained by passing gaseous ammonia over cyanogen chloride in 1838.94 
Cyanamides are weak acids and basically feature a nitrogen atom bearing a nitrile group. The 
presence of the amino and the nitrile group provides cyanamides its unique duality as a 
‘nucleophile’ and ‘electrophile’. Also, cyanamide is known to exist in its two tautomeric forms-
cyanamide and carbodiimide, cyanamide form being the more predominant (Figure 1.22).95  
 
  
 
 
 
 
 
Figure 1.22 a) Cyanamide and its derivatives, b) tautomeric forms of cyanamide 
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1.7.1 Calcium Cyanamide 
Two chemists Frank and Caro, in their quest for sodium cyanide (used for extraction of gold), 
started studying the absorption of nitrogen by carbides. They heated barium and calcium 
carbide and found that both the carbides absorbed nitrogen on heating giving barium cyanide 
and calcium cyanamide (identified later in 1898 by Rothe, equation 1, Scheme 1.21). They 
filed a patent for this process in 1895 which came to be known as the Frank Caro process.96  
 
  
 
 
Scheme 1.21 Synthesis of calcium cyanamide and its reaction with water  
The accidental discovery of calcium cyanamide lead to its use as a fertiliser, when Caro 
observed that calcium cyanamide in presence of water releases ammonia in the soil (equation 
2, Scheme 1.21). Industrial production of calcium cyanamide was started in 1907, with a new 
refined process which lowered the operating temperature to 700-800 oC. The production 
reached 4000 tons/ year in 1908, and was a great success, such that Frank Washburn acquired 
the exclusive American and Canadian rights for the process. It became the beginning of one of 
the biggest chemical industry- American Cyanamid. Calcium cyanamide was further utilised 
for the production of ammonia, which was oxidised to nitric acid (nitrates used as explosives), 
the demand for which increased during the World War I. 
Cyanamide and Nitrate Chemistry at War 
The importance of ‘Nitrogen Fixation’ in soil was realised late (1886), when the only options 
for fixed nitrogen were bird and animal wastes which contained nitrates. One of the 
largest sources of this fixed nitrogen was found in Chile. Over thousands of years, the deposits 
of bird droppings, a vast number of which nested on the coast of Chile resulted in the "natural" 
deposits called "Guano". A huge industry developed to supply this Chilean saltpetre (sodium 
nitrate) to the rest of the world, which came to be entirely dependent on the Chilean 
resource for fertilisers and high explosives. 
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Figure 1.23 Historical timeline of calcium cyanamide 
Concerns over the depletion of Chilean reserves and its monopoly stimulated European 
scientists to explore the direct fixation of atmospheric nitrogen. The challenges of nitrogen 
fixation, and its implications were intricately expressed by Ostwald in 1903, ‘The significance 
for bound nitrogen…is especially high for both war and peace…Without saltpetre the best 
military is almost helpless…Were war to break out today between two great powers, one of 
which was able to prevent the export of saltpetre from Chile’s few harbours, that ability alone 
would render its opponent almost incapable of fighting”. 97 The solution of this nitrate problem 
seemed to be a strategic necessity, apart from its use in fertiliser. 
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Nitrates were essential to production of modern explosives mainly trinitrotoluene (TNT) and 
picric acid. In 1903, Berkeland and Eyde devised an electric arc which stimulated lightening, 
enabling the capture of atmospheric nitrogen in the form of nitric acid. It was reacted with 
limestone to form calcium nitrate which was used as a fertiliser (Figure 1.24). In 1904, Haber 
started working on the high pressure synthesis of ammonia from its elements. Bosch was 
responsible for the scaling up, and he set it up on an industrial scale, and the process came to 
be known as ‘Haber-Bosch ammonia process.’98 Production of ammonia started in 1913, which 
was converted to ammonium sulphate to be used as a fertiliser.  
Figure 1.24 Cyanamide and World War I 
The important conversion of ammonia to nitric acid gained importance for the use in 
explosives. In 1914, Frank and Caro developed a process for oxidation of ammonia using 
platinum catalysts. Synthetic ammonia, and oxidation of ammonia to nitric acid would not have 
gained much importance, unless for the beginning of the Great War (World War I). The 
restriction of the Chilean saltpetre by the British forces, forced the German government to 
upscale the production of nitrogen products, wherein all the cyanamide, Norwegian nitrogen 
as well as Haber-Basch ammonia process were expanded and production was carried out on a 
large scale. At the end of the war, Germany was producing more than 500,000 tons of nitrogen 
products annually, more than one-third of it coming from the cyanamide process, which was 
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to become the basis of the fertiliser industry. Thus, the World War and the role of nitrates, 
accelerated the productions of cyanamide and other nitrogen compounds.99  
Calcium Cyanamide: Role in Agriculture and Chemical Industry 
The importance of calcium cyanamide is that it was the first fully synthetic fertiliser ever 
achieved. Calcium cyanamide is used in agriculture mainly as a slow-release nitrogen fertiliser, 
which also exhibits beneficial side-effects against soilborne plant diseases, slugs and 
germinating weeds. The fertiliser is broken down by soil moisture into lime and free cyanamide 
which provides its herbicidal and fungicidal effects. The cyanamide is further converted to 
ammonia through urea by the soil microbes. A second pathway leads to dicyandiamide which 
acts as the nitrification inhibitor of the soil, wherein the conversion of ammonia into nitrate is 
slowed down for several weeks, thus preventing the leaching of nitrogen into the soil (Scheme 
1.22).100 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.22 The mechanism of action of calcium cyanamide as a fertiliser 
Calcium cyanamide is also used to control animal pests on pasture, protection against gastric 
and intestinal parasites in grass, and salmonella in sewage. In present times, despite the 
availability of different fertilisers, calcium cyanamide is still widely used. This can be 
attributed to some peculiar properties, one being its high alkalinity, which is useful in acidic 
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soils or as a neutraliser with acidic fertilisers. Its ability to speed the equilibration in mixed 
fertilisers (from years to days) also makes it an important constituent for fertilisers.  It is also 
effective as a scrubbing agent for removal of nitric oxide gases from waste gases.100 
Figure 1.25 Derivatives of calcium cyanamide 
Apart from its use as a fertiliser and herbicide, calcium cyanamide has been used for production 
of different chemicals, largest being the dimer preparation- dicyandiamide, which is further 
polymerised to get the trimer melamine (Figure 1.25). Melamine has been used in plastic resins 
for its strength, hardness, moisture and temperature stability. Most of these resins are used in 
molding compounds, but are also used to provide strength to paper, shrinkage control and 
crease resistance to wool and rayon, and in water-resistant laminates.100  
Other commercial derivatives include cyanide derivatives, mainly calcium and sodium 
cyanide, which finds its use in extraction of gold in mines. Acidification of calcium cyanide 
yields hydrocyanic acid which is an important starting material for different chemica l 
derivatives. One of the important being acrylonitrile, which is made by condensation of 
ethylene oxide to produce ethylene cyanohydrin, which is dehydrated to acrylonitrile (Figure 
1.25).100 It finds a wide use in the manufacture of synthetic rubber by copolymeriation with 
butadiene. Many other new uses are being explored, one being in the production of wool-like 
synthetic fibres.  
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Biological significance of Cyanamide 
Cyanamide is produced naturally, by the plant- Hairy vetch (Vicia villosa) which produces it 
from inorganic nitrates.101 It is an aldehyde dehydrogenase inhibitor, and blocks ethanol 
metabolism at acetaldehyde stage,102 leading to toxic acetaldehyde syndrome on alcohol 
consumption, causing unpleasant symptoms in the alcohol-addict.103 
It is also an important reagent in prebiotic chemistry, detected in interstellar clouds. Stanley 
Miller, in 1953 showed how amino acids could have formed on earth by sparking a gas mixture 
of methane, ammonia, water and hydrogen.104 However, the formation of peptides from these 
amino acids proved a mystery. He conducted some experiments in 1958 to study the 
polymerisation of amino acids under simulated early earth conditions, however the analys is 
was never reported. The boxes of unanalysed experimental prebiotic samples were passed on 
to Jeffrey Bada, his second graduate student recently. These samples contained a potential 
prebiotic condensation agent- cyanamide. A recent analysis of these samples105 prove that the 
addition of cyanamide while sparking the same mixture resulted in amino acids, dipeptides and 
diketopiperazines, thus indicating the importance of condensation agents like cyanamide in the 
origin of life. The studies indicated the formation of dicyandiamide formed by cyanamide 
dimerisation (in the simulated conditions) and its role as a prebiotic condensing agent, which 
could polymerise amino acids and lead to complex molecules like peptides. It has also been 
suggested to be involved in the synthesis of activated pyrimidine ribonucleotides and 
deoxynucleotides.106 
Cyanamide finds use mainly in the agrochemical and pharmaceutical industry. It is also one of 
the key raw material for many herbicides, fungicides and insecticides like Amitr io l, 
Bensulfuron, Pyrimethanil, etc. and anti-ulcer drug Cimetidine.100 Moreover, many antivira l 
and anticancer drugs with pyrimidine and purine moiety are based on cyanamide and guanid ine 
chemistry.  
1.7.2 N-Substituted cyanamides 
N,N-Disubstituted cyanamides and N-monosubstituted cyanamides with the NCN functiona lity 
provide a means for the various organic transformations at both the amino and the nitrile centre. 
Various advances have been made in the synthetic routes towards the synthesis of N-substituted 
cyanamides as well as their utilisation in heterocycle synthesis in the last two decades.107,108 
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1.7.2.1 Synthesis of N-Substituted Cyanamides 
Early Synthesis 
One of the earliest examples for the synthesis of dialkylcyanamides was based on the alkylat ion 
of sodium or calcium cyanamide in aqueous ethanol (1924).109 The easy accessibility of 
calcium cyanamide salt then, made this an obvious choice of synthesis, however it was 
laborious and suffered from low yields. After cyanamide became commercially available in 
1965, direct alkylation of cyanamide were carried out under phase transfer catalysis,110 the 
simple procedure making it a promising method for industrial applications.  
Scheme 1.23 Synthesis of disubstitued cyanamide from calcium cyanamide 
However, this method was only applicable to disubstituted cyanamide synthesis, since 
monoalkylated cyanamides are more nucleophilic and acidic than cyanamide, thus making it 
difficult to stop the reaction at monoalkylation stage. As an exception to this, Sharpless 
reported the synthesis of monoalkylated cyanamide by the treatment of cyanamide potassium 
salt with tosylate in toluene at 90 oC (Scheme 1.24).111 
 
 
 
Scheme 1.24 Synthesis of mono-substituted cyanamide from potassium cyanamide 
Cyanation of amines 
The most commonly used reagent for electrophilic cyanation is cyanogen bromide (BrCN). 
Cyanogen bromide is toxic and must be handled with caution. The reaction of cyanation of 
amines follows the addition-elimination pattern, wherein the first stage is the addition of 
cyanogen bromide to the amino group with the formation of a resonance stabilised cation (95’). 
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The latter is more electrophilic than cyanogen bromide, and it reacts with a second amine 
molecule giving the corresponding ammonium salt and monosubstituted cyanamide (96). It 
was first reported by Harrison and colleagues112 in 1976, and has been widely used since113,114 
(Scheme 1.25). Secondary amines also follow a similar pattern giving a disubstituted 
cyanamide and ammonium salt. 
  
 
 
 
 
 
 
Scheme 1.25 Harrison’s methodology for the cyanation of primary amines. 
The ammonium salt formed are capable of reacting with cyanamide to give guanidine, hence 
the reactions are performed in cooling conditions along with a hydrogen bromide acceptor like 
Na2CO3 (or DMF, NaOH, etc.) to prevent further reactions of cyanamide.  
The reaction of tertiary amine with cyanogen bromide was reported in 1900 by Braun, and is 
called the von Braun reaction.115 Unlike primary and secondary amines, the reaction of 
cyanogen bromide with tertiary amines (97) takes place through the intermediate formation of 
N-cyanotrialkylammonium bromide (97’) which decomposes to disubstituted cyanamide (98) 
and alkyl bromide (Scheme 1.26). Unsymmetrical cyanamide could be obtained with the 
elimination of a more labile third substituent in the tertiary amine116 (for eg. Benzyl groups). 
Other electrophilic cyanating agents like 1-cyanoimidazole117 (99) and 2-cyanopyridazin-
3(2H)-one118 (100) have been reported as efficient reagents for cyanamide synthesis (Figure 
1.26). However, their preparation involves the use of toxic cyanogen bromide. Recently, an in 
situ generated electrophilic cyanating reagent for disubstituted cyanamides has been developed 
from bleach and trimethylsilylcyanide (TMSCN),119 which avoids the use of cyanogen bromide 
completely. The oxidation of TMSCN (101) by bleach is proposed to generate cyanogen 
chloride in situ which reacts with amine to give cyanamides.  
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Scheme 1.26 The von Braun sequence116 
Based on the fashion of hypervalent iodine compounds, which are very effective electrophilic 
group transfer reagents, the concept of hypervalent sulfur compounds was developed by 
Alcarazo group120 in 2015. The dihalo (imidazolium) sulfuranes were found to be isolobal to 
hypervalent iodine species, and also depict the key three centre four electron bond motive. 
These are readily prepared from thiourea, and give imidazolium thiocyanates in a single step 
by treatment with TMSCN. The imidazolium thiocyanate (102) is a shelf stable, easily scalable 
compound which was found to be an effective CN+ synthon for cyanation of both mono and di-
substituted amines (Figure 1.26).120 
Figure 1.26 Electrophilic cyanating agents for cyanation of amines 
Copper-promoted N-cyanation of sec-amines was achieved using CuCN by oxidative 
coupling.121 The procedure employs O2 as the oxidant along with CuCN, catalytic CuBr2, 
TMEDA (N,N’,N’, N’- Tetramethylenediamine) and Na2SO4 in CH3CN, and provides a diverse 
range of disubstituted cyanamides.  
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Desulfurisation of thioureas and isothiocyanates 
One of the earliest examples for desulfurisation of thioureas by iodate and bromate ions was 
achieved in 1932.122 Over the course of years, other oxidative desulfurizing agents like lead 
acetate,123 mercury and copper salts,124 (diacetoxyiodo)benzene (DIB),125 iodine,126 hydrogen 
peroxide,127 methylating agent (MeI) followed by a basic workup128 and brominating agent 1,2-
ethyllenepyridinium bistribromide (EDPBT)129 have been used to synthesise mono-substituted 
cyanamide from thioureas (Scheme 1.27). 
 
 
 
 
 
 
Scheme 1.27 Desulfurisation of phenylthiourea using different desulfurizing agents 
One pot-conversion of alkyl/ aryl dithiocarbamate salts (obtained by action of CS2 on amines) 
to cyanamides has been carried out using DIB and iodine separately in good yields125,126 
(Scheme 1.28). The oxidative desulfurisation of the in situ generated thiourea is the key step in 
the synthesis.  
 
 
 
 
Scheme 1.28 One-pot synthesis of cyanamide from a thiocarbamate salt 
Desulfurisation of isothiocyanates (106) has been carried out using a strong hindered base like 
sodium bis(trimethylsilyl) amide NaN(SiMe3)2.130 Aliphatic, aromatic, benzoyl and 
diisothiocyanate were converted into the corresponding cyanamide in good yields. The 
plausible mechanism proposed by the authors is as depicted in Scheme 1.29. It involves a 
nucleophilic attack by the base followed by 1,2-elimination to sila-carbodiimide (106”), which 
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leads to cyanamide upon desilylation (Scheme 1.20). Similarly, deoxygenation of 
isocyanates131 using the same base resulted in cyanamides in efficient yields. 
 
 
 
 
 
 
 
 
 
Scheme 1.29 One-flask transformation of isothiocyanates to cyanamides 
Dehydration of urea and amide oximes (Tiemann Rearrangement) 
Reactions involving direct dehydration of urea by the action of arenesulfonyl chlorides in 
pyridine was first carried out by Kurzer in 1949.132 It lead to substituted aryl-sulphonyl 
cyanamides as the main product (Scheme 1.30). It first forms the N-aryl-N-arylsulfonylurea 
(108) which upon dehydration in presence of arenesulfonyl chlorides yields the sulfonyl 
cyanamide (109) in 50-70% yields.133 
 
 
 
 
 
 
 
Scheme 1.30 Dehydration of urea to cyanamide with arenesulfonyl chloride 
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N-substituted cyanamides were synthesised by the Tiemann rearrangement of amidoximes with 
benzensulfonyl chlorides and DIPEA (Scheme 1.31).134 The mechanism was postulated as 
sulfonylation of the oxime to O-sulfonyl amidoxime, which rearranges (Tiemann 
rearrangement) upon the cleavage of the sulfonyl leaving group to give the N-substituted 
cyanamides in good yields.  
 
 
 
 
Scheme 1.31 Tiemann rearrangement of amidoximes to cyanamide 
1.7.2.2 Cyanamides in the construction of heterocycles 
[4+2] cycloaddition  
The C≡N bond of the cyanamide acts as a dienophile in [4+2] cycloaddition (hetero Diels-
Alder) reactions with 1,3-dienes.135 One of the examples being the addition of cyanamides (90) 
to acylketenes (114) to form 1,3-oxazin-4-ones (115).136 The acylketenes, being unstable are 
generated in situ by thermolysis of their precursors 111-113 (Scheme 1.32).136–139  
Scheme 1.32 Generation of acyl ketene and its cycloaddition with cyanamide 
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In contrast to classic Diels-Alder reaction, the [4+2] cycloaddition of cyanamides with dienes 
involves cycloaddition of electron-rich dienophiles with electron-deficient dienes.139 This 
inversion of electronic effects in the addends is observed in almost all the [4+2] cycloaddit ion 
of cyanamides.135 
Scheme 1.33 [4+2] cycloaddition of electron-rich cyanamide with electron-deficient dienes 
Another example includes the reaction of electron-poor 1,2,4-triazine140 (116) (containing 1,3-
diazine fragment) and 1,2,4,5-tetrazines141 (118) (2,3-diaza-1,3-butadiene fragment) with 
electron-rich N-substituted cyanamides to give 1,3,5-triazines (117) and 1,,2,4-triazines (119) 
respectively (Scheme 1.33). Thus, these characteristic reactions involving cyanamide are 
known as reverse diene synthesis (or [4+2] cycloaddition with inversion of electronic effects) . 
[3+2] cycloaddition 
The [3+2] cycloaddition of activated cyano compounds like alkyldicyanamides142 and 
heteroaryl cyanamides143 with various 1,3-dipoles is known in the literature.  
Nitrile oxides, nitrile imines and azides react at the cyano group of the cyanamides in a 1,3-
dipolar cycloaddition to give hetarylamino-1,2,4-oxadiazoles (122),144 hetarylamino-1,2,4-
triazoles (124)144 and 5-hetarylaminotetrazoles (126)145 (Scheme 1.34). 
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Scheme 1.34 [3+2] cycloaddition of heterocyclic cyanamides with different 1,3-dipoles142–145 
Dicyanamides react with the 1,3-dipoles nitrile oxide and azide, where the nitrile oxide returned 
quantitative yields of the oxadiazole product at room temperature, whereas the organic azide 
required heating for 70 hours for 60% yield (Scheme 1.35).142 
An intramolecular [3+2] cycloaddition between azides and cyanamides was reported by 
Sharpless111 in 2001. The 1,5-fused tetrazoles (133) were obtained in quantitative yields for 
dialkylcyanamides at 140 oC, whereas the monosubstituted arylcyanamides (132) returned 
good yields at just 60 oC (Scheme 1.36). 
 
 
 
 
 
 
 
Scheme 1.35 1,3-dipolar cycloaddition of dicyanamide with nitrile oxide and azides142 
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Scheme 1.36 Intramolecular cycloaddition of azidocyanamide (132)111 
Recently, Sharpless demonstrated the cycloaddition of dialkyl cyanamides with azides in water 
in presence of catalytic zinc salts. The role of zinc proved to be crucial in this cycloaddition as 
5-amino tetrazole (134) was obtained in good yields 146 (Scheme 1.37).  
 
 
 
 
 
 
 
Scheme 1.37 Cycloaddition of dilakylcyanamides with nitrones and azides using zinc 
catalysts 
Alternatively, zeolites like natrolite147 has been used as a heterogeneous, reusable catalyst for 
the cycloaddition of azide with aryl cyanamide. The cycloaddition of dialkyl cyanamides with 
nitrones was carried out by Kukushkin et al. using Zn(II)148 (Scheme 1.37) and platinum 
(PtCl2)149 catalysts to give 5-aminosubstituted 2,3-dihydro-1,2,4-oxadiazoles (136) in good 
yields. 
Cyclotrimerisation and [2+2+2] cycloaddition 
Monosubstituted cyanamides undergo spontaneous cyclotrimerisations to 1,3,5-triazines when 
stored without particular care or on heating.133 However, disubstituted cyanamides need 
activation to participate in cyclotrimerisation, using harsh reagents like triflic anhydride150 or 
bis (silyl-substituted)methyl lithium.151 The antitumour compound hexamethylmelamine 
(138)152 was prepared by cyclotrimerisation of dimethylcyanamide (137) using catalytic 
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[Al(NMe2)3]2 (Scheme 1.38).153 Mechanistic studies predicted the three insertions of 
cyanamide into the aluminium-nitrogen bonds followed by nucleophilic ring closure.  
 
            
 
 
 
 
Scheme 1.38 Aluminium-catalysed cyclotrimerisation of dimethylcyanamide153 
Cyanamides also participate in [2+2+2] cycloadditions with unsaturated partners. Cobalt-based 
catalysts154–156 are the most common catalysts used for this reaction. However, lately, iron157–
159 and iridium-based160 catalysts have been investigated as well, expanding the scope of these 
reactions.  
 
 
 
 
 
Scheme 1.39 Cobalt-catalysed cycloaddition of a cyanamide and bis-alkyne156 
The cycloaddition of cyanamides with symmetrical and disymmetrical diynes have been used 
for the synthesis of 2-aminopyridines, including macrocyclic products.161 A typical example of 
substituted 2- aminopyridine (140) synthesis obtained by cobalt-catalysed cycloaddition of 
cyanamide with a bis-alkyne (139) is shown in Scheme 1.39.156 
Metal-catalysed heterocyclisation  
Amino-substituted heterocycles have been synthesised by metal-catalysed heterocyclisation of 
cyanamides with suitable partners like amidoxime162 and alkynes.163 The reaction of aliphatic 
and aromatic amidoximes with the cyanamide (90) in the presence of catalytic amounts of 
ZnCl2 (Kukushkin et al., 2014)162 gave 5-amino 1,2,4-oxadiazoles (141, Scheme 1.40). 
Whereas this reaction involves the activation of cyanamide, the gold-catalysed 
heterocyclisation of cyanamides with alkynes163 does not involve cyanamide activation. The α 
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oxo gold carbenes generated in situ from the gold activated alkynes and 2-picoline N-oxide 
(oxidant), when trapped with cyanamide gave 2-amino-1,3-oxazoles (142) in good to excellent 
yields with broad substrate scope (Scheme 1.40). 
 
 
 
 
 
 
 
Scheme 1.40 Metal-catalysed heterocyclisation of cyanamides to give aminoheterocycles 
Cyanamides as radical partners 
Cyanamides have been used as radical partners for cascade synthesis of polycyclic quinazolines 
(Scheme 1.41).164 The bromo- and iodoaryl precursors 143 bearing an N-acylcyanamide moiety 
on treatment with tributyltin hydride and 2,2’-azobis(isobutyronitrile) efficiently underwent 
the desired radical cascade to 144. Synthesis of a natural alkaloid luotonin A was developed 
based on this strategy. Cyanamidyl radical has been recently used as an aminating species for 
the  synthesis of aryl-, heteroaryl primary amines from boronic acids.165 
Scheme 1.41 Synthesis of polycyclic quinazolines via radical cascades employing cyanamide 
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N-cyano N-phenyl-p-toluenesulfonamide (NCTS) as a cyanating agent 
N-cyano N-phenyl-p-toluenesulfonamide (145) (NCTS) is a bench stable, crystalline solid. It 
was first synthesised by Kurzer132 by treatment of p-toluenesulfonyl chloride with N-phenyl 
urea in pyridine (Scheme 1.30). 
                                                
 
 
 
 
Figure 1.27 N-cyano N-phenyl-p-toluenesulfonamide (NCTS) 
Since its initial synthesis in 1949, report on the use of NCTS has been very limited. However, 
in 2011 Beller and colleagues166 first reported the use of this reagent as a benign cyanating 
agent which was bench-stable and easy to handle. The bond dissociation energy of N–CN (ca. 
497 kJ mol-1) is generally lower compared with C–CN (ca. 555 kJ mol-1)167, favouring its use 
as a cyanating reagent. Moreover, N–CN bond cleavage of NCTS is believed to be further 
promoted and activated by both tosyl (Ts) and phenyl groups.168 Below are the few examples 
of the use of NCTS as a cyanating agent. 
Cross-Coupling of aryl-organometallic/ transition metal reagent with NCTS 
Cyanation of aryl organometallic reagents has been achieved with NCTS as the cyanating agent 
as illustrated in Scheme 1.42. Functionalised aryl halides166 (in situ generated Grignard 
reagent) unlike CH activation does not need transition metals, directing groups and high 
temperature for the cross-coupling reaction with NCTS. Arenediazonium tetrafluorobora tes 
(147) and aryl halides (148) undergo cyanation utilising Pd(II)/ Ag catalysis system in 
ethanol,169 whereas aryl boronic acid (149)170 coupling with NCTS is catalysed by rhodium 
catalysts (Scheme 1.42). The cyanation of arylzinchalides (150)171 has been accomplished by 
its reaction with NCTS in presence of cobalt catalysts. 
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Scheme 1.42 Cyanation of functionalised aryl groups using NCTS as the cyanating agent 
C-H activation with NCTS as the cyanating agent 
Direct cyanation through C–H bond functionalisation has been found to be an attractive 
strategy due to the conciseness of the synthetic route without pre-functionalisation.172 It 
provides a means for improving the step- and atom-economy in organic synthesis. Wang et al. 
(2011)173 first reported the C-H activation of indoles using lewis acid as the catalyst, wherein 
BF3. Et2O was used to activate the N-CN bonds in NCTS for the C-3 cyanation of indoles and 
pyrroles (Scheme 1.43) 
 
                 
 
 
Scheme 1.43 Lewis acid-catalysed cyanation of indoles and pyrroles using NCTS173 
The first use of transition metal for the direct cyanation of aromatic C-H bonds was reported 
by Yao Fu (2013)172 using oxime (O-methyl oximes) as the directing group (DG) and rhodium 
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as the catalyst. At the same time, Anbarasan (2013)174 also carried out a rhodium catalysed 
cyanation using pyridine as the DG (isoquinoline, benzoquinoline, pyrazine and pyrimid ine 
were also tolerated).  
 
Scheme 1.44 Transition-metal catalysed cyanation by C-H activation using NCTS 
Since then, various directing groups like dialkyl phosphoryl,175 azo-group (Jie Han et al., 
2014),176 CONHMe group (Wie Yi et al., 2015)177 and N-nitroso (Peipei Sun et al., 2015)178 
have been utilised for the cyanation of arenes and heteroarenes using Rh (III) as the metal 
catalyst and NCTS as the cyanating agent. The use of Rhodium has also been extended to the 
cyanation of indoles179 (C-2 cyanation with pyrimidine as DG), C-7 cyanation for indolines1 8 0  
with pivaloyl group as DG. Vinylic C-H cyantions was also carried out independently by 
Anbarasan et al.181 and Wei Su et al.182 who used pyridine and amides/oximes as the directing 
group respectively. 
 
Ruthenium-catalysed cyanation have been carried out recently using NCTS, as a cheaper 
alternative. Ackerman (2014)183 first reported the use of a Ru (II) catalyst for C-H cyanation of 
arenes and heteroarenes using amide as the directing group. It was followed by a recent report 
of C-H cyanation using 7-azaindole as the directing group.184  
 
Compared to noble metals, first-row transition metals are more earth-abundant, easily 
available, and inexpensive. As such, their use as catalysts attracts increasing attention, 
especially for C−H activation reactions.185 Ackermann et al. (2014)186 and Glorius et al. 
(2014)185 both carried out CH activation of arenes/Het-arenes using Co (III) carboxylate as the 
catalyst using pyridine as the directing group. Ackermann has signified the importance of the 
carboxylate assistance in the catalytic activity of the Cobalt catalyst. In another example, a 
cobalt catalysed C-C bond cleavage followed by cyanation was carried out in a single step 
using NCTS as the cyanating agent by Ozkal et al. (2015).187 
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Intramolecular cyanation 
Rh(I) catalysed intramolecular cyanation of styrene was carried out, wherein the Rh(I) metal is 
responsible for the N-CN bond cleavage as well as the C (sp2) H activation, which gives the 
product 157 in good to excellent yields (Scheme 1.45a).188 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.45 Intramolecular cyanation and amino-cyanation of alkenes 
Intramolecular aminocyanation of alkenes followed by cyclisation to synthesise indolines and 
tetrahydroquinolines using lewis acid 189 (Scheme 1.45b) and palladium/boron catalysts 190 
have also been carried out separately.  
 
NCTS in heterocycle synthesis  
NCTS has been further exploited for the synthesis of heterocycles. The reaction of NCTS with 
variously substituted aminophenols 160a and benzene-1,2-diamines 160b gave 2-
aminobenzoxazoles (161a) and 2-aminobenzimidazoles (161b) respectively (Scheme 1.46).191  
 
 
 
 
Scheme 1.46 Synthesis of 2-aminobenzoxazoles and 2-aminobenzimidazole using NCTS 
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Scheme 1.47 One-pot synthesis of 2-amino quinazolin-4(3H)-one using MCR strategy 
A novel multicomponent reaction (MCR) was developed by Raghunadh et al.192 for the 
synthesis of 2-amino 3-substituted quinazolinone derivatives from isatoic anhydride, amine 
and NCTS (Scheme 1.47). 
1.7.3 Conclusion 
The utilisation of N-substituted cyanamides in the construction of heterocyclic molecules has 
seen a rise in the past two decades, contributing a novel route towards heterocycle synthesis. 
A review of the cycloaddition reactions of the cyanamide (as described above) shows a major 
trend towards the utilisation of the nitrile group as a dipolarophile or reacting group in 
heterocycle synthesis. The reaction leads to an amino-substituted heterocycle in which the 
nitrile group forms a part of the heterocyclic ring, whereas the amide group RR’N remains 
intact as the amino substituent of corresponding heterocycle. It should be noted that the 
concurrent utilisation of both the amino and the nitrile segments of cyanamide has not yet been 
realised and remains unexplored. We envisaged that exploring this untapped area of cyanamide 
chemistry could be a new strategy towards heterocycle synthesis. 
1.8 Goal: Developing novel strategies for heterocycle synthesis 
using cyanamide chemistry 
Drug resistance has become a burden on public health, social, political and global economies. 
Recovery time is longer; imposing further stress on the patient, longer hospitalisation and the 
chance of spreading disease is even higher.193 As a result, available treatments against 
infections and tumours diminished, calling for more specific and sophisticated drugs.193,194 
Medicinal chemists are constantly trying to optimise the process of drug discovery by offering 
alternative procedures for lead hit identification.67,195,196 However, these processes have proven 
to be expensive, challenging and time-consuming. 
Traditionally, drug discovery involves identification of small bioactive molecules through 
high-throughput screening of compound collections (libraries) which involve either phenotypic 
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screening or biochemical assays.197,198 The success of such a screening endeavor inherently 
depends on the nature of the compounds forming the collection (libraries). In cases of well-
defined biological targets, the structure of a known natural ligand or knowledge of the target 
structure binding site is used to define the library compounds.199 Collections are also based on 
different derivatives of bioactive natural products. However, when the precise nature of the 
biological target is not known, a rational compound selection process is clearly not possible. 
In such cases, libraries produced by combinatorial type methods, which involve thousands to 
millions of compounds are screened to identify bioactive molecules against different isolated 
biological targets.199,200 
 
Most of the existing collection of compounds (libraries) are comprised of large numbers of 
structurally similar compounds. A general consensus has emerged that library size is not 
everything; library diversity, in terms of molecular structure and thus function, is crucial.196 –
198,201 The lack of structural diversity along with poor physicochemical properties in the  
commercial compound libraries have caused the current drug discovery process to slow down 
and more dependent on serendipitous observations.  
 
Heterocyclic structures play an integral part in the drug discovery due to their favourable 
characteristics (as described in section 1.2). Thus, in the present scenario, devising new 
strategies to generate libraries of molecules consisting of structurally diverse heterocyclic cores 
could contribute towards providing a solution to boost the stagnant drug discovery programs. 
  
Moreover, the synthesis of heterocycles is plagued by harsh conditions, prolonged reaction 
times and laborious procedures202 rendering such protocols less likely to be incorporated into a 
drug discovery program. Thus, versatile, efficient and high yielding reactions which avoid 
multi-step protocols are required. These problems could be overcome using the cyanamide 
chemistry, where the accessibility of the NCN linkage in a single moiety could lead to 
heterocycles in single-step protocols in an efficient manner.   
Moreover, the utilisation of the dual functionalities (nucleophilic amine and electrophilic nitrile 
centres) of the cyanamide in heterocycle synthesis, can provide a new route towards generation 
of diverse heterocyclic cores. In principle, a large library of compounds could be built by 
making use of few cyanamide derivatives and its cycloaddition with various 1,3-dipoles.   
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Chapter 2 
Cyanamides and their reaction with dipoles 
2.1 Hypothesis  
Cyanamides feature a Nitrogen-Carbon-Nitrogen (NCN) connectivity, which could provide an 
important framework for the construction of nitrogen-rich scaffolds. Also, the unique duality 
of cyanamides, which contain both electrophilic and nucleophilic centres has not yet been fully 
exploited.  Report by Oballa et al.1 reveals enhanced electrophilicity at the nitrile centre of the 
cyanamide, due to the unshared pair of electrons of the adjacent amino group, as supported by 
their density functional theory calculations. On the other hand the nucleophilicty of the amino-
N is reduced due to the conjugation of its unshared pair of electrons with the carbon-nitrogen 
triple bond. The reactivity of both these centres has been individually explored in a variety of 
reactions. As depicted in scheme 2.1, reactions at the nitrile group mainly involve nucleophile 
additions such as addition of water and amines to the cyanamides lead to substituted urea (168)2 
and guanidine (169) 3–5 respectively which are important building block 
Scheme 2.1 Explored and un-explored avenues of N-substituted cyanamide in synthesis 
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in organic synthesis. The reactions like, acylation of cyanamides take place at the amino group 
giving N-acyl and N-sulfonyl cyanamides6 (164, 165). Like secondary amines, monosubstituted 
cyanamides undergo nitrosation and halogenation reactions at the amino centre.7,8 However, a 
concomitant utilisation of both the reactions centres has not been thoroughly investigated. We 
envisaged that harnessing the intrinsic electro- and nucleophilic duality of cyanamides 
simultaneously could be utilised towards the construction of cyclic systems. This can be 
achieved by reacting with complimentary reactive partners like 1,3-dipoles 172 (eg. nitrile 
oxide and nitrile imine) as illustrated in Scheme 2.2. The present method would incorporate 
the cyanamide N1- nitrogen atom directly into the core of the ring while the nitrile (-CN2) 
forming the exocyclic imine, giving heterocyclic molecules like 1,2,4-oxadiazol-imines and 
1,2,4-triazol-3-imines. 
 
 
 
 
Scheme 2.2 Retrosynthetic analysis of the hypothesised new heterocyclic system 
1,3-dipoles like nitrile oxide, nitrile imine, nitrile sulfides and azides have very rich history and 
has been widely utilised for the synthesis of a variety of heterocyclic cores (section 1.6.2, Ch-
1). For example, the recent work from Moses9,10 and Larock's groups11 investigates the  
 
 
 
 
 
 
 
 
Scheme 2.3 Utilisation of 1,3-dipoles in cycloaddition 
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utilisation of these reactive species towards the synthesis of benzisoxazole, indazole and 
benzotriazole with in situ generated benzyne under one-pot methodology (Scheme 2.3).  
Development of a method where the NCN linkage of the cyanamides can be incorporated as a 
three atom-two centre dipolarophile like species, would give access to a number of novel 
heterocyclic scaffolds (Scheme 2.4). Further postfunctionalisation of these 1st generation 
scaffolds would lead to structurally diverse 2nd and 3rd generation scaffolds, which could help 
in creating a diverse collection (library) of molecules. Thus the concept of utilising cyanamide 
in: a ‘single-reagent—diverse-scaffolds’ strategy for generating a diverse library of 
compounds, avoiding unfavourable multi-step transformations offered a particularly attractive 
prospect for investigation. 
Scheme 2.4 Proposed use of cyanamide for construction of diverse heterocyclic cores 
Figure 2.1 illustrates a number of drugs comprising 1,2,4-oxadiazol-5(4H)-imines12 (177),   
1,2,4-oxadiazol-5(4H)-one (178), amidine (179) and 1,2,4-triazol-3-imine 13 (180) cores that 
could be readily realised starting from cyanamide like 90 and complementary dipoles like 
nitrile oxide and nitrile imine. In addition, cores such as oxadiazol-5(4H)-one (178) also serve 
as a useful precursor and protecting group for amidines,14 carboxylic acid15 and amide1 6  
bioisosteres. 1,2,4-oxadiazole-5(4H)-ones have also been used as prodrugs for anti-
thrombosis17 and peroxisome proliferator-activated (PPAR) delta receptor agonists indicated 
in the treatment of fatty acid metabolism and glucose utilisation disorders.18 1,2,4-
oxadiazolones have been previously synthesised from amidoximes by condensation with ethyl 
chloroformate,19 pentafluorobenzoylchloride,20 phosgene;21 by action of DCC with 
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phenylimino-triphenyl-phosphoran followed by acid hydrolysis22 and triphosgene-media ted 
cyclisation with hydrazido alcohols.23 The acid hydrolysis of 1,2,4-oxadiazole-5(4H)- imines 
(177) provides a new route for the synthesis of 1,2,4-oxadiazol-5(4H)-ones (178).  
Amidines (179) are pharmaceutically important cores,24,25 which have been indicated as 
potential agents for the treatment of Alzheimer’s disease,26 malaria,27  parasitic diseases,28  
neurological disorders, 29 platelet aggregation 30 and as serine protease inhibitors.31 They have 
also been utilised as useful precursors for the synthesis of various heterocyclic structures like 
quinazolines,32 pyrimidines,33 triazoles 34 and benzimidazoles.35  Apart from the traditiona l 
methods36-38 used, amidines have been recently synthesised by palladium(II)-catalysed 1,2-
carbopalladtion of cyanamides with aryltrifluoroborates39 and in another instance, aryl 
carboxylic acids. 40   
 
Figure 2.1 Representative examples of clinically important oxadiazolimine, oxadiazolone, 
triazolone and amidine containing pharmaceuticals 
There are very limited examples of cycloaddition protocols to the target cores, and these are 
mostly restricted to the use of symmetric carbodiimide substrates, leading to the N-aryl 
substituted products. In 1958, Partridge et al. first documented an isolated example of N-3,4-
triphenyl-1,2,4-oxadiazol-5(4H)- imine (184) synthesis from N,N’-diphenyl cabodiimides 
(183) and N-hydroxybenzamidine41 (182)  (Scheme 2.5). Later Huisgen reported42 a two-step 
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protocol to 1,2,4-oxadiazol-5(4H)- imine involving carbodiimide and triphenyl 
iminophosphorane.  
 
Scheme 2.5 Partridge synthesis of N-3,4-triphenyl-1,2,4-oxadiazol-5(4H)- imine 
The only known method of making a 1,2,4-oxadiazol-5(4H)- imine core was reported by Steren 
et al. in a patent literature.43 The stepwise method included a 1,3-dipolar cycloaddition of 
cyanamide (NH2CN) with nitrile oxide (121) to the 1,2,4-oxadiazole-5-amine (185), followed 
by isomerisation and an alkylation to yield the target imine product 187 (Scheme 2.6). 
 
Scheme 2.6 Steren synthesis of 1,2,4-oxadiazol-5(4H)-imine 
The key challenge to our hypothesis was the identification of appropriately substituted 
cyanamide derivatives that could participate in reaction with dipoles under mild and benign 
conditions. Alternatively, a precursor that could generate an anionic species, like [RNCN]¯, 
with enhanced reactivity at the nucleophilic amino centre would be ideally suited.  
During the early investigation towards a suitable cyanamide substrate and its reactivity, Zeng 
et al. reported the amino cyanation of benzyne 190 on reaction with phenyl cyanamide (104) 
(Scheme 2.7).44 The reaction offered support to our hypothesis on the simultaneous utilisa t ion 
of the electrophilic and nucleophilic centre to engage in a ring formation. Here, due to the 
intrinsic strain of the four membered ring 192 ultimately led to the cleavage of the N-CN bond 
to offer the amino cyanated final product 188. Though N-phenyl cyanamide (104) participated 
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in the reaction fairly easily, the long reaction time and stability of the starting material is 
discouraging. 
Scheme 2.7 Aminocyanantion of benzyne with phenyl cyanamide 
Amongst the other N-substituted cyanamides presently studied in literature, N-cyano-4-methyl-
N-phenylbenzenesulfonamide (145), also known as NCTS, seemed to be particularly attractive 
substrate to us. It is a shelf-stable crystalline solid, which can be synthesised easily in a single 
step from urea. Since its reintroduction by Beller et al., in 201145 it has found use as an effective 
and benign electrophilic cyanating agent. However, its use as cyanating reagent involves the 
loss of a huge part of the reagent i.e sulphonamide 193 as a waste by-product (Scheme 2.8).  
Thus, despite its use in a variety of reactions (as discussed in chapter 1), a strategic and atom 
economic utilisation of the NCN linkage into the core framework of heterocycles is yet to be 
thoroughly explored.  
 
 
 
 
 
Scheme 2.8 N-Cyano-4-methyl-N-phenylbenzenesulfonamide (NCTS) as electrophilic 
cyanating agent 
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Further, N-cyano-4-methyl-N-phenylbenzenesulfonamide (145) also offers us an appropriately 
substituted cyanamide which can be demasked to offer the proposed cyanamide anio n 
[RNCN]¯. Sulfonyl functionalities such as benzenesulfonyl, toluenesulfonyl and 
methylsulfonyl are well documented protecting groups for amino groups, due to their high 
stability, ease of formation and simple removal.46 N-Desulfonylation is usually accomplished 
using a variety of methods ranging from- a) dissolving metal reductions (Li or Na) in ammonia,  
46 b) single electron transfer reagents like sodium napthalenide,47a Na-Hg, n-Bu3SnH; 47b c) 
reducing agents  like L-Selectride, Red-Al; 46 d) electrolysis; 48 e) photolysis; 49 f) bases like 
NaOH/KOH (harsh conditions) 50 and  Cs2CO3 (milder conditions); 51 g) fluoride sources like 
KF on alumina52 and tetrabutyl ammonium fluoride (TBAF) 53a-c. However, the most 
commonly used methods include the use of base and fluoride sources,54 which have been 
widely used for the desulfonylation of N-sulfonyl hetero-aromatic compounds as well as N-
sulfonyl amines (Scheme 2.9 a and 2.9 b).  
 
 
Scheme 2.9 Base/Fluoride ion-assisted desulfonylation of N-sulfonylamines and proposed 
detosylation of N-aryl/alkyl-N-tosyl cyanamide53a-c 
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2.1.1 Coupling of [RNCN]¯ and nitrile oxide  
The known ability of the base/fluoride ions to instigate desulfonylation as well as the easy 
availability of N-sulfonyl cyanamide provided the basis for our hypothesis that base-induced 
desulfonylation of 197 could generate the reactive cyanamide anionic species [RNCN] ─ (199) 
(Scheme 2.10). A cyclisative capture reaction of the intermittently generated [RNCN] ─ (199) 
with dipoles like nitrile oxide (121) in an exo-dig fashion could deliver a five-membered 
cycloadduct like 1,2,4-oxadiazol-5(4H)- imine (177) (Scheme 2.10). Such a cyclisation would 
be an unprecedented example of a formal 1,3-dipolar cycloaddition between cyanamide ion 
and nitrile oxide. Further chemical transformations such as hydrolysis and decarboxylat ion 
would provide pharmaceutically interesting building blocks such as oxadiazolone20 178 and 
amidine21 179. 
Scheme 2.10 Proposed cyclisative reaction of nitrile oxide 121 with cyanamide intermediate 
199 and further transformations 
In the development of novel synthetic methods for high throughput synthesis, protocols which 
are reliable, efficient, precludes the use of too many reagents and generate inoffens ive 
byproducts are quintessential.55 In this regard an efficient coupling technology of in situ 
generated short lived reactive species utilising single reagent are the best bargain. Hence, it 
was reasoned that simultaneous generation of both the [RNCN]─ and 1,3-dipole (nitrile oxide 
for instance) coupling partners in a single-pot would offer an attractive prospect towards an 
efficient and practical outcome. Thus, the reaction of in situ generated [RNCN]─ and nitrile 
oxide as a coupling partner was envisaged as the first step towards developing cyanamide as a 
reagent for generation of diverse heterocyclic structures. NCTS (145) was envisioned to be 
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used as the cyanamide precursor along with hydroximoyl chlorides 198 as the precurosrs for 
nitrile oxide. 
Nitrile oxides 1,3- dipoles56(121) have found wide applications in the synthesis of various 
heterocycles. Nitrile oxides are routinely generated via dehydrohalogenation of hydoximoyl 
chlorides57,58 (198) either in the presence of appropriate base such as triethylamine (TEA), 
K2CO3, pyridine etc. or fluoride ion using reagents such as TBAF, CsF/18-crown-6 (18-C-6). 
Unfortunately the chemistry of nitrile oxide is often marred with the high reactivity of the 
species. Nitrile oxides are known to dimerise in dilute solutions within seconds or minutes59 to 
corresponding furoxans60 (203), even at low temperatures (0 oC) (Scheme 2.11). Under 
elevated temperatures, the nitrile oxide isomerise into isocyanates (200),61 whereas in the 
presence of pyridine in ethanol or excess BF3 in benzene, self-dimerise into 1,4,2,5-
dioxadiazines (201).62 The formation of 1,2,4-oxadiazole 4-oxides (202) in the presence of 
TEA or BF3 is less significant (Scheme 2.11).61 
Scheme 2.11 Self reactions of nitrile oxide 
In the recent times nitrile oxide has been very efficiently utilised in dipolar cycloaddit ion 
reaction wherein in almost all of the cases these reactive species has been generated in situ with 
the complimentary reacting partners. In our present work, to circumvent the problem associated 
with nitrile oxide reactivity, an in situ generation of reacting partners was considered. Hence, 
detailed studies on the conditions for their generation, stability and reactivity was undertaken. 
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2.2 Results and Discussion 
2.2.1 Synthesis of NCTS  
NCTS (145) was readily synthesised by the reaction of N-phenyl urea (204a) with p-
toluenesulfonyl chloride (p-TsCl) in pyridine following literature procedure (Scheme 2.12).6 
   
 
 
Scheme 2.12 Synthesis of NCTS (145) from N-phenyl urea 
 2.2.2 Reactivity of NCTS with different nucleophiles 
Studies towards the rate of formation of the cyanamide anion from the corresponding 
precursor under varying reaction conditions were carried out. A number of both fluoride and 
non-fluoride nucleophiles were screened to instigate the detosylation of NCTS (145) as 
displayed in Table 2.1. Reactions were followed by a combination of TLC and GC-MS 
analysis. 
Scheme 2.13 Products formed by the reaction of fluoride ion with NCTS 
The use of ammonium fluoride did not lead to any detosylated product even under heating 
conditions (entry 1, Table 2.1). Gratifyingly, the use of TBAF resulted in the complete 
consumption of the starting material forming two new products (TLC) under 5 minutes (entry 
2, Table 2.1).  
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Table 2.1 Screening of NCTS with various nucleophiles 
 
[a] monitored by TLC and GC-MS [b] starting material remains unreacted [c] complex mixture of 
products formed apart from phenyl cyanamide and tosyl fluoride 
 
GC-MS analysis of the reaction mixture indicated that the two products formed could be N-
phenyl cyanamide (104) or the isomeric carbodiimide (104’) with m/z 118 and tosyl fluor ide 
(205) with m/z 174, confirming our hypothesis that TBAF could instigate detosylation of 
NCTS (Scheme 2.13 and Figure 2.2). Although having similar mass, carbodiimide and 
cyanamide can be distinguished with IR spectroscopy. Cyanamide63 shows C-N stretching in 
the range of 2210-2270 cm-1 and the same stretching in carbodiimide64 is detected at 2100-
 
 
 
 
 
Entry Nucleophile 
Mol 
Equiv. 
Solvent Temp (oC) Time 
% 
Conversion[a] 
1 NH4F 1-3 THF/CH3CN rt – 50 24 h --[b] 
2 TBAF 1 THF/CH3CN rt 5 min 100 % 
3 CsF 1 THF rt 24 h 30 % 
4 CsF 2 THF rt 24 h 70 % 
5 CsF 2 THF 50 24 h 90 %[c] 
6 CsF 2 CH3CN rt 24 h 50 % 
7 
CsF: 18-C-6 
(1:1) 
2 THF rt 4 h 80 % 
8 t-BuOK 1 THF rt 4 h --[b] 
9 t-BuOK 1 THF 50 4 h 100 % 
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2150 cm-1. The formation of phenyl cyanamide (104) and tosyl fluoride (205) from NCTS is 
proposed to be initiated by an SN2 like attack of the fluoride ion on the sulfoxide leading to 
cleavage of the S-N bond in the NCTS (Scheme 2.13). The tosyl fluoride formed is known to 
be a highly stable compound, with resistance to reduction,65 nucleophilic substitution65 and 
thermolysis.66 
 
 
 
 
 
 
 
 
Figure 2.2 GC-MS spectra for the products formed by detosylation of NCTS 
A trapping reaction was performed to ascertain the formation of [RNCN]─ anion. NCTS (145) 
was trapped with benzyne (84) in presence of TBAF to give a mixture of the amino cyanated 
product 188 and N,N-diphenylcyanamide44 (206) indicating the formation of the expected 
anion intermediate (Scheme 2.14). 
Scheme 2.14 Reaction of NCTS with benzyne precursor in presence of TBAF 
 
 
 
Scheme 2.15 Reaction of NCTS with hexyl bromide in presence of TBAF 
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The rate of formation of the reactive cyanamide species [RNCN] ─ (199) was recorded for 
other bases under varying reaction conditions. CsF, being a comparatively milder base resulted 
in slower conversion of the starting material with around 30 % conversion in 24 hours at room 
temperature (as observed on TLC and GC analysis, entry 3, Table 2.1). Increasing the molar 
equivalents did result in some improvement with 70 % and 50 % conversion to phenyl 
cyanamide in THF and CH3CN respectively (entries 4-5, Table 2.1). The amount of by-
product formation was less when the reaction was carried out in acetonitrile compared to THF 
and most of the cyanamide cleaved to form PhNHCN (104). Although the conversion rate is 
higher in THF, the proportion of PhNHCN is comparatively less as compared to the by-
products. When heating conditions were used to accelerate the reaction, it resulted in a 
complex mixture of products with 50 % conversion to the detosylated product 104 (entry 6, 
Table 2.1). 
Early studies have indicated that the reduced solubility of alkali fluorides in organic solvents 6 7  
are responsible for the low reaction rates. Pederson, in 1967 discovered crown ethers and 
reported that the anions of the crown ether-metal salt complexes were very reactive in organic 
solvents.68 Based on his initial findings, crown ethers were further studied as phase transfer 
catalysts in reactions involving alkali fluorides.69 
18-crown-6 is a cyclic ether with a cavity size of 2.6-3.2 A°.70 The increased solubility and 
reactivity of KF in organic solvent in the presence of 18-crown-6 was attributed to the complex 
formation (K+-18-crown-6) and more availability of the ‘naked fluoride’ ion.71 The ability of 
crown ether to enhance solubility depends on the cavity size, cation radius and the solubility 
of the metal salt in the organic solvent.72 18-crown-6 was found to accommodate the potassium 
ion (diameter – 2.66 A°) in a 1:1 complex. 
However, in a report published by Harpp,73 CsF:18-crown-6 was also found to increase the 
reaction rate of a displacement reaction by a factor of 5, inspite of a larger ionic diameter of 
the Caesium ion (3.4 A°). His report validated Pederson’s proposal that the complexes need 
not be just 1:1 complex to solubilise the fluoride ion, and the CsF-18-crown-6 complex could 
be a 1:1 edge complex, 2:1 (sandwich) or 3:2 (club-sandwich) complex70 (Figure 2.3). The 
complexes with dibenzo-crown-8-CsF gave a similar increase in the reaction rate and the 
kinetic evidence made the authors conclude that edge (1:1) or sandwich complexes (2:1) have 
equal or comparative efficiency as with usual or flat 1:1 guest:host ratio complex.73 
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Figure 2.3 Pictorial representation of different possible complexes of CsF:18-crown-6 
Recently, Feringa et al.74 and Moses et al.9,10 reported the use of CsF:18-crown-6 complex in 
1,3-dipolar cycloaddition reactions with enhanced product yields. Accordingly, when NCTS 
was reacted with CsF:18-crown-6 in THF, it resulted in around 80% consumption (based on 
GC-MS analysis) of the starting material in 4 hours (entry 7, Table 2.1)  
In presence of tBuOK as the base, the starting material remained unconsumed at room 
temperature, but resulted in complete consumption at 50 oC (entry 8-9, Table 2.1). However, 
decyanation of NCTS was also observed in this case.  
2.2.3 Synthesis of Hydroxymoyl chlorides and generation of nitrile oxide  
 
 
 
Scheme 2.16 Synthesis of phenyl hydroximoyl chloride (211a) 
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Phenyl hydroximoyl chloride (211a) was prepared in a two-step reaction from benzaldehyde. 
Benzaldehyde (209a) was reacted with hydroxylamine hydrochloride in presence of sodium 
carbonate as the base, and refluxed in water for 3 hours to get benzaldehyde oxime (210a).75 
The use of hydroxylamine in the synthesis of oxime is due to its better nucleophilicity (owing 
to the alpha-effect)76 as compared to ammonia. The adjacent α atom (oxygen here) with a lone 
pair of electrons is responsible for the increased reactivity of the nucleophile. Some of the 
reasons considered for the increased reactivity are - ground state destabilisation of 
nucleophiles77 (repulsion between the electrons of the nucleophilic atom and the α-electrons), 
transition state stabilisation78 (on entering the TS, the electron pair on the nucleophile moves 
away from the nucleus causing a partial positive charge which is stabilised by the adjacent lone 
pair), increased polarisation of nucleophiles,79 solvent effect80 and product stability.78  
Table 2.2 Screening of bases for the nitrile oxide generation from 211a 
 
Entry Base Mol Equiv. Time (min) % Conversion to 203[a] 
1 TEA 2 30 100 % 
2 K2CO3 2 30 ~40 % 
3 CsF 2 30 ~30 % [b] 
4 CsF:18-C-6 2:3 30 50 % 
5 CsF:18-C-6 4:6 30 100 % 
6 TBAF 1.5 10 100% 
[a] analysis by TLC and GC-MS, [b] complete conversion observed in 4 hours 
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Hudson81 proposed overlap of doubly occupied p-п orbitals leading to an increase in HOMO 
energy of the nucleophiles. Studies by Ingold82 indicate an antibonding HOMO, with a node 
between the nucleophile and α-atom could be a reason for increased nucleophilicty (ground-
state destabilisation). Electronic structure analysis using Ab initio calculations83 of 
hydroxylamine show that HOMOs of NH2OH have some antibonding character thereby 
supporting the Ingold hypothesis to some extent. Thus, the alpha effect can be attributed to the 
electronic structure of products and their transition state stabilisation, although the precise 
origin is still inconclusive. 
The resultant oxime formed was then reacted with N-chlorosuccinimide (NCS) in 
dimethylformamide (DMF) to give phenyl hydroximoyl chloride (211a) after purification by 
silica gel column chromatography.84 
When triethylamine (2 mol equiv.) was added to 211a pre-dissolved in THF, it lead to the 
formation of nitrile oxide 212, immediately forming the dimer 3,4-diphenyl furoxan (203, 
Figure 2.3). When acetonitrile was used as the solvent, nitrile group acted as a dipolarophile 
instead and underwent cycloaddition with nitrile oxide to form 5-methyl-3-phenyl-1,2,4-
oxadiazole (213) and the furoxan (203). The reactions were analysed by GC-MS which showed 
the corresponding peaks for the oxadiazole (213) and 203 (Scheme 2.17).   
 
 
 
 
 
 
 
 
Scheme 2.17 Different products formed by the reaction of TEA with 211a in different 
solvents 
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When 2 equivalents of K2CO3 was added to a reaction flask containing 211a in THF, the 
starting material still remained unconsumed after 30 minutes with around 40 % conversion to 
the dimer (entry 2, Table 2.2). This suggests that the rate of nitrile oxide formation is faster 
with triethylamine than with potassium carbonate. 
The use of CsF (2 mol equiv.) resulted in 30% conversion to the dimer (203) in 30 minutes, 
however the reaction went to completion when kept for 4 hours in the same reaction conditions 
(entry 3, Table 2.4). Furthermore, to increase the solubility and nucleophilicity of the fluor id e 
ion, 2:3 molar ratio of CsF:18-crown-6 was used which saw 50% conversion to the dimer, 
however increasing the ratio to 4:6 resulted in complete consumption of the starting material 
(entry 4-5, Table 2.2). 
On reacting the hydroximoyl chloride (211a) with TBAF (1 mol equiv.) in THF, the TLC 
signified no change in the reaction mixture within the 10 minutes, but was later found to be 
consumed in 1 hour. However, increasing the concentration of TBAF to 1.5 molar equivalents, 
resulted in complete conversion of the starting material to the dimer (203) in 10 minutes (entry 
6, Table 2.2). 
Figure 2.4 GC-MS spectrum for reaction of 211a with TEA - formation of dimer (203) 
,  05-Feb-2014 + 21:40:51
3.85 4.35 4.85 5.35 5.85 6.35 6.85 7.35 7.85 8.35 8.85 9.35 9.85 10.35 10.85
Time0
100
%
sb-28a Scan EI+ 
TIC
1.41e8
9.41
,  05-Feb-2014 + 21:40:51
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240
m/z0
100
%
sb-28a 377 (9.405) Scan EI+ 
3.84e6178
103
76
51
44
41
49
63
6153 7465
89
8778 91 10298 119104
115
176
152126
150
139 163
179
192 222207 238
86 | P a g e  
 
2.2.4 Optimisation of the cycloaddition reaction of cyanamides with nitrile 
oxide precursors 
It was conclusive from the studies carried out for the rates of formation of the reactive 
complimentary species (as discussed in sections 2.2.2 and 2.2.3), that bases like potassium 
carbonate and TEA, generate the nitrile oxide (indicated by the dimer formation) but fail to 
generate the reactive cyanamide species. Whereas, TBAF and CsF were found to generate both 
the nitrile oxide as well as the [RNCN]─ species (indicated by the detosylation of NCTS 145) 
from their corresponding precursors. 
Scheme 2.18. Reaction of 211a and NCTS in presence of various bases 
So, accordingly when a mixture of NCTS (145) and phenyl hydroximoyl chloride (211a) in 
THF was treated with bases like potassium carbonate and triethylamine, furoxan (203) was 
isolated as an exclusive product along with the unreacted NCTS (entry 1-2, Table 2.3). The 
nitrile centre of NCTS was found immune to the nitrile oxide in presence of TEA/K2CO3, as 
no cycloaddition product was detected. 
However, in the presence of TBAF, formation of a new product 214 was observed, which 
showed a m/z of 237 in GC-MS (Scheme 2.18). The GC-MS also showed peaks corresponding 
to phenyl cyanamide (104), p-toluenesulfonyl fluoride (205) and the dimer (203) indicating the 
detosylation instigated by the nucleophilic fluoride ion. We reasoned that the reaction can 
proceed in two ways: through pathway a (Scheme 2.19) to give 1,2,4 oxadiazol- imine 214 or 
through pathway b (Scheme 2.19) to give the isomeric heterocycle, 5-amino substituted-1,2,4-
oxadiazole 215. The formation of the isomeric heterocycle was proposed by the reaction of 
nitrile oxide with carbodiimide ion, which is the tautomeric form of cyanamide ion. 
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Scheme 2.19 Possible reaction pathways: fluoride ion-mediated reaction of 211a and NCTS 
Preliminary GC-MS study of the reaction indicated that the product is 3,4-diphenyl 1,2,4-
oxadiazol-5(4H)- imine (214) as opposed to (215) (see figure 2.5 for fragmentation pattern). 
The M─43 peak is characteristic for 214 arising from the loss of CHNO species, and formation 
of the amidine species (m/z = 194) (Figure 2.5). The product was further confirmed by IR which 
showed the characteristic peaks for NH and C=N (exocyclic) at 3288 and 1692 cm-1 
respectively. 
 
Figure 2.5 Fragmentation pattern for 214 leading to the M-43 peak 
The product was further confirmed by NMR analysis (1H, 13C, COSY, HMBC, HMQC). 
Though the product 214 was solid, all attempt to generate appropriate size crystals for 
diffraction failed. Later on in our studies the hydrolysed product of the oxadiazol- imine (214) 
to the corresponding oxadiazolone (216) (Scheme 2.20) was successfully crystallised and X-
ray recorded. The atom-connectivity of 216 was confirmed through single x-ray 
crystallography (Figure 2.6), which in turn confirmed the formation of 214 in the first place in 
the reaction between cyanamide and nitrile oxide. 
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Scheme 2.20 Hydrolysis of oxadiazol- imine to oxadiazolone  
 
 
 
 
 
 
 
 
 
 
Figure 2.6 ORTEP view of 216 
Once the structure of the major product was established, the TBAF-mediated cycloaddit ion 
reaction was explored for further optimisations. The initial screening involved reacting 1 molar 
equivalent of phenyl hydroximoyl chloride (211a) with NCTS (145) in presence of 3.4 
equivalents of 0.5 M TBAF in THF at room temperature, which resulted in 61 % yield of the 
cycloadduct (214) under 10 minutes. Self-competing reactions like the dimerisation of nitrile 
oxide and protonation of the cyanamide anion [NCN]─ were also observed along with the 
desired cycloaddition reaction. Slow addition of TBAF over a period of 20 minutes did not 
have any significant effect on the yield (59%, entry 7, Table 2.3). Changing the order of 
addition resulted in a lower yield of 33%, where 211a was added after 5 minutes to a solution 
of pre-dissolved NCTS and TBAF in THF (entry 8, Table 2.3). 
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Table 2.3 Preliminary screening of base/F− for the cycloaddition reaction 
[a] Reactions were performed on 0.64 mmol scale, [b] 0.5 M, [c] Isolated yield, [d] 214 not detected; 145 
remained unreacted with 203 detected by TLC only, [e] TBAF added over a period of 20 min, [f] 211a 
added after 5 min to a mixture containing 145, TBAF in THF  
Hence, the initial studies indicated towards a fast and unmatched rate of generation of both 
reactive species in presence of TBAF giving the cycloadduct as a product in 10 minutes. 
However, a moderate product yield of 61% called for further optimisation studies, in order to 
decrease the self-competing reactions and get optimum yields. Meanwhile, CsF was explored 
next as the fluoride source for the cycloaddition reaction. 
 
Entry[a] Base Molar Equiv. Solvent[b] Time Yield (%)[c] 
1 K2CO3 2 THF 10 min -24 h --[d] 
2 Et3N 2 THF 10 min -24 h --[d] 
3 NH4F 2 THF 10 min -24 h --[d] 
4 TBAF 3.4 THF 10 min 61 
5 TBAF 3.4 CH3CN 10 min 62 
6 TBAF 3.4 THF (1 M) 10 min 50 
7 TBAF 3.4 THF 20 min[e] 59 
8 TBAF 3.4 THF 10 min[f] 33 
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2.2.5 Reaction optimisation with CsF as the fluoride source 
Reacting NCTS (145) and phenyl hydroximoyl chloride (211a) in the presence of 2.4 molar 
equivalent of CsF in THF at room temperature yielded no product. Increasing the CsF to 3.4 
molar equivalent lead to product formation, albeit in very low yield (15%, entry 2, Table 2.4), 
whereas heating the reaction mixture only caused a marginal increase in the yield (24 %, entry 
3, Table 2.4). 
Table 2.4 Reaction screening with CsF as fluoride source 
[a] Isolated yield, [b] no product formed, [c] not attempted, [d] slow addition of 211a (in THF) over a period 
of 1.5 hours 
 
It is known73 that addition of 18-crown-6 to CsF results in sandwich-type complexation of the 
Cesium with the 18-crown-6 resulting in the availability of more naked fluoride ion. Using 
equal amounts of CsF and 18-crown-6 (3.4 mol equiv.) helped in increasing the yield to 27%, 
 
 
Entry Base 
Molar 
Equiv. 
Solvent 
Temp 
(oC) 
Time 
R=Ts 
Yield 
(%)[a] 
R=H 
Yield 
(%)[a] 
1 CsF 2.4 THF rt 4 h --[b] --[b] 
2 CsF 3.4 THF rt >24 h 15 32 
3 CsF 3.4 THF 50 4 h 24 40 
4 CsF:18-C-6 3.4:3.4 THF rt  4 h 27 36 
5 CsF 6 THF rt 10 min 38 --[c] 
6 CsF 6 CH3CN rt 4 h[d] 57 63 
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whereas excess CsF (6 mol equiv.) in THF resulted only in 38 % yield of the desired product. 
In all the cases, competing self-dimerisation reaction of the nitrile oxide was prominent as the 
nitrile oxide formation rate was found to be comparatively faster than that of the cyanamide 
[NCN]¯ species. Taking this into consideration, NCTS was treated with 6 molar equivalents of 
CsF, and the phenyl hydroximoyl chloride (211a) was added slowly over a period of 1.5 hours 
with the help of a syringe pump. Slow addition of 211a helped in increasing the yield to 57% 
(entry 6, Table 2.4). Using N-phenyl cyanamide (104) instead of tosyl cyanamide as the 
dipolarophile substrate gave comparable yields (entries 2-6, Table 2.4). However, similar 
yields in a few minutes with TBAF render the use of CsF less attractive. Hence, further 
optimisations were carried out with TBAF as the fluoride source for the nitrile oxide-
cyanamide (formal) cycloaddition reaction. 
2.2.6 Reaction optimisation with TBAF as fluoride source 
The initial reaction with 1 molar equivalent each of the starting material (211a) and (145) with 
3.4 molar equivalents of TBAF yielded the product in 61 % yield in 10 minutes. The molar 
equivalents of TBAF was reduced to 2.5, which gave the product 214 in similar yields (57%, 
entry 1, Table 2.5). TLC analysis showed that NCTS was immediately detosylated forming 
phenyl cyanamide (104), with nitrile oxide dimer (203) also forming as a by-product. 
Nucleophilic attack by a fluoride anion is heavily dependent on the counter cation, solvent 
choice and the extent of hydration.67b TBAF is known to form a weak intimate ion pair and it 
is a good source of “naked” fluoride ion in organic media.85 That would explain the higher 
nucleophilicty of TBAF (hence faster reaction rates) in comparison to CsF.  
The key to the cyclisation reaction was undoubtedly the concomitant generation and 
subsequent cyclisation of the two highly reactive species. Hence, a systematic investiga t ion 
into the optimisation studies was conducted by: changing the relative ratios of the substrates; 
molar equivalents of TBAF and its rate of addition; reaction temperature and the effect of 
solvent. 
The reaction of 211a and NCTS (1 molar equiv. each) at 0 oC in presence of TBAF in THF 
caused a marginal increase in the yield with 62 % product formation and 12 % of NCTS 
recovered (entry 2, Table 2.5).  However, phenyl cyanamide (104) formation was observed 
after 5 minutes even in ice-cold conditions. This observation lead us to speculate that the ice-
conditions slowed down the formation of cyanamide species [RNCN]¯.  
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Table 2.5 Reaction optimisation with TBAF as fluoride source  
 
 
Entry 
145 
X equiv. 
211a 
Y equiv. 
Z 
equiv. 
Solvent Temp Time 
Yield 
(%)[a] 
1 1 1 2.5 THF rt 10 min 57 
2 1 1 2.5 THF 0 oC 10 min 62 
3 1 (104) 1 2.5 THF 0 oC 10 min 61 
4 1 1.25 3 THF 0 oC 10 min 67 
5 1 1.5 3 THF 0 oC 10 min 65 
6 1 1.5 3 THF 0 oC 1 h[b] 55 
7 1.5 1 3 THF 0 oC 10 min 69 
8 1.25 1 3 THF 0 oC 10 min 65 
9 1.25 1 3 THF 0 oC 1 h[b] 79 
10 1.25 1 3 THF[c] 0 oC 1 h[b] 49 
11 1.25 1 3 DCM 0 oC 1 h[b] 77 
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 [a] Isolated yield [b] addition of TBAF over a period of 1 h by the use of syringe pump, [c] reaction carried 
out with reagent grade THF in open flask conditions, [d] also performed in phosphate buffer, [e] starting 
material remain unreacted, [f] crude NMR 
Hence, it was hypothesised that reacting the cyanamide with excess of nitrile oxide precursor 
211a would give an optimum product yield as the fast-generating nitrile oxide (in excess) could 
react with the available cyanamide fully. So, a reaction of 1.25 molar equivalents of 211a with 
1 molar equivalent of NCTS (145) in presence of TBAF (3 mol equiv.) at 0 oC was tried (entry 
4, Table 2.5), which gave the product 214 in 67 % yield (mild improvement over 61 % yield). 
Increasing 211a to 1.5 molar equivalents did not help, neither did the slow addition of TBAF 
as yields dwindled lower down to 55 % (entry 5-6, Table 2.5). 
In each of the above cases, furoxan (203) formation was observed (TLC and GC-MS), calling 
for higher amounts of NCTS to be used in the reaction. It was hypothesised that the reactive 
cyanamide species in excess would react fully with the nitrile oxide, leading to the exclusive 
formation of the product 214 with minimum side reactions. Hence, when excess NCTS was 
used, the cycloadduct (214) was obtained in yields ranging from 69-73% (entry 7-8, Table 2.5). 
Optimal results were obtained using 1 molar equivalent of 211a and 1.25 molar equivalents of 
NCTS (145) with slow addition of TBAF (3 mol equiv.) over a period of 1 hour at 0 oC, leading 
to the formation of product in 79 % yield (entry 9, Table 2.5). The slow addition of TBAF was 
12 1.25 1 3 CH3CN 0 oC 1 h[b] 76 
13 1.25 1 3 Toluene 0 oC 1 h[b] 64 
14 1.25 1 3 DMF 0 oC 1 h[b] 58 
15 1.25 1 3 1,2-DME 0 oC 1 h[b] 68 
16 1.25 1 3 Et2O 0 oC 1 h[b] 67 
17 1.25 1 3 H2O[d] rt 24 h 0[e] 
18 1.25 1 3 
H2O:acetone 
(9:1) 
rt 24 h Trace[f] 
19 1.25 1 3 
H2O:DMSO 
(9:1) 
rt 24 h 17 
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found to be crucial for the concomitant generation of nitrile oxide 212 and the [NCN]¯ species 
189, as the product- 1,2,4 oxadiazol-5 (4H)-imine (214) was isolated in the best possible yields. 
The desired cycloadduct 214 was also obtained when reagent grade THF was used in open 
flask conditions (49%, entry 10, Table 2.5). The hydrolysis of oxadiazol-5-imine (214) was 
observed in this condition as 12% of the oxadiazolone (216) was isolated from the reaction 
mixture. 
Next, the solvent effect was studied, wherein polar solvents like DCM and acetonitrile provided 
a comparative yield to THF, whereas other solvents had deleterious effects (entry 11-16, Table 
2.5). To extend the use of this method in biological systems, the reaction was tried in water and 
phosphate buffer, but the starting materials remained unreacted. However, water: DMSO (9:1) 
system returned the desired product in a modest 17% yield.  
The optimised method presents the first example of one-pot reaction of cyanamide as a 
dipolarophile like species towards nitrile oxide to render the five-membered oxadiazol-5-imine 
(214) product. 
2.3 Substrates scope: Substituted hydroximoyl chlorides and N-
aryl-N-tosyl cyanamides 
2.3.1 Synthesis of hydroximoyl chlorides  
Once the optimisations were done, we set out to investigate the robustness of the reaction 
conditions. Thus, a range of aryl hydroximoyl chlorides bearing different substituents includ ing 
aliphatic, electron-donating and electron-withdrawing groups were synthesised (Figure 2.7).  
The hydroximoyl chlorides were prepared in two-steps from aldehydes. The aldehydes were 
reacted with hydroxylamine hydrochloride in presence of sodium carbonate as the base, and 
refluxed in water for 3 hours to get aldoximes (210).75 The aldoximes were obtained in excellent 
yields and were used further without any purification.  
 
Scheme 2.21 Synthesis of hydroximoyl chlorides 
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Figure 2.7 Oximes and hydroximoyl chloride derivatives 
An anomaly was observed, when 1H-indole-3-carbaldehyde oxime (209m) was attempted to 
synthesise from the corresponding aldehyde, it lead to the formation of 1H-indole-3-
carbonitrile (217) instead of the aldoxime. It was confirmed through GC-MS and IR, with m/z 
142 and a strong peak at 2230 cm-1 corresponding to the CN (nitrile) respectively.  
 
Scheme 2.22 Unwanted dehydration of 1H- Indole-3-carbaldehyde oxime to indole-3-
carbonitrile and its IR spectrum 
C  N 
(nitriles) 
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The conversion of aldehyde to nitrile through oxime is known in the literature,86 wherein the 
oxime formed is dehydrated to nitrile in the presence of base. Similarly, here the formation of 
1H-Indole-3-carbonitrile (217) would suggest that the 1H-indole-3-carbaldehyde oxime 
(210m) formed as an intermediate further undergoes dehydration. Expectedly, on reducing the 
reaction time to 1h resulted in the desired oxime product in excellent yields (Scheme 2.23). IR 
analysis showed the absence of the nitrile peak at 2230 cm-1, with a new band at 1639 cm-1 
(C=N stretching) confirming the product as 1H-indole-3-carbaldehyde oxime (210m). It was 
further confirmed by NMR and mass. A repeat experiment was also performed by putting the 
oxime back into the reaction, which gave nitrile (217) as the main product. 
 
Scheme 2.23 Synthesis of 1H-Indole-3-carbaldeyhyde oxime from 1H-Indole-3-carbaldehyde 
The synthesis of hydroximoyl chlorides were carried out according to literature using N-
chlorosuccinimide (NCS) as the chlorinating agent in N, N-dimethylformamide (DMF) as the 
solvent. In this method, NCS was slowly added (in portions) to a solution of aldoximes in DMF 
at ambient temperature. The initiation of the reaction was marked by a sudden increase in 
temperature (after 5-10 minutes of addition of first portion of NCS), sometimes external heat 
being necessary to initiate the reaction. The subsequent portions of NCS were added while 
maintaining the warm conditions (water bath was used, in case the temperature got too high). 
The cessation of heat indicated the completion of reaction, and the reaction was allowed to stir 
for 1 hour at room temperature. Once finished, the reaction mixture was poured into cold water, 
and extracted with DCM.  
Scheme 2.24 Plausible mechanism for formation of chloroximes (211) from oximes (210) 
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The organic fractions were evaporated and the residue purified by silica gel column 
chromatography to give hydroximoyl chlorides (211a-k). The mechanism of the NCS-
chlorination of oximes is depicted in the Scheme 2.24.  
Although the NCS-DMF chlorination worked in most of the substrates (Figure 2.7), it failed to 
provide the hydroximoyl chlorides in some cases. The N-hydroxyfuran-3-carbimidoyl chloride 
(211-l) was not obtained as black-lumpy precipitates were obtained which could be a result of 
the furan undergoing polymerisation Although the N-indolyl-carbimidoyl chloride (211m) has 
been reported in the literature, the NCS chlorination did not lead to the desired product. It can 
be speculated that ring chlorination could be a reason,87 as has been observed with some 
activated (electron-rich) aldoximes.  
 2.3.2 Synthesis of N-aryl N-tosyl Cyanamides 
Till 1949, N-aryl-N-tosyl cyanamides (145) were prepared by the action of toxic cyanogen 
bromide on arylsulfonanilides in the presence of sodium ethoxide. In 1949, Kurzer published 
his studies on the reaction of N-aryl ureas 204 with p-toluenesulfonyl chloride in pyridine, 
which gave 145 readily and in good yields. This method was advantageous as it avoided the 
use of toxic cyanogen bromide and is obtained in a time-efficient manner. The reaction uses an 
excess of the sulfonyl (tosyl) chloride, which acts as a dehydrating agent and facilitates the 
cyanamide formation (mechanism discussed in Ch-1, Scheme 1.21).                                    
Table 2.6 Synthesis of N-substituted tosyl cyanamide derivatives 
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Different cyanamide substrates bearing electron-withdrawing, electron-donating and alkyl 
groups were synthesised following the known procedure from the corresponding urea (Table 
2.6). 
The p-methoxybenzene N-tosyl cyanamide (145b) was synthesised in good yields, whereas the 
p-fluorobenzene N-tosyl cyanamide (145c) was obtained in a moderate yield of 32%. It has 
been reported by Kurzer that the reactions with halogenoureas are prone to polymerisat ion, 
where melamine-type compounds are formed as by-products along with the tosyl cyanamides 
resulting in low yields of the cyanamide.88 While the N-methyl urea gave the corresponding 
cyanamide 145d in good yields, p-nitrophenyl urea (204e) failed to return any product at room 
temperature. The reaction was further heated to reflux for 24 hours, which just returned the 
starting material. The reactions were monitored by TLC and IR, wherein no peak was observed 
at 2230 cm-1 (characteristic for NCN of the cyanamide).  
Phenyl cyanamide (104) was prepared by facilitating Tiemann rearrangement of amidoximes 8 9  
(219) using p-toluenesulfonyl chloride and DIPEA (Ch-1, section 1.7.2.1). The corresponding 
amidoxime was synthesised from benzonitrile (218) by refluxing it with hydroxylamine in 
ethanol (Scheme 2.25). 
Scheme 2.25 Synthesis of phenyl cyanamide from benzonitrile by Tiemann rearrangement of 
amidoximes with p-toluenesulfonyl chloride 
2.3.3 Investigating the substrate scope for the reaction 
Having optimised the reaction conditions for benzonitrile oxide (212) generated in situ from 
phenyl hydroximoyl chloride 211a in satisfactory yields, we decided to investigate other 
electron-rich and electron-poor nitrile oxides. Sterically hindered nitrile oxides are known to 
be relatively stable in solution,90 hence a substrate like 2,4-dimethylbenzenehydroximoyl 
chloride (211h) was evaluated to gain an insight on the influence exerted by sterically hindered 
groups on the reaction. Heterocyclic substrates were also investigated to extend the scope the 
reaction. The results are represented in Table 2.7.  
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Table 2.7 Substrate scope of the cyanamide-nitrile oxide cycloaddition 
[a] one-shot addition of TBAF gave 53% yield, [b] p-hydroxyphenyl hydroximoyl chloride gave 
corresponding tosylated oxadiazol-5-imine product 230  
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Both electron-rich (211b-d) and electron-poor (211e-g) nitrile oxide precursors participated in 
the reaction to render the cycloadducts (entry 1-3, 5-7, Table 2.7). The electron rich nitrile 
oxide precursor 4-methoxyphenylhdroximoyl chloride (211d) delivered the oxadiazol-5-imine 
(219) in 84 % yield. The 4-hydroxyphenylhydroximoyl chloride (211c) when reacted with 
TBAF under the optimised conditions gave the tosylated oxadiazolimine product 230 in 42% 
yield (entry 13, Table 2.7). The formation of tosylated product could be either due to the 
nucleophilic attack of the OH of hydroximoyl chloride on either NCTS or p-toluenesulfonyl 
fluoride (205). The sterically hindered nitrile oxide returned the desired product in good yields 
(73%, entry 4, Table 2.7), its stability in solution not yielding any advantage over 
benzonitrileoxide (79%) 
Electronically poor substrates like p-chloro and p-fluoro phenylhydroximoyl chlorides 211e-f 
gave moderate yields of the target oxadiazolimine (entry 5-6, Table 2.7). The p-
nitrophenylhydroximoyl chloride (211g) gave poor yields of 224 (35%), due to the strong 
electron-withdrawing nature of the nitro group. The result was not surprising as the highly 
electron deficient nitrile oxides are known to be stabilised quickly in solution, making them 
less reactive.91 Although, changing the rate of addition of TBAF (added in a single shot) 
returned an improved yield (53%) of the oxadiazolimine 224. The cycloaddition protocol was 
also tolerated by heterocyclic substrate such as thiophenehydroximoyl chloride (211j) yielding 
the cycloaddition product 225 in 54 % yield (entry 8, Table 2.7) 
Next, we decided to investigate the effect of the varying electronics on the N-aryl-N-tosyl 
cyanamide substrates. The reaction of phenylhydroximoyl chloride 211a with p-
methoxyphenyl tosyl cyanamide (145b) gave a good yield of 68%. However a union of 
electron-rich nitrile oxide with an electron rich cyanamide resulted in a decreased yield of 62% 
(entry 9 and 10, Table 2.7). A dramatic change in the reactivity pattern was observed with the 
introduction of the electron-deficient cyanamide substrate. 89 % yield was registered when the 
electron deficient p-fluorophenyl cyanamide (145c) was reacted with phenyl nitrile oxide 
precursor (211a) under optimised condition. Further, a combination of electron poor cyanamide 
with electron rich nitrile oxide offered the product (229) in an impressive 96 % isolated yield 
(entry 12, Table 2.7).  
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2.4 Synthesis of 1,2,4-oxadiazol-5(4H)-one 
The 1,2,4-oxadiazolimine core could be functionalised further by hydrolysis to the medicina l ly 
important 1,2,4-oxadiazolone. The importance of the 1,2,4-oxadiazolone core in medicina l 
chemistry and as a synthetic intermediate has been discussed before (section 2.1, Ch-2). Earlier 
reports by Huisgen on nitrile oxide cycloaddition42 involved the synthesis of 1,2,4-oxadiazol-
5-anil and its acid-catalysed hydrolysis to 1,2,4-oxadiazolone (Scheme 2.26). 
 
 
 
 
Scheme 2.26 Acid hydrolysis of the substituted imine to 1,2,4-oxadiazolone 
We decided to use a similar approach for the hydrolysis of our substrate 1,2,4-oxadiazol-imine. 
Thus treating 214 with conc. HCl in methanol and refluxing the reaction mixture for 3 hours 
gave the 1,2,4-oxadiazolone (216) in excellent yield (95%, entry 1, Table 2.8). The reaction 
was observed to be slow at room temperature, hence reflux conditions were used. The 
procedure was tolerant to a number of differently substituted imine analogues includ ing 
electron-rich, electron-deficient and heterocyclic substituents, furnishing the 1,2,4-
oxadiazolones in excellent yields in 3-5 hours (85-95%, 231-235, Table 2.8). The 1,2,4-
oxadiazolones were characterised by the strong peak at 1770 cm-1 arising from the C=O 
(carbonyl stretch), along with comparison of NMR with the reference compounds. 
This method provides an easier and alternative route towards 1,2,4-oxadiazolones, which 
otherwise involves tedious, unreliable and multi-step protocols.19-23 
1,2,4-oxadiazolones have been used as protecting groups and precursors to amidines,14 as they 
are stable to acid and base under non-aqueous conditions, and easily removable under mild 
conditions. The highly basic nature of amidine makes it susceptible to hydrolysis to amides, 
which makes it difficult to work with amidines without the defense of a protecting group. So, 
the next logical step was to use the 1,2,4-oxadiazolone compounds obtained by hydrolysis of 
1,2,4-oxadiazol-imine to access amidines. Amidine groups are found in many medicinal drugs 
as well as are important intermediates in chemical transformations (as described in section 2.1, 
Ch-2).  
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Table 2.8 Hydrolysis of 1,2,4 oxadiazol-5 (4H)-imines to 1,2,4 oxadiazol-5(4H)-one 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.8 Pd/C catalysed reduction of 1,2,4-oxadiazol-5(4H)-one to amidines 
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Among the methods known in literature for the synthesis of amidine from oxadiazolones 
include the catalytic reduction using Pd/C with H214a or Zn/HOAc.92 The reductive 
decarboxylation with these catalytic systems involves the reduction of the N-O bond which 
releases the amidine. The hydrogenation of an ethyl acetate solution of the oxadiazolone 216 
in presence of 10% Palladium on carbon (Pd/C) and 1 molar equivalent of acetic acid was 
attempted, which furnished the amidine 236 in an excellent yield of 94%. Similarly, the p-
methoxy and 2,4-dimethoxy amidine derivatives (237-238) were obtained in excellent yields 
without the need of any tedious purification step (entry 2-3, Table 2.8). 
2.5 Aliphatic substrates and imolamine 
Studies were conducted to extend the established cyclisation protocol to include the aliphatic 
substrates to demonstrate access to drug molecules like Imolamine (239, Figure 2.1, Ch-2). The 
drug Imolamine, an 1,2,4-oxadiazol-5(4H)- imine derivative is a known coronary vasodilator,9 3  
which has been tested for acute and chronic coronary insufficiency94 as well as for the long-
term treatment of angina pectoris.95 However, mot much studies have been carried out since 
the late 1970s.  
As previously discussed, a stepwise route which included a 1,3-dipolar cycloaddition of 
cyanamide with nitrile oxide to the 1,2,4- oxadiazole-5-amine, followed by isomerisation and 
an alkylation has been reported in 1960’s by Steren (Scheme 2.6).  
We decided to use our optimised one-pot method to synthesise Imolamine, which could be 
beneficial than the step-intensive method reported in the literature. Retrosynthetically, the 
union of the N-alkyl cyanamide 240 with the nitrile oxide precursor 211a would give 
imolamine (Scheme 2.27).  
Scheme 2.27 Proposed retrosynthesis of the drug imolamine (239) 
The synthesis of the (N,N-diethyl) ethyl cyanamide 240 was thought to be the bottle-neck in 
the synthesis of the imolamine as the compound was not known in the literature. We decided 
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to start with a simple N-alkyl cyanamide like N-methyl-N-tosyl cyanamide (145d) and check 
its detosylation for the generation of the cyanamide ion and consequently its reaction with 
nitrile oxide. Various fluoride sources like ammonium fluoride (NH4F), potassium fluor ide 
(KF), CsF and TBAF were screened for the detosylation of 145d (Table 2.10).  
Table 2.10 Screening of fluoride source for the detosylation of N-methyl-N-tosyl cyanamide 
[a] first screened with 1, 2 and 4 molar equivalents, TLC analysis showed no new spots, [b] screened with 
1 and 2 molar equivalents with major spots for starting material on TLC, [c] monitored by GC-MS, % 
conversion calculated using peak area, [d] monitored by TLC 
 
Entry F¯ Source Mol Equiv. Temp (oC) Time (h) % Conversion[c] 
1 NH4F 6[a] rt 24 0 %[d] 
2 KF 6[a] rt 24 trace [d] 
3 TBAF 3[b] rt Overnight 100%  
4 TBAF 1 50 2 100%  
5 CsF 4[b] rt Overnight 40%  
6 CsF:18-C-6 3:4 rt Overnight 60%  
7 CsF:18-C-6 3:4 50 6 70 %  
8 CsF:18-C-6 6:4 rt 12 100% 
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Reactions with NH4F (6 mol equiv.) and KF (6 mol equiv.) in THF at room temperature were 
monitored by TLC, which showed no major spots except the starting material 145d (entry 1 
and 2, Table 2.10). The more nucleophilic TBAF (3 mol equiv.) resulted in the complete 
consumption of the starting material when kept overnight at room temperature (entry 3, Table 
2.10). However, the reaction time was reduced to 2 hours when the reaction mixture was heated 
to 50 oC (entry 4, Table 2.10). Similarly after trying different molar equivalents of CsF and its 
combination with 18-crown-6, 100% consumption of the starting material was achieved with 
6:4 molar ratio of CsF: 18-crown-6 in 12 hours at room temperature (entry 5-8, Table 2.10, 
analysed by TLC and GC-MS). 
Surprisingly, the GC-MS analysis of the reaction mixtures indicated that the main product in 
the above reactions was N-Methyl-p-toluenesulfonamide (243, decyanation product), instead 
of the expected N-methyl cyanamide (242, detosylation product). The decyanation of 145d was 
found to be favoured over the detosylation as no detosylated product nor the signature p-
toluenesulfonyl fluoride (205, m/z = 174) could be detected on the GC-MS spectrum.  
Scheme 2.28 Products formed by the reaction of N-methyl-N-tosyl cyanamide (145d) with 
fluoride sources 
The reaction of 145d with TBAF at 50 oC gave a major peak corresponding to the decyanated 
product 243 (m/z 185), along with some water-soluble by-products which were not visible on 
the GC-MS spectrum after workup (Scheme 2.28). The decyanated product was also the main 
product in the CsF:18-crown-6 reaction along with some minor by-products (GC-MS). The 
reaction also gave 245 as a product on heating (not observed at room temperature), which may 
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have formed by the nucleophilic attack of the decyanated product 243 on the parent cyanamide 
145d (Scheme 2.28).  
In order to further confirm the unprecedented fluoride-assisted decyanation, it was decided to 
react the methyl cyanamide 145d with 2-(Trimethylsilyl)phenyl Trifluoromethanesulfonate- a 
benzyne precursor (84) (Scheme 2.29). The reaction proceeded through the decyanation route 
giving the sulphonamide product 246, which was a major peak in the GC-MS spectrum with 
m/z 261 along with the decyanated product 243. The reaction of the methyl cyanamide with the 
target hydroximoyl chloride (211a) failed to yield any desired oxadiazolimine (249) product 
(Scheme 2.29). Instead the diphenyl furoxan (203) and decyanated product 242 were detected 
as the major peaks in the GC-MS spectrum. 
Thus, the utilisation of different fluoride sources for the detosylation of N-methyl N-tosyl 
cyanamide (145d) resulted in decyanation instead of expected detosylation as seen in the 
aromatic counterparts. It should be noted that a fluoride-assisted decyanation and particula r ly 
in alkyl tosyl cyanamides is unprecedented, and could be a subject of future studies. Moreover, 
the generation of cyanuric fluoride could be investigated, which is a known fluoride source.  
 Scheme 2.29 Reactions of N-methyl-N-tosyl cyanamide (145d) with (a) benzyne precursor 
and (b) nitrile oxide precursor 
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Cyanuric fluorides have wide applications including synthesis of acid fluorides from carboxylic 
acid, deoxygenation of alkyl sulfoxides, reduction of acids to alcohols and activation of alkenyl 
boronic acids for 1,4-addition reactions.  
Next, we decided to use unsubstituted alkyl cyanamides, as phenyl cyanamide (104) is known 
to participate in the cyclisation reaction with nitrile oxides. Propyl cyanamide (252) was 
synthesised in two steps starting from butyronitrile (250) with the formation of amidoxime 251 
as the intermediate step. The tiemann rearrangement of aliphatic amidoximes have been 
reported by Lin et al.89 with o-nosyl chloride (o-NsCl) and DIPEA in dichloromethane (Scheme 
2.30).  
 
Scheme 2.30 Synthesis of propyl cyanamide by tiemann rearrangement of amidoxime 
The propyl cyanamide was then treated with phenyl hydroximoyl chloride (211a) in presence 
of TBAF (3 mol equiv.) in THF according to the optimised method (Scheme 2.30). When the 
reaction mixture was analysed by GC-MS, gratifyingly it showed the formation of the desired 
oxadiazol-5-imine (253) along with the hydrolysed product- oxadiazolone (254) in a 65:35 
ratio as calculated from the peak area of the GC-MS chromatogram (Figure 2.8). 
Scheme 2.31 Reaction of propyl cyanamide with 211a in presence of TBAF 
It was suspected that the hydrolysis might have taken place during the aqueous mini-workup 
for the GC-MS sample preparation. Furthermore, during the scale-up, when the crude reaction 
mixture was loaded onto silica gel, further hydrolysis and degradation was observed as new 
spots could be seen forming on the TLC. This could be due to the acidic nature of the silica 
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gel. In order to prevent the hydrolysis and degradation, the reaction mixture was loaded onto a 
neutralised silica gel column without workup and the product 253 was isolated in 35% yield. 
The product was further confirmed by NMR, HRMS and IR (characteristic 1689 cm-1 band for 
exocyclic C=N) studies.  
Figure 2.8 Part of the GC-MS chromatogram and spectrum for the reaction in scheme 2.30 
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2.6 Efforts towards the synthesis of ‘Imolamine’ 
2.6.1 Tiemann rearrangement of amidoximes 
The key step for imolamine synthesis was the synthesis of the corresponding alkyl cyanamide 
241. Synthesis of aliphatic cyanamides has been accomplished using tiemann rearrangement 
of amidoximes89 (Scheme 2.30), hence a similar approach was envisaged for the synthesis of 
alkyl cyanamide 241. The corresponding amidoxime 258 was synthesised starting from 
acrylonitrile (255) and diethyl amine (256) in a two-step reaction sequence (Scheme 2.32). 
Scheme 2.32 Attempted synthesis of 241 by Tiemann rearrangement 
 
Subjecting the amidoxime 258 to conditions reported by Lin et al. did not yield the cyanamide 
241 as expected. A variety of benzenesulfonyl chlorides, base, solvents and temperature were 
screened for the reaction, with no positive results. Next, the rearrangement was attempted with 
2-hydroxyethylamidoxime (259) in presence of p-TsCl and DIPEA in DCM at room 
temperature,89 but O-tosylamidoxime (262) was isolated as the sole product (Scheme 2.33). 
Scheme 2.33 Attempted synthesis of 265 
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Lin and colleagues proposed that the heterolytic N-O bond cleavage of the amidoxime was the 
driving force for the rearrangement. Hence, o-nitrobenzenesulfonyl chloride (o-NsCl) was 
employed instead of p-TsCl to provide a better leaving group, and the reactions carried out at 
higher temperatures. The reaction was also carried out using different base (pyridine, DMAP) 
and under microwave heating conditions (70-140 oC), but the rearrangement of 262 was not 
observed. Tosyl and THP protected hydroxyethyl amidoxime (260-261) also returned the 
sulfonylated product (263-264). With the failure to synthesise the cyanamide (241 and 265) by 
amidoxime rearrangement, other approaches were tried. 
2.6.2 Desulfurisation of thioureas and isothiocyanates 
Desulfurisation of thioureas and isothiocyanates provide another route towards cyanamide 
synthesis (section 1.7.2.1, Ch-1).  The N,N-diethylaminoethyl isothiocyanate (266) was 
prepared from the corresponding amine (265) using a previously reported procedure from 
McElhinney,96 using carbon disulphide (CS2) and HgCl2 in acetone. Removal of the mercury 
salts by filtration, followed by chromatographic purification, provided the isothiocyanate 266 
in 60% yield. Direct desulfurisation of the isothiocyanate using a hindered base like 
NaN(SiMe3)2, yielded the cyanamide 241 in poor yield (5%, Scheme 2.34a). Next, 
desulfurisation of thioureas formed by the action of ammonia on 266 was attempted using 
iodine as the desulfurizing agent to give the corresponding cyanamide 241 in inferior yields 
(15%, Scheme 2.34b). The difficulties in the isolation of the pure product as well as the unstable 
nature of 241 were found to be the reasons for poor yield. No further synthesis was carried out 
in pursuit of the cyanamide 241. 
Scheme 2.34 Synthesis of target cyanamide 241 by desulfurisation of isothiocyanates and 
thioureas 
The traditional synthesis route of cyanamide involving cyanation of the corresponding amine 
265 was not attempted owing to the known toxicity of cyanogen bromide (CNBr) gas. Hence, 
most of the efforts were put into alternative methods of cyanamide synthesis. 
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2.7 Mechanistic studies  
Computational studies were performed by colleagues at University of Nottingham to determine 
the reaction mechanism and understand the nature of the bonding within the cyanamide ion 
(189). Density functional theory calculations were employed using the ωB97X functional97 6-
31+G* (geometries)98 and 6-311++G** (energies)99 basis sets. The cyanamide ion was found 
to retain the triple bond to the terminal nitrogen (−CN2), while fitting partial atomic charges to 
the electrostatic potential revealed that the negative charge was localised on N1 (Figure 2.9).  
 
Figure 2.9 Phenyl cyanamide and carbodiimide structures  
The reaction was found to proceed via the stepwise cyclisation pathway, while no transition 
state could be located for the concerted mechanism (Scheme 2.35). The reaction profile is 
shown in Figure 2.9, the stationary points being the two transition states and the intermed ia te 
267. The presence of the intermediate structure 267 signifies the initial attack of the cyanamide 
ion on the electrophilic centre of the nitrile oxide, which then undergoes a ring closure in an 
exo-dig fashion. The reaction shows a low barrier for the cyclisation step of the intermed ia te 
(267) to the product (214). 
Scheme 2.35 Reaction mechanism for the cyclisative capture of cyanamide ion with nitrile 
oxide 
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Figure 2.9 Reaction energy profile calculated using ωB97X/6-311++G(d,p)//ωB97X/6-
31+G(d) in the gas phase. 
2.8 Conclusions and future studies 
In summary, the present protocol describes an expedient one-pot access to 1,2,4-oxadiazol-
5(4H)-imines (177) in good to excellent yields from cyanamide ion and nitrile oxide generated 
in situ. The use of cyanamide as a three-atom two centre dipolarophile like species and its 
reaction with a 1,3-dipole (nitrile oxide) has been achieved, leading to a cyclisation product 
through a formal [3+2] cycloaddition route. The reagent toolkit further offers access to yet 
other pharmacologically and chemically significant cores such as oxadiazolones and amidines 
in a very straight forward manner.  
As a part of future studies, the synthesis of imolamine can be carried out using the existing 
protocol. The synthesis of the corresponding cyanamide for the cyclisation with nitrile oxide 
has been attempted, but the low yields and instability problem persist. Efforts can be made 
267 
214 
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towards solving this problem, as it would further the scope for use of aliphatic cyanamides in 
heterocycle synthesis. 
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Chapter 3  
Reaction of Cyanamide ion with Nitrile imine 1,3-dipole 
Our studies with NCTS established the generation of cyanamide ion and its in situ cyclisat ive 
capture with 1,3-dipole nitrile oxide to offer oxadiazol-5-imine as the product. Continuing with 
our studies on construction of new and under-represented heterocyclic cores, we were keen to 
extend the methodology to some other reactive 1,3-dipole viz nitrile imine.  
 
 
 
Scheme 3.1 Cyclisative capture of cyanamide ion by nitrile imine 
The present work explores the synthesis of a heterocyclic imine – 1,2,4-triazole-3-imine (180) 
via the in situ reaction of cyanamide ion with nitrile imine, as illustrated in Scheme 3.1. 
3.1 1,2,4-Triazol-3-imine 
1,2,4-Triazol-3-imine (272) was first synthesised in 1950 by Krollpfeiffer et al.1 and Baker et 
al.2 independently, but erroneously identified as another product. Krollpfeiffer identified it as 
a deacylation product of 273, a 1,2,3,4-tetrazine compound 274, whereas Baker et al. identified 
the rearranged product of 1,2,4,5-tetrazine (271) as 3-anilino-1-phenyl-1,2,4-triazole (275, 
Scheme 3.2).  
In 1965, Huisgen3 corrected the dimerised product of pyridinium betaine 269 as 1,2,4,5-
tetrazine (271), and  the sodium ethoxide treated product as 1,2,4-triazol-3-imine (272) using 
detailed UV and IR studies (Scheme 3.2). He showed that an IR value of  3320 cm-1 for NH 
vibration and 2 C=N bands at 1632 cm-1 and 1565 cm-1 were incompatible with both 274 or 
275. Huisgen demonstrated that the sodium ethoxide (0.6%) driven rearrangement of 1,2,4,5-
tetrazine (271) to 1,2,4-triazol-3-imine (272) was reversible and 271 could split into 2 
molecules of phenyl cyanamide (104) on heating. On heating 271 with 10% sodium ethoxide 
in ethanol, phenyl cyanamide (104) was furnished in 66% yield (Scheme 3.3a). 
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Scheme 3.2 Identification and first synthesis of 1,2,4-triazol-3-imine (272) 
Further confirmation of the structure of 272 was given by Huisgen via synthesis, as a 
cycloaddition product of nitrile imine (268) and cyanamide (96), albeit in lower yields4  
(Scheme 3.3b). Huisgen proposed that the cycloaddition product could be due to the reaction 
of the carbodiimide tautomer of the cyanamide or through an open chain intermediate structure. 
The 1,2,4-triazol-3-imine (180) was isolated only in 11% yield, as the exo-cyclic C=NH of 180 
acted as a dipolarophile to undergo further reactions with nitrile imine and yield other 
cycloadducts (Scheme 3.3b).   
3.2 Nitrile imine as 1,3-dipole 
Ever since its discovery by Huisgen,5,6 nitrile imines have been vastly utilised in organic 
synthesis, predominantly in regioselective dipolar cycloaddition reactions leading to a variety 
of five-membered heterocycles like pyrazole, triazole, etc. (as illustrated in Scheme 1.9, Ch-
1).7 Recently they have garnered much interest amongst theoretical chemists debating the 
structure and reactivities of nitrile imines.8,9 
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Scheme3.3 Synthesis of 272 by - a) rearrangement of tetrazine, b) cycloaddition of nitrile 
imine and cyanamide 
Huisgen classified nitrile imine 1,3-dipoles under two categories: allenic and propargylic type, 
which were described by their resonance structures attributed to the single-minimum potential 
energy wells (Figure 3.1). Nitrile imine, being a flexible system with four п electrons 
distributed over three atoms, it can be written in six different canonical forms which include : 
allenic, propargylic, carbonic, 1,3-dipolar, reverse 1,3-dipolar and 1,3-biradical.  Recently, 
theoretical studies accompanied with matrix isolation and IR spectroscopy of the largely 
elusive nitrile imines have indicated mainly allenic (IR absorptions for C=N - 2000-2100 cm-
1) and propargylic (IR absorptions for nitrile – 2200 cm-1) structures for nitrile imine.9 
 
 
 
Figure 3.1 Resonance structures of nitrile imine: allenic and propargylic forms 
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Recently, Wentrup and colleagues discovered the existence of two different structures for 
nitrile imine (phenylnitrile imine) corresponding to two different energy minima, representing 
bond-shift isomers. The two isomers ─ allenic and propargylic nitrile imines were captured in 
a matrix and characterised by IR spectroscopy, suggesting the two forms are not resonance 
structures but bond shift isomers. This was the first observation of a 1,3-dipole existing in two 
different structures.10  
With evidence for the existence of carbenic form of nitrile imine as well,8 the understanding of 
the structures of nitrile imine has increased considerably over the past few years. However, the 
effect of these structures on the reactivities of nitrile imines have eluded researchers especially 
with substituted nitrile imines, as all forms of nitrile imines have been found to undergo 
different 1,3-dipolar cycloadditions without much distinction.8 
Nitrile imines are known to be short-lived intermediates and readily undergo [3+3] 
cycloaddition in presence of base to a tetrazine5 (281) (Scheme 3.4). They are also known to 
rearrange to azirines (279) or carbodiimides11 (280) in the presence of a heat or UV source, 
fragment to nitriles12 (277) or even undergo intramolecular cyclisation to indazoles13 (278).  
Scheme 3.4 Reactivity of nitrile imines 
Although some stable nitrile imines have been isolated,14 most of the nitrile imines have short 
half-life and hence are generated in situ from their precursors (Scheme 3.5). The first reported 
instance of nitrile imine generation by Huisgen involved the thermal breakdown of 2,5-
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disubstituted tetrazole6,15 (282)Simultaneously, he also reported the generation of nitrile imine 
by a base-induced dehydrohalogenation of hydrazonyl halides5,16 (276). Over the years, 
hydrazonyl chlorides have proved to be more popular as a nitrile imine precursor as they are 
easy to synthesise, do not involve hazardous reagents (use of azide in tetrazole synthesis) or 
harsh conditions (thermolysis of tetrazoles). Hydrazonyl chlorides are readily accessible from 
different sources (ref), the most common being chlorination of aryl hydrazides (283) with 
PCl517or PPh3/CCl418 (Scheme 3.5).  
Given that the generation of nitrile imines follows a similar path as that of nitrile oxide, we 
endeavoured to transfer our knowledge of nitrile oxide-cyanamide chemistry for the effective 
trapping of nitrile imine and cyanamide generated in situ. For this purpose, N-
phenylbenzenecarbohydrazonyl chloride (70) was used as the nitrile imine precursor.  
 
 
Scheme 3.5 Common methods for generation of nitrile imines 
3.3 Generation of nitrile imine and its rate of formation 
We decided to generate nitrile imine from hydrazonyl chlorides by a base-induced 
dehydrohalogenation. The use of base as well as fluoride source19,20 for the generation of nitrile 
imine has been well-documented, with triethylamine as the base of ‘choice’.21 Similar to nitrile 
oxides, nitrile imines undergo a head-to-tail dimerisation in the presence of a base to give 
tetrazines (281). We decided to follow the rate of the nitrile imine generation by detecting the 
corresponding dimer formation. 
Attempts to generate nitrile imine using triethylamine (1 mol equiv.) proved to be slow in the 
absence of a dipolarophile, as just 30% conversion was observed after 5 hours at room 
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temperature (GC-MS, entry 1, Table 3.1). Reactions involving triethylamine as the base often 
need long reaction times or reflux conditions. The reaction with TEA was performed to obtain 
the preliminary data for the dimer (284). The use of K2CO3 as the base did not return any dimer 
when reacted with N-phenylbenzenecarbohydrazonyl chloride (70) after 10 hours at room 
temperature (entry 2, Table 3.1).  
Table 3.1 Study of the rate of formation of nitrile imine using different bases 
 
Entry Base  Mol Equiv. Time % conversion[a] 
1 Triethylamine  1 >5 h 30 %  
2 K2CO3  1 >10 h 0 % 
3 KF  1 2 h 10 %  
4 CsF  1 2 h 40 %  
5 CsF:18-C-6  1:1 1 h 100 % 
6 CsF:18-C-6  1.5:1.5 10 min 100 % 
7 KF:18-C-6  1.5:1.5 10 min 100 % 
6 TBAF  1 5 min 100 % 
7 t-BuOK  1 4 h 90 %  
[a] monitored by GC-MS 
Next, the alkali metal fluorides like KF and CsF were tested, which resulted in 10 % and 40 % 
conversion of 70 after 2 hours at room temperature (entry 3 and 4, Table 3.1). A combination 
of the F¯ source with 18-crown-6 accelerated the reaction, as the starting material was 
consumed in 1 hour - 10 minutes (entry 5-7, Table 3.1). When 1 molar equivalent of TBAF 
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was used as the fluoride source, expectedly the reaction was completed in 5 minutes of the start 
of reaction (TLC and GC-MS, entry 6, Table 3.1). When compared with the rate of cyanamide 
ion formation (section 2.2.2, Ch-2), TBAF and alkali metal fluorides/18-crown-6 seemed to 
generate the nitrile imine at a similar rate. 
With these observations in hand, we decided to proceed towards screening these fluor ide 
sources for the generation of both reactive species in situ, which is discussed below. 
3.4 Preliminary studies for the in situ generation of nitrile imine 
and cyanamide ion  
Initial screening for the in situ generation of nitrile imine and cyanamide ion from their 
corresponding precursors was started with TBAF as the fluoride source. It yielded a product 
with m/z 312 which was predicted to be 1,3,4-triphenyl-4,5-dihydro-1H-1,2,4-triazol-3-imine 
(285) (Figure 3.2). 
Figure 3.2 GC-MS spectrum of the main product 285 in the reaction of hydrazonyl chloride 
and NCTS with TBAF as fluoride source 
The product obtained was a pale brown solid and readily soluble in water. The structure (Figure 
3.3) was confirmed by NMR spectroscopic studies which displayed the presence of 15 aromatic 
protons with a broad singlet for NH at 4.48 ppm and a characteristic doublet at 8.12 ppm. The 
quaternary carbons C-5 and C-3 were assigned at 145.5 and 153.5 respectively in the 13C NMR. 
The protons and the carbon were assigned with the help of DEPT, COSY and HSQC.  
The IR spectrum for 285 showed a very strong band at 1629 cm-1 for the exo-cyclic C=N bond 
as well as a moderate band at 1590 cm-1 for the endo-cyclic C=N bond. These values were in 
accordance with those reported by Huisgen3 - 1632 and 1564 cm-1 for the exo- and endo-cyclic 
C=N bond. In addition, HRMS (ESI) detected the [M+H]+ mass of the 1,2,4-triazolimine and 
a final confirmation was achieved with the X-ray crystallographic analysis of a single crystal 
of 285. Unlike 1,2,4-oxadiazol-5-imine compound, the compound 1,2,4-triazol-3-imine (285) 
was easily crystallised in ethyl acetate: petroleum ether system.  
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Figure 3.3 The structure and ORTEP diagram of 1,3,4-triphenyl-4,5-dihydro-1H-1,2,4-
triazol-3-imine (285) 
Interestingly, GC-MS analysis of the reaction mixture also showed the presence of a peak 
(Figure 3.4b) at 12.81 minutes along with the 1,2,4-triazol-3-imine peak at 12.95 minutes in a 
ratio of 3:7. A close mass to the product 285 with m/z 311 as M+ ion peak and m/z 312 as M+1 
ion peak, arose our suspicion if the new product is the heterocyclic isomer 1,2,4-triazole-amine 
(286). The product was difficult to isolate as the Rf value of this product overlapped with that 
of phenyl cyanamide (104). After much efforts, a toluene-acetone solvent system for the 
column purification yielded the new product in considerable purity.  
Figure 3.4 a) GC-MS chromatogram for the reaction spectrum, b) GC-MS spectrum for the 
new product at 12.81 minutes 
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The isolated product was analysed by NMR (1H, 13C, DEPT, COSY and HSQC) and IR 
spectroscopic studies. An apparent doublet at 8.20 ppm and a broad singlet at 6.45 ppm with 
the 15 aromatic protons in the region of 8.20-7.0 ppm was recorded on the 1H NMR spectrum 
in CDCl3. 13C NMR spectrum showed signals for 5 quaternary carbons (triazole ring 13C at 
150.7 and 159.4 ppm) and 9 signals for methine protons which corresponds to 3 aromatic rings. 
IR spectrum showed two medium bands at 1598 and 1561 cm-1 and the HRMS detected the 
[M+H]+ mass at 313.1451 (expected 313.1448 for C20H17N4). 
Figure 3.5 Predicted structure for the new compound (286) with m/z = 312 
With a view to confirm the structure, an exhaustive literature search for the 1,2,4-triazole-5-
amine compound (286) was performed. Neugebauer et al. reported 286 as a thermolys is 
product of 1,2,4,5-tetrazine. The NMR signals for 286 were reported in the range of 1.8-3.2 τ 
(8.2-6.8 ppm) which matched the signals for the isolated compound (8.2-7.0 ppm).  Zarguil 
and colleagues23 reported a series of 1,2,4-triazole-amines with the NH proton at 6.3-6.4 ppm 
and IR absorption at 1560 cm-1 for the C=N. Further compounds with the main core of 1,2,4-
triazole-amine were found24,25 which showed specific signals for the quaternary carbon C-3 at 
159.1-159.4 ppm and a C=N band (IR) at 1596 cm-1.  
Figure 3.6 ORTEP diagram of 5-anilino-1,3-diphenyl-1,2,4-triazole (286) 
286 
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The available data made a strong case for the isolated new compound to be 286. The compound 
was confirmed finally by single crystal X-ray diffraction, the ORTEP drawing of which is 
shown in Figure 3.6. Having identified the three main products forming in the reaction, further 
optimisation with different fluoride source were carried out (Table 3.2).  
Table 3.2 Screening of F¯ source for reaction between hydrazonyl chloride (70) and NCTS 
 [a] 0.21 mmol scale, [b] isolated yield, [c] calculated from NMR, [d] TBAF added slowly over a period of 
15 minutes 
As illustrated in Table 3.2, TBAF gave 285 in low yields. When 1 molar equivalent of N-
phenylbenzenecarbohydrazonyl chloride (70) was reacted with NCTS (1 mol equiv.) in 
presence of TBAF (2 mol equiv.) in THF for 10 minutes at room temperature, it yielded the 
1,2,4-triazol-3-imine (285) in a modest yield of 13 % with majority of the hydrazonyl chloride 
converted to its dimer 284. As with the case of nitrile oxide-cyanamide reaction, we considered 
the slow addition of TBAF to suit the concomitant generation of both the reactive species. The 
slow addition of TBAF over a period of 15 minutes did result in an improved yield of 38 % 
(along with some minor impurities, more description in section 3.5). While the KF/18-crown-
6 returned the product in just 25 % yield, an improved yield of 46 % was obtained for CsF/18-
crown-6 in CH3CN at room temperature (entry 3 and 4, Table 3.2).  
 
Entry[a] F─ Source 
Mol 
Equiv. 
Solvent 
Time 
(min) 
Yield 
285[b] (%) 
Ratio[c] 
(285:286) 
Ratio[c] 
(285:284) 
1 TBAF 2 THF 10 13 55:45 18:72 
2 TBAF 2 THF 15[d] 38 60:40 45:55 
3 KF/18-C-6 2.5:2.5 CH3CN 10 25 85:15 30:70 
4 CsF/18-C-6 2.5:2.5 CH3CN 10 46 65:35 55:45 
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Scheme 3.6 Competing formation of triazole- imine 285 and the nitrile imine dimer 284 
The major competing byproduct in the reaction between cyanamide ion and nitrile imine is the 
dimer (284, Table 3.2, Scheme 3.6) formed as a result of the head-to-tail dimerization of the 
nitrile imine.  
With the aim to match the rate of formation of both reactive species, further optimisation with 
TBAF was carried out by changing the molar concentration of the reactants and their order and 
rate of addition. Adding 1 M TBAF (2 mol equiv.) and 0.5 M of 145a dropwise to a 0.1 M 
solution of 70, 51 % of triazole- imine was formed along with 45% of the dimer 284 (entry 1, 
Table 3.3). Changing the molar concentration to 0.5 M decreased the dimer formation 
considerably, but formed 38 % triazole-amine 286 instead (entry 2, Table 3.3). No dimer 
formation was observed when TBAF was added slowly (over 1 hour) and an improved 285:286 
ratio of 62:38 was recorded (entry 3, Table 3.3). Performing the reaction at -78 oC, with TBAF 
added over a period of 15 minutes, lead to an increase in the dimer formation (63%) with lower 
ratios of imine 285 and amine 286 (entry 4, Table 3.3).  
Although the dimer formation was eliminated in the reaction with TBAF, the triazole-amine 
(286) formation could not be controlled (entry 2 and 3, Table 3.3). Moreover, difficulties in the 
purification of the product from tetrabutylammonium impurities (described in section 3.6) 
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prompted us to switch to a less basic fluoride source like CsF to optimise the nitrile imine -
cyanamide ion cyclisation. 
Table 3.3 Further optimisation with TBAF as the fluoride ion source 
[a] 0.21 mmol scale, [b]ratio calculated using GC-MS 
3.5 Optimisation with CsF as Fluoride source  
As described earlier, an initial screening of CsF/18-crown-6 returned the 1,2,4-triazol-3-imine 
product (285) in 46% yield (entry 4, Table 3.2). Further optimisations with CsF/18-crown-6 
were carried out to increase the yield of 285, and thereby control the formation of the dimer 
and 286. The stoichiometric changes in the CsF/18-crown-6 system resulted in a moderate to 
reduced product yield (entry 1-2, Table 3.4). With both the reactive species forming at a fast 
rate (<5 min), there was clearly a mismatch between the rate of generation of nitrile imine as 
well as cyanamide ion. 
 
 
 
Entry[a] 
Molar Conc. 
70:145a:TBAF 
Order of addition 
Time 
(min) 
Temp 
Ratio[b] 
285: 286: 284 
1 0.1: 0.5: 1 
TBAF and 145a added 
dropwise 
15 rt 51:4:45 
2 0.5: 0.5: 0.5 
TBAF and 145a added 
dropwise 
15 rt 54:38:8 
3 1: 1: 1 TBAF added dropwise 60 rt 62:38:0 
4 1: 1: 1 TBAF added dropwise 15 -78 oC 25:12:63 
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Table 3.4 Screening of CsF for the nitrile imine and cyanamide reaction 
[a] 0.21 mmol scale, [b] isolated yields, [c] ratio calculated from the NMR of the crude reaction mixture, 
[d] 70% phenyl cyanamide was recovered [e] hydrazonyl chloride 70 was added to a reaction mixture 
containing 145a, CsF and 18-C-6 
Previous studies (chapter 2) have shown positive results when the reaction temperature was 
lowered down to 0 oC. The knowledge that the detosylation of NCTS slows down in ice-cold 
conditions, could provide a leverage point for further optimisations. Hence, when the reaction 
of N-phenylbenzenecarbohydrazonyl chloride (70) and NCTS (145a) was carried out in the 
presence of CsF/18-crown-6 at 0 oC, the hydrazonyl chloride (70) was completely consumed 
within 5 minutes, whereas NCTS remained unconsumed, giving a low product yield of 25%. 
Expectedly due to slower detosylation rate, around 70% of the phenyl cyanamide was 
recovered (entry 3, Table 3.4). Thus, the formation of nitrile imine was found to be faster than 
that of cyanamide ion at 0 oC. 
In order to match the rate of formation at 0 oC, it was thought that by changing the order of 
addition of 70, better yields could be obtained. So, hydrazonyl chloride was added to a reaction  
 
 
Entry[a] 
Mol Equiv. 
CsF:18-C-6 
Time 
(min) 
Solvent Temp 
Yield 285[b] 
(%) 
285:286[c] 
1 3.5:3.5 5 0.86 M rt 46 64:36 
2 3:4 2 0.43 M rt 25 82:18 
3 3.5:3.5 20 0.86 M 0 oC 25[d] 80:20 
4[e] 3:3 30 0.86 M 0 oC 27 87:13 
5[e] 3:3 30 0.17 M 0 oC 27 84:16 
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Table 3.5 Slow addition of hydrazonyl chloride (70)- Screening with CsF/18-C-6 
 
[a] 0.86 M, [b] slow addition of 70 to a suspension of 145a, CsF and 18-C-6, [c] isolated yields,   [d] ratio 
calculated from the NMR of the crude reaction mixture, [e] 10 mol %, [f] 20 mol %, [g] 70 added after 10 
minutes to a suspension of 145a, CsF and 18-C-6, [h] 0.43 M, [i] isolated as a mixture 
 
 
 
 
Entry 
X 
equiv. 
Additive Solvent[a] 
Time 
(min)[b] 
Temp 
Yield 
285[c] 
(%) 
285:2
86[d] 
Yield 
286, 
104 
(%)[c] 
1 2.5:2.5 -- THF 60 rt 43 75:25 -- 
2 2.5:2.5  THF 120 rt 44 74:26 -- 
3 2.5:2.5 -- CH3CN 60 rt 55 90:10 9[i] 
4 2.5:2.5 MS 4 Å[e] CH3CN 60 rt 66 92:8 10[i] 
5 2.5:2.5 Na2SO4[f] CH3CN 60 rt 52 92:8 12[i] 
6 2.5:2.5 -- CH3CN 60 0 oC 65 93:7 5, 20 
7 3:3 -- CH3CN 60 0 oC 63 80:20 16, 24 
8 3:3 -- CH3CN 30 0 oC 64 80:20 17,16 
9 3:3 -- CH3CN 15 0 oC 79 93:7 7,4 
10[g] 3:3 -- CH3CN[h] 20 0 oC 81 92:8 5, 4 
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mixture containing 145a, CsF/18-crown-6 in CH3CN at 0 oC, but it resulted in just 27% of the 
desired product (entry 4, Table 3.4). Diluting the reaction mixture (0.17 M) did not affect the 
formation rates and gave similar product yields (27%, entry 5, Table 3.4). 
Considering the faster generation of nitrile imine than the cyanamide ion, it was decided to add 
the hydrazonyl chloride (70) slowly to a mixture containing 145a, CsF/18-crown-6 in a solvent. 
So, addition of 70 over a period of 1 hour to a reaction mixture containing NCTS, CsF/18-
crown-6 with THF as the solvent, resulted in 43% product yield (entry 1, Table 3.5). The 
addition was next carried out over a period of 2 hours, which did not result in any significant 
change in the yield (44 % yield, entry 2, Table 3.5). The ratio of 285:286 was found to be 75:25, 
with rest of the hydrazonyl chloride (70) converted to the dimer. Changing the solvent polarity 
(CH3CN) resulted in an increased yield of 55%, with an improved 285:286 ratio (entry 3, Table 
3.5).  
We reasoned that the triazole-amine (286) is forming due the availability of phenyl cyanamide 
(104) from the cyanamide ion (protonation). To verify this we thought to decrease the phenyl 
cyanamide formation via the use of molecular sieves (4 Å). An addition of 10 mol% molecular 
sieves resulted in an increased yield of 66%, with the phenyl cyanamide isolated in very low 
yields as expected (entry 4, Table 3.5).  Although, the dimer formation also increased to 11% 
from 7%, indicating the acceleration of nitrile imine formation. When 20 mol% Na2SO4 was 
used, it reduced the yield of 285 to 52 % (entry 5, Table 3.5). When the reaction was tried in 
ice-cold conditions (same conditions as entry 3, Table 3.5) the yield was found to increase to 
65% with a much improved ratio of 93:7 of 285:286 without the use of any additives (entry 6, 
Table 3.5). 
The rate of addition of N-phenylbenzenecarbohydrazonyl chloride (70) was next controlled, 
which resulted in an increased yield of 79% when 70 was added over a period of 15 minutes 
(entry 9, Table 3.5), clearly indicating that both the reactive species are formed in the first 15 
minutes of addition of the respective starting materials 1 and 2. Based on the above results and 
previous observation, it was evident that nitrile imine forms within 5 minutes whereas the 
cyanamide anion forms over a period of 15-20 minutes at 0 oC.   
To avoid using slow addition protocol, hydrazonyl chloride 70 was added after 10 minutes of 
the addition of CsF/18-crown-6 to NCTS at 0 oC. TLC showed complete consumption of both 
the starting materials after 20 minutes (total, after 10 minutes of addition of 70). The reaction 
yielded the desired triazole- imine product (285) in 81% yield with a 92:8 ratio of imine 285: 
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amine 286 (entry 10, Table 3.5). The reaction was diluted to 0.43 M as the reaction mixture 
formed a thick paste which impeded the stirring.  
 Table 3.6 Stoichiometry and solvent-screening with CsF/18-C-6 as fluoride source 
 [a] 0.21 mmol scale, [b] total time, [c] isolated yields, [d] calculated from crude NMR 
With excess of fluoride source being used in the reaction, the reaction was attempted with 
2.5:2.5 molar ratio of CsF:18-crown-6, which returned similar product yields (82%, entry 2, 
Table 3.6). An increase in the molar equivalent of 70 resulted in decreased yield of 66%, 
whereas using 1.25 molar equivalents of 145a increased the yield to 89% with 94:6 ratio of 
285:286 (entry 4, Table 3.6). 
 
 
Entry[a] X equiv. Y equiv. Z equiv. Solvent 
Time 
(min)[b] 
Yield 
285[c] (%) 
285:286[d] 
1 1 1 3:3 CH3CN 20 81 92:8 
2 1 1 2.5:2.5 CH3CN 20 82 94:6 
3 1.25 1 2.75:2.75 CH3CN 20 66 77:23 
4 1 1.25 2.75:2.75 CH3CN 20 89 94:6 
5 1 1.25 2.75:2.75 CH2Cl2 20 82 90:10 
6 1 1.25 2.75:2.75 DMF 20 61 86:14 
7 1 1.25 2.75:2.75 THF 90 45 55:45 
8 1 1.25 2.75:2.75 Toluene 90 49 67:33 
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Solvent screening was performed with the optimised stoichiometry of the reagents (entry 4, 
Table 3.6). The use of DCM gave a similar product yield as with CH3CN, whereas lower yields 
were recorded with DMF as the solvent (entry 5-6, Table 3.6). Changing the solvent to THF, 
resulted in a significant reduction in the product yield (45%), with a prominent increase in the 
formation of 286 (entry 7, Table 3.6). The reaction was found to be sluggish when toluene was 
used as a solvent, as both the starting materials remained unconsumed even after 90 minutes 
(TLC), resulting in inferior product yields (49%, entry 8, Table 3.6).  
Thus, optimal results were obtained by the late addition (10 min) of the hydrazonyl chloride 
(70) to a reaction mixture containing 145a and CsF/18-crown-6 (2.75:2.75 mol equiv.) in 
CH3CN at 0 oC, with a total reaction time of 20 min (entry 4, Table 3.6). 
3.6 Investigating the substrate scope 
3.6.1 Synthesis of hydrazonyl chlorides 
Following the successful result obtained with N-phenylbenzenecarbohydrazonyl chloride (70), 
we were keen to investigate the reactivity of other nitrile imines (268) with NCTS (145a) under 
these optimised conditions. Therefore, several hydrazonyl chloride derivatives were 
synthesised bearing electron-withdrawing, electron-donating, heteroaryl and aliphatic groups. 
Also, o-substituted nitrile imines were synthesised, as these are known to stabilise nitrile imines 
and give comparable yields to 70.  The hydrazonyl chlorides were synthesised using a number 
of different methods reported in literature. 
3.6.1.1 Chlorination of acyl hydrazides 
Several chlorinating agents have been used for the chlorination of acyl hydrazides. A 
triphenylphospine and carbon tetrachloride (PPh3/CCl4) 18 system was used wherein CCl4 was 
added to a suspension of aryl hydrazides and PPh3 in MeCN and allowed to stir at room 
temperature (Scheme 3.7). The precipitates formed were filtered and recrystallised or purified 
by silica gel column chromatography, giving the hydrazonyl chlorides (70, 290-299) in varying 
yields (Figure 3.7). 
The reaction begins with the formation of phosphonium salt (I, Scheme 3.8), which is thought 
to exist as a tight ion-pair with II. Deprotection of the aryl hydrazide by the CCl3- ion (II, 
Scheme 3.8) forms chloroform and yields an alkoxide (III). The nucleophilic substitution of 
chloride in the phosphonium salt (I) by the alkoxide yields an oxyphosphonium intermed ia te 
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(IV). The chloride ion attacks the C-centre in IV via a SN2 process forming the hydrazonyl 
chloride (276) and triphenylphosphine oxide (V, TPPO). The formation of triphenylphosphine 
oxide and the strong P=O bond is considered the driving force in this reaction (Scheme 3.8). 
 
 
 
Scheme 3.7 Synthesis of hydrazonyl chlorides (276) from aryl hydrazides (283) 
 
Scheme 3.8 Mechanism for the formation of hydrazonyl chlorides (276) 
The aryl hydrazides were in turn synthesised using two different methods from the literature, 
method A and method B (Scheme 3.9). In method A, the corresponding acyl chloride (287, 1.0 
mol equiv.) was added dropwise to a solution of hydrazine derivative (288, 1.0 mol equiv.) and 
pyridine (1.0 mol equiv.) in DCM at 0 oC. The reaction mixture was left to warm up slowly to 
room temperature and monitored by TLC. After the completion of the reaction, the solids were 
filtered off, washed and recrystallised from ethanol to give the desired aryl hydrazides (283) in 
high purity and in good yields. Only 70 was synthesised using this procedure. The rest of the 
acyl hydrazides were preferred to be synthesised by method B.  
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Scheme 3.9 Synthesis of aryl hydrazides from A) acyl chlorides 287, B) carboxylic acids 289 
Figure 3.7 Hydrazonyl chlorides synthesised from aryl hydrazides 
(d.r ratio = 4:1, [α]D + 19.94o) 
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According to a report,26 products derived from hydrazine salts (commercially available form) 
were obtained in lower yields using method A, as bis-acylation was found to be more favoured 
over mono-acylation. To overcome this drawback, less reactive acylating agents were used, 
which was adopted here in the form of method B (Scheme 3.9B). Method B involved the 
addition of DIPEA (2.0 mol equiv.) to a solution of hydrazine derivative (288, free or as HCl 
salt), carboxylic acid (289, 1.0 mol equiv.) and N-(3-Dimethylaminopropyl)-N ′-
ethylcarbodiimide hydrochloride (EDC.HCl, 1.3 mol equiv.) in MeCN at ambient temperature. 
The reaction was left to stir until completion (TLC). The reaction mixture was then worked up 
and the crude product was carried forward either as it is or in some cases purified by silica gel 
column chromatography. The products 300-310 were obtained in good yields (Figure 3.8). 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Aryl hydrazides synthesised using method B 
d.r ratio = 4:1, [α]D – 37.34o 
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3.6.1.2 Chlorination of aryl hydrazones 
For the synthesis of the corresponding boc-protected hydrazonyl chlorides 313-315, we 
employed a method reported by Pramanik et.al,27 where in NCS-DMF was used for 
chlorinating the hydrazones. While NCS has been used for the chlorination of oximes, the 
chlorination of hydrazones has been only reported using NCS-dimethylsulfide complex in 
DMF at -78 oC.28 We tried to replicate the method by Pramanik et al. by condensing aromatic 
aldehydes 311 with tert-butyl carbazate to yield the corresponding hydrazones 312, which was 
successfully chlorinated using NCS/DMF to give the hydrazonyl chlorides 313-314 in varying 
yields (Scheme 3.10, Figure 3.9). 2-Pyridine carboxaldehyde and 3-furancarbaldehyde also 
gave the corresponding hydrazonyl chlorides (315-317) in good yields using the above protocol 
(Figure 3.9) 
 
Scheme 3.10 Synthesis of hydrazonyl chlorides from aldehydes 
 
Figure 3.9 Hydrazonyl chlorides 313-317 synthesised from aromatic aldehydes 
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3.6.1.3 Japp-Klingemann synthesis 
In order to synthesise alkyl ester derivatives of hydrazonyl chlorides, Japp-Klingemann 
reaction29 was employed. The aryl diazonium salt was generated in situ by adding a solution 
of aniline (14, 0.02 mol) in dilute HCl (1:1, 8 mL) to NaNO2 (1.1 mol equiv.) in H2O (10 mL) 
under ice-cold conditions over a period of 5 minutes (Scheme 3.11). 
Scheme 3.11 Japp-Klingemann synthesis of hydrazonyl chlorides from diazonium salts 
The diazonium solution was immediately added dropwise to a solution containing sodium 
acetate and commercially available ethyl 2-chloro-3-oxobutanoate (320) to yield the 
hydrazonyl chlorides 321a-c in good to excellent yields (Figure 3.10).  
 
 
 
 
 
 
Figure 3.10 Hydrazonyl chlorides synthesized by Japp-Klingemann synthesis  
The mechanism for the Japp-Klingemann synthesis is shown in scheme 3.12. The nitrosonium 
cation (NO+) present in the acidic nitrous acid solution reacts with aniline to form the aryl 
diazonium salt 319 (Scheme 3.12a and 3.12b). In another solution, the acetate ion is involved 
in the deprotonation of the β-keto-ester (320) forming an enolate 320a (Scheme 3.12c). The 
nucleophilic addition of the enolate anion to the diazonium salt produces the azo compound 
320b. The nucleophilic attack of the acetate anion at the carbonyl centre of 320b produces a 
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tetrahedral intermediate 320c, which quickly decomposes to release the carboxylic acid ester 
and form 320d. After hydrogen exchange, the final hydrazonyl chloride (321a) is produced 
(Scheme 3.12c). 
 
  
Scheme 3.12 Mechanism for Japp-Klingemann synthesis of hydrazonyl chloride (321) 
3.6.2 Substrate Scope 
Various nitrile imine precursors were investigated including 290-299, 313-317, 321a-c towards 
the construction of the target triazol-3-imines. The results are illustrated in Table 3.7. The 
protocol was found to tolerate a wide range of functionalities, including aryl, aliphatic and 
heterocyclic substituted carbahydrazonyl chloride (entries 1-20, Table 3.7). 
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The triazol-5-amines (286, 322’-340’) were also detected along with the target triazole-3-
imines. The ratio of triazole-3-imine: triaozol-5-amine was calculated from the NMR of crude 
reaction mixture (Table 3.7). 
All the products obtained were isolated by silica gel column chromatography and characterised 
by NMR (1H, 13C, DEPT, COSY and HSQC), IR and HRMS. Hydrazonyl chlorides bearing 
electron-donating as well as electron withdrawing aryl groups on the R1 were well tolerated 
with yields raning from 76 – 86 % (322-325, Table 3.7). Change in the electronics on R2 had a 
substantial effect on the efficiency of the reaction, as p-methoxy aryl group gave excellent yield  
(328, 83 %), whereas electron-withdrawing group caused a decrease in the yield (326, 44%). 
This is in accordance with a study by Qing Lin et al.30 who suggested the role of electron-
donating groups on R2 in lifting the HOMO energy of the dipole, as well as lowering of EHOMO 
due to the presence of electron-withdrawing groups. The hypothesis was supported by both 
experimental rate constants as well as theoretical calculations of the energy of the nitrile imine 
species.  
Furthermore, the sterically hindered nitrile imines gave the 1,2,4-triazol-3-imines in moderate 
yields only (326-327, 44%). The introduction of electron-poor cyanamides lead to poor yields 
(329, 44 %), with electron-rich cyanamides giving moderate yields (330, 61 %). Furthermore, 
combination of electron-rich nitrile imine and electron-poor cyanamide and vice versa gave 
good yields of the 1,2,4-triazoleimine product (331, 71% & 332, 78%). Hydrazonyl chlorides 
bearing heterocycles, such as thiophene (297) and pyridine (316) were well tolerated (entries 
13 and 14, Table 3.7), giving 333 and 334 in 85 % and 70 % yield respectively. Aliphatic 
hydrazonyl chlorides bearing cyclopropyl, alkyl esters as well as NH-boc protected alkyl 
groups gave good product yields (335, 337-340, 58-82%).   
The N-(tert-butoxycarbonylamino)-phenylhydrazonoyl chloride 313 gave 3,4-diphenyl-1,2,4-
triazole-3-imine 336 in 62% yield after silica gel column purification (the acidic silica gel 
caused the boc-removal from N-1 of the triazole- imine), saving the further step of boc-
deprotection. The triazole- imine 336 with a free NH (N-1) could be functionalised by 
introduction of alkyl, alkyl-ester, alkyne or aromatic groups providing handles for further 
functionalisation. 
The other N-boc protected aromatic hydrazonyl chlorides 314 and 315 failed to give the desired 
product, as the nitrile imine could not be generated in both the cases.  
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 Table 3.7 Substrate scope of the nitrile imine- cyanamide ion cyclisation 
 
 
 
 
 
 
 
 
 
            aIsolated yield by column chromatography, bratio determined by NMR, cundifferentiable peaks 
[α]D – 41.55
o 
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3.7 Workup and Isolation of the 1,2,4-triazol-3-imine compounds 
As the target compound was found to be water-soluble, an aqueous workup to get rid of excess 
of TBAF was not possible. Hence, Dowex H+ resin along with CaCO3 was used to remove the 
tetrabutylammonium impurities,31 but complete removal of the TBA impurities could not be 
achieved (1:18 of 285: TBAF went down to 1:9). Also, using the Dowex ion exchange resin to 
trap the product in exchange of H+, and finally eluting the product with ammonia did not offer 
clean product. The TBA impurities did not get completely washed off the resin and co-eluted 
with product during ammonia wash. In the total synthesis of fulicinerine,32 the reaction mixture 
after TBAF-mediated desilylation was taken in diethyl ether and washed with sat. aq. 
ammonium chloride (NH4Cl) to get rid of the tetra butyl ammonium impurities as a chlor ide 
salt. Using a similar approach, when the reaction mixture was washed with aq. NH4Cl, the 
product was obtained in considerable purity (but with minor TBA peaks in NMR).  
With the CsF/18-crown-6 system, the purification of the product from the 18-crown-6 
impurities posed a problem. Considering the aqueous solubility of the product, direct loading 
of the reaction mixture on a silica gel column was tried, but it resulted in the elution of 18-
crown-6 along with the product.  
Forming a hydrochloride salt of the product 285, did not yield the pure product as 18-crown-6 
impurities were present. Finally, washing the reaction mixture with sat. aq. potassium chloride 
(KCl) thrice helped in removing all the 18-crown-6 impurities, and pure product was isolated 
after silica gel column chromatography.  
3.8 Post-functionalisation of 1,2,4-triazol-3-imines: Synthesis of 
1,2,4-triazole-3-ones 
1, 2, 4-triazol-3-ones are important heterocyclic cores found in many leading drugs candidates 
for example, etoperidone (anti-depressant), itraconazole (anti-fungal) and herbicides like 
carfentrazone, benzcarbazone, etc. (Figure 3.11). They also show a broad spectrum of 
biological activities such as antivirals, anti-microbials, anti-hypertensives, anti-inflammatory, 
anti-obesity (CB1 selective anatognist) and fungicidals.33 
Ganetepsib (343), a triazolone containing investigational drug molecule is a small-molecule 
heat shock protein 90 (Hsp90) inhibitor, being developed for treating multiple solid tumor and 
hematologic cancers. In in-vitro and in-vivo models, ganetespib has shown potent activity 
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against a wide range of cancer types, including lung, prostate, colon, breast, gastric, pancreatic, 
gastrointestinal stromal tumors, melanoma, acute myeloid leukemia, chronic myeloid 
leukemia, Burkitt's lymphoma, etc., and also in Phase II clinical trials as a combination with 
other drugs (with Paclitaxel for ovarian cancer, with dutasteride for hormone resistant prostrate 
cancer, with fulvestrant for metastatic breast cancer. 
 
Figure 3.11 1,2,4-triazolone containing pharmaceuticals and agrochemicals 
It has also been used as a drug conjugate for targeted delivery of topoisomerase I inhibitors to 
tumours. Various methods exist to synthesise the 1,2,4-triazolone ring, the most common 
involving a cyclisation-dehydration sequence of acyl semicarbazides in alkaline solutions, 
reaction between 1,2,4-triazolium salts with aqueous potassium carbonate, the condensation of 
mono Boc-protected hydrazines with acyl isocyanates and the subsequent deprotection and 
then an intramolecular cyclisation of the intermediate, a reaction of amidrazones and isocyanate 
esters and the cyclisation of the imidoylsemicarbazide of ethyl chloroformate and N-1-
tosylamidrazones, the cyclisation of 1-aryl-1 nitroso-3-(2-pyridylmethyl) ureas and a reaction 
between thiocarbohydrazide and substituted benzoyl hydrazine. 
The hydrolysis of 1,2,4-triazol-3-imine could provide an alternative route towards the 
pharmaceutically important 1,2,4-triazolone core. Following our success with the acidic 
hydrolysis of 1,2,4-oxadiazol-5-imines 177 to 1,2,4-oxadiazol-5-ones 178, we followed the 
protocol by refluxing 285 in the presence of conc. HCl in MeOH, which did not yield any 
product (entry 1, Table 3.8). The use of trifluoroacetic acid returned the starting material, 
whereas under alkaline conditions (KOH, t-BuOK) which included heating microwave 
conditions (220 oC) did not afford any hydrolysed product 1,2,4-triazoleimine (entry 2 and 3, 
Table 3.8). 
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Alper and Baeg34 utilised 5 % sodium hypochlorite under phase transfer catalysis conditions 
for the hydrolysis of imidazolidenimine to the correspinding imidazolidinone in 57% yield 
(JOC, 1992). Utilising similar conditions – 10% sodium hypochlorite and tetra-n-butyl 
ammonium hydrogen sulfate in chloroform gave only 10% yield of 1,2,4-triazolone 345 after 
24 hours (entry 4, Table 3.8). 
Table 3.8 Hydrolysis of 1,2,4-triazol-3-imine 
[a] Isolated yield, [b] also heated in microwave at 220 oC for 10 minutes in toluene 
A system comprising of sodium nitrite and sodium acetate in 50% acetic acid gave the desired 
product 345 in good yield of 76%. The reaction is known to produce nitrous acid in situ, which 
is responsible for the hydrolysis of the 1,2,4-triazolimines 285. The method was adopted from 
Huisgen’s earlier reported findings on 1,2,4-triazol-3-imine.3 In this method, slow addition of 
sodium nitrite to a solution of 285 and sodium acetate in 50% acetic acid at 0-5 oC was crucial. 
The reaction was allowed to come to room temperature slowly and stirred for 4-6 hours. The 
residual nitrous gases were released by heating the reaction mixture after diluting it with water.  
The solid precipitated product was filtered and washed to give the product 345. The product 
obtained showed a new band for C=O at 1700 cm-1, while the band for C=N disappeared. The 
 
Entry Reagents Solvent Temp 
Time 
(h) 
Yield (%)[a] 
1 Conc. HCl MeOH reflux 24 0 
2 Trifluoroacetic acid MeOH reflux 24 0 
3 KOH, t-BuOK (3:3) THF rt[b] 24 0 
4 10% NaOCl, Bu4N+HSO4- CHCl3 rt 24 10 
5 NaNO2, NaOOCCH3 50% CH3COOH 0 oC- rt 6 76 
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product was further confirmed by NMR (ref literature), HRMS and unambiguously confirmed 
by single crystal X-ray crystallography.  
Table 3.9 Hydrolysis of 1,2,4-triazol-3-imine to 1,2,4-triazol-3-one 
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A substrate scope was carried out to test the application of this method towards other 1,2,4-
triazol-3-imines bearing aromatic, heteroaromatic, aliphatic and sterically hindered groups, 
which gave the desired hydrolysis product (345-354) in good to excellent yields. The 3,4-
diphenyl 1,2,4-triazolone (unsubstituted NH) 354 was obtained in a good yield of 70%, 
showing direct applicability towards ganetespib (343) synthesis (Figure 3.11) which shares a 
similar core as the product 354.  
3.9 Efforts towards preferable formation of 5-anilino-1,2,4-triazo le  
During our preliminary studies on the hydrazonyl chloride with NCTS we observed the 
competitive formation of the 1,2,4-triazol-3-imine and 5-anilino-1,2,4-triazole in varying ratio 
(55:45 to 94:6), imine being the major in every case. We optimised the condition for the 
preferred formation of the 1,2,4-triazol-3-imine over its heterocyclic isomer 286 5-anilino -
1,2,4-triazole in 94:6. Next, efforts were made towards optimising the conditions to access 5-
anilino -1,2,4-triazole (286) preferably (Scheme 3.13). 
 
Scheme 3.13 Different strategies employed for 5-anilino-1,2,4-triazole synthesis 
Strategy A: Reaction of hydrazonyl chloride 70 with N-substituted cyanamides 145’ in presence 
of base/heat 
According to strategy A, it was hypothesised that introducing a base such as K2CO3, Et3N, t-
BuOK in the reaction of hydrazonyl chloride 70 and N-substituted cyanamide derivatives, 
would lead to the nitrile imine generation but no cyanamide ion formation. This would facilita te 
the nucleophilic attack of the nitrile imine on the electrophilic nitrile centre of the cyanamide 
(145’) (Scheme 3.13 and 3.14).  
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Scheme 3.14 Strategy A: Reaction of 70 and 145’ in presence of base 
Based on this hypothesis, reactions were carried out with NCTS (145a) in presence of bases 
like: TEA/DCM/rt, TEA/toluene/microwave (MW)/150 oC, 1M NaOH/H2O/Acetone, 5% 
Na2CO3/TBAB/THF/rt, 5% Na2CO3/TBAB/THF/MW/150 oC), t-BuOK/THF/50 oC, t-
BuOK/toluene/MW/150 oC, TEA/Cu(I)/toluene/rt, t-BuOk/Cu(I)/toluene/rt, and lewis acids 
like CuSO4/H2O, Cu(NO3)2/H2O, but all the reaction conditions generated nitrile imine (as 
confirmed by detection of dimer formation-TLC/GC-MS); NCTS remained unconsumed or got 
degraded (trimer formation). Unfortunately, no anilino-1,2,4-triazole (355a) formation was 
observed. 
The inability of the nitrile imine to attack the nitrile carbon in NCTS lead us to think if the 
steric bulk of the toluenesulfonyl group was hindering the reaction. Hence, N-methanesulfonyl-
N-phenyl cyanamide (145f, X = Ms) was synthesised and reacted in excess with the hydrazonyl 
chloride (70) under varying conditions – DIPEA/CH2Cl2/rt, TEA(excess)/toluene/ref lux, 
neat/132 oC, neat/µwave/150 oC. Again, the hydrazonyl chlorides were readily dimerised, with 
145f either getting degraded or remaining unreacted. Thus, even the introduction of a less bulky 
group (methane sulfonyl) in the cyanamide did not yield the 5-anilino-5-methanesulfonyl-
1,2,4-triazole 355f.  
Next, phenyl cyanamide 104 (X = H), was reacted with the hydrazonyl chloride under altered 
conditions - neat/100 oC, TEA/toluene/reflux which just resulted in the dimer formation and 
degradation of the phenyl cyanamide. The reaction with DIPEA/DCM/rt resulted in the 
formation of the dimer and 1,2,4-triazole-5-imine (285), instead of the expected 5-anilino 1,2,4-
triazole 286. 
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Strategy B: Reaction of hydrazonyl chloride 70 with NCTS 145a in presence of fluoride 
source/additives/solvent 
As per our previous study, reactions of hydrazonyl chlorides with NCTS carried out in the 
presence of fluoride source gave a mixture of 5-anilino-1,2,4-triazole (286) and 1,2,4-triazole-
3-imine (285). Various solvents were screened for the slow addition of hydrazonyl chloride 
(70, 1 hour) to a heterogenous mixture containing 145a, CsF/18-crown-6 and the ratio of 
286:285 (amine:imine) were recorded: CHCl3 (16:84), THF (25:75), dioxane (29:71), Et2O 
(31:69).  
Under the optimised conditions (adding hydrazonyl chloride after 10 minutes), THF was more 
favourable towards 5-anilino-1,2,4-triazole (286) as it returned the products in the ratio of 
45:55 (entry 7, Table 3.6). Even more enhancement of the 286:285 was observed when 1.1 
molar equivalents of TEA was used along with CsF:18-crown-6 (2.5:2.5) in THF, and 
hydrazonyl chloride (70) was added over a period of 20 minutes at room temperature. The 
above reaction yielded the products in a ratio of 67:33 of 286: 285. The ratios were determined 
by NMR analysis of the crude reaction mixture. 
 
Scheme 3.15 Optimal conditions for preferential formation of 1,2,4-triazol-5-amine (286) 
3.10 Conclusions and future work 
We have demonstrated that 1,2,4-triazole-3-imines (180) can be prepared by the cyclisat ive 
capture of in situ generated nitrile imines (268) and cyanamide ion (199), using CsF/18-crown-
6 as base and fluoride source. The reaction is complete within 20 min, affording a wide variety 
of 1,2,4-triazol-imine compounds in good to excellent yields.  
The 1,2,4-triazol-3-imine core can be further functionalised to pharmaceutically important 
1,2,4-triazolone by hydrolysis in good yields. The present methodology offers a new route 
towards Ganetespib, an investigational anti-cancer drug, the synthesis of which can be a part 
of future studies.  
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The selective synthesis of 5-anilino-1,2,4-triazole (286) which is the heterocyclic isomer of 
1,2,4-triazol-3-imine, can be further investigated. This will further enhance the utility of 
cyanamide in the construction of different heterocyclic cores. 
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Chapter 4 
Experimental Section 
General Information 
1H NMR spectra were recorded on Bruker AV 400, DPX 400 and AV 500 spectrometers at 
400 and 500 MHz respectively. 13C NMR spectra were recorded using the same spectrometers 
at 100 and 125 MHz respectively. Chemical shifts (δ in ppm) were referenced to 
tetramethylsilane (TMS) or to residual solvent peaks (CDCl3 at δH 7.27, δC at 77.00 ppm, 
MeOD at δH 3.31, δC at 49.15 ppm). J values are given in Hz and s, d, dd, t, td, q, m and br 
abbreviations correspond to singlet, doublet, doublet of doublet, triplet, triplet of doublet, 
quartet, multiplet, broad and combinations thereof. High-resolution mass spectra (HRMS) were 
recorded on a VG micron Autospec or Bruker microTOF. Infrared spectra were obtained on 
Perkin-Elmer Spectrum 100 FT-IR Universal ATR Sampling Accessory or Bruker Alpha FT-
IR Spectrometer, deposited neat to a diamond/ZnSe plate. Specific rotation of the samples were 
measured using polarimeter in concentration of 1g/100 ml, path length – 0.5 dm3 and 
temperature – 24.5o C. An average of 5 readings was taken. Melting Point was recorded on a 
Stuart SMP10 digital melting point apparatus.  
Column chromatography was carried out using silica gel 60 and thin layer chromatography was 
performed using silica gel 60 F254 pre-coated sheets and visualised by UV (254 nm) or stained 
by the use of aqueous acidic KMnO4, alcoholic solution of p-anisaldehyde, or molecular iodine 
as appropriate. Petroleum ether refers to petroleum ether (40–60 %) and EtOAc refers to ethyl 
acetate. Conc. HCl refers to the 37 % HCl analytical grade. NH3 refers to 37% aqueous solution 
of ammonia.  All chemicals were used without further purification unless otherwise stated.  
4.1 General Procedure for the synthesis of N-aryl N-toluenesulfonyl 
cyanamide1 
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A 250 mL round bottom flask was charged with aryl urea (8 mmol) and dissolved by addition 
of pyridine (54 mL). The flask was immersed in room temperature water bath. p-
toluenesulfonyl chloride (27.7 mmol) was added portion wise over 3 min. The reaction mixture 
was stirred for additional 15 min and poured into ice-cold water (400 mL) with mechanica l 
stirring. Precipitate formed during mechanical stirring was filtered under vacuum and washed 
with water. Precipitated product was further purified by column chromatography using Pet 
ether:EtOAC (9:1) as eluent to yield N-aryl N-tosyl cyanamide. 
N-phenyl N-toluenesulfonyl cyanamide (145a)2 
 
Following general procedure 4.1: N-Phenyl urea (1.08 g, 8 mmol) and p-toluenesulfonyl 
chloride (5.27 g, 27.7 mmol) were reacted to afford the product 145a (1.62 g, 74 % yield) as a 
white crystalline solid; M. p. 85-87 oC (85-87 oC)1; 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 
8.4 Hz, 2H, Ar-H), 7.45 – 7.34 (m, 5H, Ar-H), 7.21-7.19 (m, 2H, Ar-H), 2.48 (s, 3H, CH3) 
ppm;13C NMR (100 MHz, CDCl3) δ 146.7 (C), 134.5 (C), 132.3 (C), 130.2 (CH), 129.9 (CH), 
129.8 (CH), 128.4 (CH), 126.4 (CH), 108.6 (C), 21.8 (CH3) ppm; IR: ῦ (cm-1) 2232, 1591, 
1485, 1389, 1171. 
 
N-(4-Methoxyphenyl) N-toluenesulfonyl cyanamide (145b) 
 
 
 
Following general procedure 4.1: 4-methoxyphenyl urea (0.5 g, 3.0 mmol) and p-
toluenesulfonyl chloride (1.98 g, 10.4 mmol) were reacted to afford the product 145a (0.47 g, 
52 % yield) as a white crystalline solid; M. p. 117-118 °C; Rf 0.55 (4:1 Pet Ether:EtOAc); 1H 
NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.2 Hz, 2H, Ar-H), 7.34 (d, J = 8.2 Hz, 2H, Ar-H), 
7.05 (d, J = 9.0 Hz, 2H, Ar-H), 6.84 (d, J = 9.0 Hz, 2H, Ar-H), 3.8 (s, 3H, OCH3), 2.47 (s, 3H, 
CH3); 13C NMR (100 MHz, CDCl3) : δ 160.6 (C), 146.6 (C), 132.0 (C), 130.1 (CH), 128.3 
(CH), 128.2 (CH), 126.6 (C), 114.8 (CH), 108.7 (C), 55.5 (OCH3), 21.7 (CH3); IR: ῦ (cm-1): 
2923, 2848, 2230, 1589, 1503, 1399, 1174 ; HRMS (ESI) calculated for C15H15 N2O3S [M+H]+ 
303.0798, found: 303.0796. 
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N-(4-Fluorophenyl) N-toluenesulfonyl cyanamide (145c) 
 
Following general procedure 4.1: 4-fluorophenyl urea (0.5 g, 3.25 mmol) and p-
toluenesulfonyl chloride (2.14 g, 11.2 mmol) were reacted to afford the product 145a (0.24 g, 
26 % yield) as a white crystalline solid; M. p. 108-109 °C; Rf 0.63 (4:1 Pet Ether:EtOAc); 1H 
NMR (400 MHz, CDCl3): δ 7.62 (d, J = 8.4 Hz, 2H, Ar-H), 7.36 (d, J = 8.4 Hz, 2H, Ar-H), 
7.18-7.15 (m, 2H, Ar-H), 7.09-7.04 (m, 2H, Ar-H), 2.48 (s, 3H, CH3); 13C NMR (100 MHz, 
CDCl3) : δ 162.9 (C, d, J = 250.6 Hz), 146.9 (C), 131.8 (C), 130.3 (CH), 128.6 (CH, d, J = 9.1 
Hz), 128.3 (CH), 116.8 (CH, d, J = 23.3 Hz), 108.4 (C), 21.7 (CH3); IR: ῦ (cm-1)  2232, 1595, 
1498, 1386, 1179; HRMS (ESI) calculated for C14H12FN2O2S [M+H]+ 291.0598, found: 
291.0593. 
N-methyl N-toluenesulfonyl cyanamide (145d) 
 
 
 
Following general procedure 4.1: N-methyl urea (1.0 g, 13.5 mmol) and p-toluenesulfonyl 
chloride (8.9 g, 46.7 mmol) were reacted to afford the product 145a (2.0 g, 72 % yield) as a 
white crystalline solid; M. p. 67-68 °C; Rf 0.32 (4:1 Pet Ether:EtOAc); 1H NMR (400 MHz, 
CDCl3): δ 7.84 (d, J = 8.3 Hz, 2H, Ar-H), 7.44 (d, J = 8.0 Hz, 2H, Ar-H), 3.14 (s, 3H, N-CH3),  
2.50 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) : 146.6 (C), 132.5 (C), 130.5 (CH), 127.9 
(CH), 109.4 (C), 36.8 (N–CH3), 21.7 (CH3) ppm; IR: ῦ (cm-1)  2232, 1595, 1498, 1385, 1177; 
HRMS (ESI) calculated for C9H11N2O2S [M+H]+ 211.0462, found: 211.0474. 
4.2 Synthesis of N-aryl and N-alkyl cyanamides 
 
4.2.1 General procedure for the preparation of amidoximes from carbonitriles 3 
To the solution of carbonitrile in EtOH (0.1 M) was added 50wt% aqueous hydroxylamine 
solution (1.5~2 equiv). The mixture was stirred at reflux temperature for 3 h under nitrogen. 
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After cooling to room temperature, the reaction mixture was concentrated under reduced 
pressure and the residue was used for the subsequent reaction without further purification. 
 
Benzamidoxime (219):4 
 
Compound 219 was prepared by the Procedure 4.2.1 from benzonitrile (5.0 g, 48.5 mmol) 218 . 
The crude product was used for the subsequent reaction without further purification (white 
solid, 5.34 g, 81% yield). 1H NMR (400 MHz, CDCl3) δ 9.67 (s, 1H, OH), 7.71-7.69 (m, 2H, 
Ar-H), 7.38-7.36 (m, 3H, Ar-H), 5.82 (s, 2H, NH2) ppm; 13C NMR (100 MHz, CDCl3) δ 151.0 
(C), 133.4 (CH), 129.0 (CH), 128.2 (CH), 125.5 (C). 
Butyramidoxime (251)4: 
 
Compound 251 was prepared by the Procedure 4.2.1 from propionitrile (3.0 g, 43.4 mmol) 
250. The crude product was used for the subsequent reaction without further purifica t ion 
(colourless oil, 3.37 g, 76% yield). 1H NMR (400 MHz, CDCl3) δ 8.64 (br s, 1 H, OH), 4.63 
(s, 2 H, NH2), 2.10 (t, J = 7.4 Hz, 2 H, CH2), 1.61-1.51 (m, 2 H, CH2), 0.93 (t, J = 7.4 Hz, 3 H, 
CH3) ppm; 13C NMR (100 MHz, CDCl3): δ 153.9 (C), 33.0 (CH2), 20.0 (CH2), 13.4 (CH3). 
 
4.2.2 General procedure for the preparation of N-substituted cyanamides from amidoximes 
with p-toluenesulfonyl chloride4  
To the mixture of amidoxime and DIPEA (1.05 equiv) in CH2Cl2 (0.1 M) at 0 oC was added p-
TsCl (1.05 equiv). The mixture was stirred for 3 h under nitrogen while the temperature was 
allowed to rise to room temperature. The mixture was concentrated under reduced pressure and 
the residue was purified by column chromatography.  
 
4.2.3 General procedure for the preparation of N-substituted cyanamides from amidoximes 
with o-nitrobenzenesulfonyl chloride4  
To the mixture of amidoxime and DIPEA (1.05 equiv) in CH2Cl2 (0.1 M) at 0 oC was added o-
NsCl (1.05 eq). The mixture was stirred at 0 oC for 10 min and then at reflux temperature for 1 
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hour under nitrogen. After cooling to room temperature, the reaction mixture was concentrated 
under reduced pressure and the residue was purified by column chromatography. 
 
N-Phenylcyanamide4 (104):  
 
 
 
The compound (104) was prepared by the Procedure 4.2.2 from benzamidoxime (3.0 g, 22.0 
mmol) and p-toluene sulfonyl chloride (4.4 g, 23.1 mmol) 219. The reaction was purified by 
column chromatography (Pet. Ether / EtOAc = 8 : 2, Rf = 0.20) to give 38a (brown syrup, 1.95 
g, 75% yield); 1H NMR (400 MHz, CDCl3) δ 7.33 (t, J = 7.8 Hz, 2H, Ar-H), 7.08 (t, J = 7.3 
Hz, 1H, Ar-H), 7.02 (d, J =8.5 Hz, 2 H, Ar-H); 13C NMR (100 MHz, CDCl3) δ 137.3 (C), 129.6 
(CH), 123.4 (CH), 115.3 (CH), 111.8 (C); IR: ῦ cm-1 :3461, 3173, 2982, 2915, 2221, 1594.  
 
N-propyl cyanamide4 (252):  
 
 
The compound (252) was prepared by the Procedure 4.2.2 from butyramidoxime 251 (2.0 g, 
19.6 mmol) and o-nitro phenylsulfonyl chloride (4.55 g, 20.5 mmol). The reaction was purified 
by column chromatography (Pet. Ether / EtOAc = 8 : 2, Rf = 0.35) to give 252 (Yellow oil,   
1.05 g, 64 % yield), 1H NMR (400 MHz, CDCl3): δ  4.48 (s, 1H, NH), 3.00-2.96 (m, 2H, CH2), 
1.63-1.54 (m, 2H, CH2), 0.93 (t, J = 7.5 Hz, 3H, CH3) ppm; 13C NMR (100 MHz, CDCl3) δ = 
116.8 (CN), 47.5 (CH2), 22.8 (CH2), 10.6 (CH3) ppm; IR: ῦ cm-1= 2970, 2676, 2214, 1538, 
1464. 
4.3 Synthesis of oximes and hydroximoyl chlorides 
4.3.1 General procedure for the preparation of aldoximes (210) from aldehydes (209)5  
A mixture of the aldehyde (20.0 mmol), hydroxylamine hydrochloride (26 mmol) and Na2CO3 
(4.6 mmol) in 60 ml of water was refluxed for 2 h. After the reaction mixture was allowed to 
cool down to room temperature, it was extracted with dichloromethane (2 × 40 ml), and the 
organic fractions were combined and concentrated under reduced pressure. The residue was 
used for the subsequent reaction without further purification. 
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Benzaldehyde oxime6 (210a) 
 
Following general procedure 4.3.1: Benzaldehyde (2.12 g, 20 mmol) gave the product 210a 
(2.4 g, 99 % yield) as a colourless oil; 1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H, sp2 CH), 
7.65-7.57 (m, 3H, OH and Ar-H), 7.42-7.38 (m, 3H, Ar-H); 13C NMR (100 MHz, CDCl3) δ 
150.3 (C), 131.8 (C), 129.9 (CH), 128.6 (CH), 126.9 (CH) ppm. 
4-methyl benzaldehyde oxime6 (210b) 
 
Following general procedure 4.3.1: 4-methylbenzaldehyde (2.4 g, 20 mmol) gave the product 
210a (2.64 g, 98 % yield) as a white solid; M. p. 72-74 °C; 1H NMR (400 MHz, CDCl3): 8.78 
(brs, 1H, OH), 8.16 (s, 1H, sp2 CH), 7.49 (d, J = 8.1 Hz, 2H, Ar-H), 7.21 (d, J = 8.1 Hz, 2H, 
Ar-H), 2.39 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) : δ 150.3 (CH), 140.3 (C), 129.5 (CH), 
129.1 (C), 126.9 (CH), 21.4 (CH3) ppm. 
4-hydroxy benzaldehyde oxime6 (210c) 
 
Following general procedure 4.3.1: 4-hydroxybenzaldehyde (2.45 g, 20 mmol) gave the 
product 210a (2.6 g, 95 % yield) as a brown solid; M. p. 75-77 °C; 1H NMR (400 MHz, MeOD): 
7.99 (s, 1H, sp2 CH), 7.41 (d, J = 8.2 Hz, 2H, Ar-H), 6.78 (d, J = 8.5 Hz, 2H, Ar-H); 13C NMR 
(100 MHz, MeOD): δ 160.1 (C), 150.5 (C), 134.1 (CH), 129.4 (C), 125.6 (C), 116.6 (CH) ppm.  
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4-methoxy benzaldehyde oxime6 (210d) 
 
Following general procedure 4.3.1: 4-methoxybenzaldehyde (2.7 g, 20 mmol) gave the 
product 210a (2.87 g, 96 % yield) as a yellow solid; M. p. 51-54 °C; 1H NMR (400 MHz, 
CDCl3): 8.14 (s, 1H, sp2 CH), 7.54 (d, J = 8.78 Hz, 2H, Ar-H), 6.92 (d, J = 8.78 Hz, 2H, Ar-
H), 3.83 (s, 3H, OCH3); 13C NMR (100 MHz, CDCl3) : δ 161.0 (C), 149.9 (CH), 128.5 (CH), 
124.5 (C), 114.2 (CH), 55.2 (CH3) ppm 
4-chloro benzaldehyde oxime6 (210e) 
 
Following general procedure 4.3.1: 4-chlorobenzaldehyde (2.8 g, 20 mmol) gave the product 
210a (2.97 g, 96 % yield) as a white solid; M. p. 108-110 °C; 1H NMR (400 MHz, CDCl3): 
8.73 (brs, 1H, OH), 8.14 (s, 1H, sp2 CH), 7.54-7.50 (m, 2H, Ar-H), 7.39-7.36 (m, 2H, Ar-H);  
13C NMR (100 MHz, CDCl3) : δ 149.3 (CH), 136.0 (C), 130.3 (C), 129.0 (CH), 128.2 (CH) 
ppm. 
4-fluoro benzaldehyde oxime (210f) 
 
Following general procedure 4.3.1: 4-fluorobenzaldehyde (2.5 g, 20 mmol) gave the product 
210a (2.6 g, 93 % yield) as a white solid; M. p. 85-87 °C; 1H NMR (400 MHz, CDCl3): 8.74 
(brs, 1H, OH), 8.15 (s, 1H, sp2 CH), 7.60-7.55 (m, 2H, Ar-H), 7.13-7.06 (m, 2H, Ar-H);  13C 
NMR (100 MHz, CDCl3) : δ 163.7 (C, d, J = 260.6 Hz), 149.3 (CH), 128.8 (CH, d, J = 8.4 Hz), 
128.1 (C, d, J = 3.0 Hz), 115.9 (CH, d, J = 22.2 Hz) ppm. 
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4-nitro benzaldehyde oxime6 (210g) 
 
Following general procedure 4.3.1: 4-nitrobenzaldehyde (3.0 g, 20 mmol) gave the product 
210a (3.2 g, 97 % yield) as a yellow solid; M. p. 129-131 °C; 1H NMR (400 MHz, CDCl3): 
8.26 (d, J = 8.8 Hz, 2H, Ar-H), 8.22 (s, 1H, sp2 CH), 8.07 (brs, 1H, OH), 7.76 (d, J = 8.9 Hz, 
2H, Ar-H);  13C NMR (100 MHz, CDCl3) : δ 148.3 (CH), 138.1 (C), 127.6 (CH), 124.0 (CH), 
123.7 (C) ppm. 
2,6-dimethylbenzaldehyde oxime (210h) 
 
 
 
Following general procedure 4.3.1: 2,6-dimethylbenzaldehyde (2.7 g, 20 mmol) gave the 
product 210a (2.9 g, 97 % yield) as a white solid; M. p. 151-153 °C; 1H NMR (400 MHz, 
CDCl3): 8.92 (brs, 1H, OH), 8.47 (s, 1H, sp2 CH), 7.22-7.19 (m, 1H, Ar-H); 7.11 Hz (d, J = 
7.53Hz, 2H, Ar-H), 2.45 (s, 6H, 2 x CH3);  13C NMR (100 MHz, CDCl3) : δ 149.7 (CH), 137.4 
(C), 129.3 (C), 128.9 (CH), 128.4 (CH), 20.9 (CH3) ppm. 
Thiophene-3-carbaldehyde oxime6 (210i) 
 
Following general procedure 4.3.1: 3-thiophene carboxaldehyde (2.2 g, 20 mmol) gave the 
product 210a (2.4 g, 98 % yield) as a brown solid; mixture of E and Z isomer (57:43 mixture ); 
1H NMR (400 MHz, CDCl3): δ 9.89 (br s, 1H), 8.24 (s, 1H, major), 8.21 (dd, J = 3.0; 1.1 Hz, 
1H, minor), 7.53-7.52 (m, 1H, major), 7.50 (dd, J = 3.0; 1.2 Hz, 1H, major), 7.44 (app d, J = 
0.9 Hz, 1H, minor), 7.43 (d, J = 1.2 Hz, 1H, major), 7.35-7.32 (m, 1H, minor), 7.34 (m, 1H, 
major). 13C NMR (100 MHz, CDCl3): δ 145.6 (CH), 141.0 (CH), 134.1 (C), 131.4 (CH), 131.2 
(C), 129.3 (CH), 126.8 (CH), 125.1 (CH), 124.7 (CH) ppm. 
N
H
OH
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Furan-3-carbaldehyde oxime (210j) 
 
Following general procedure 4.3.1: 3-furan carboxaldehyde (1.9 g, 20 mmol) gave the 
product 210a (2.2 g, 99 % yield) as a brown solid; mixture of E and Z isomer (1:1 mixture); 1H 
NMR (400 MHz, CDCl3): δ 10.10 (brs, 2H, OH), 8.27 (br s, 1H, E-isomer), 8.12 (s, 1H, Z-
isomer), 7.66 (brs, 1H, Z-isomer), 7.45 (t, J = 1.7 Hz, E-isomer), 7.43 (m, 1H, Z-isomer), 7.39 
(brs, 1H, E-isomer), 6.75 (m, 1H, Z-isomer), 6.68 (dd, J = 1.2; 0.5 Hz, 1H, E-isomer); 13C NMR 
(100 MHz, CDCl3): δ 147.1 (CH, E-isomer), 144.1 (CH, Z-isomer), 143.7 (CH, Z-isomer), 
142.7 (CH, E-isomer), 142.6 (CH, Z-isomer), 139.7 (CH, E-isomer), 119.4 (C, Z-isomer), 116.0 
(C, E-isomer), 110.7 (CH, E-isomer), 107.2 (CH, Z-isomer) ppm. 
Indole-3-carbaldehyde oxime (210k) 
 
Following general procedure 4.3.1: 3-Indole caboxaldehyde (2.9 g, 20 mmol) gave the 
product 210a (3.0 g, 94 % yield) as a white solid; M. p. 172-173 °C (lit- 196-198  oC); 1H NMR 
(400 MHz, CDCl3): 8.31-8.29 (m, 1H), 7.75-7.70 (m, 2H), 7.40-7.38 (m, 1H), 7.19-7.11 (m, 
2H) ppm, ESI M+  (m/z) for C9H8N2O – 160.0732 
Terepthaldehyde dioxime7 (210l) 
 
Following general procedure 4.3.1: Terepthaldehyde (2.7 g, 20 mmol) gave the product 210a 
(3.2 g, 98 % yield) as a white solid; M. p. 184-185 °C; 1H NMR (400 MHz, MeOD): 8.15 (s, 
2H, sp2 CH), 7.66 (s, 4H, Ar-H); 13C NMR (100 MHz, MeOD): δ 149.7 (CH), 135.6 (C), 128.1 
(CH) ppm. 
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4.3.2 General procedure for the preparation of hydroximoyl chlorides (211) from aldoximes 
(210)8 
To a solution of 10 mmol of oxime in DMF (10 mL) was added 1.8 mmol of N-
chlorosuccinimide (NCS) in one portion. (The beginning of the reaction can be detected by a 
slight increase of the reaction temperature. If the reaction does not start, heat was applied with 
a heat-gun to initiate the reaction. With the electron-deficient oximes, the reaction mixture was 
heated to 45 °C.) The remaining 8.2 mmol of NCS was added in small portions while keeping 
the temperature below 35 °C (below 60 °C for electron-deficient oximes). The mixture was 
stirred at room temperature for 1 h, poured into water, and extracted with dichloromethane. 
The organic phase was washed with brine and dried over Na2SO4, and the solvent was removed 
to give the imidoyl chloride products in 50-90% yield after column chromatography. 
N-hydroxybenzimidoyl chloride (211a) 
 
Following general procedure 4.3.2: Benzaldehyde oxime (1.2 g, 10 mmol) gave the product 
211a (1.32 g, 86 % yield) as a white solid; M. p. 48-49 °C; 1H NMR (400 MHz, CDCl3) δ 8.29 
(brs, 1H, OH), 7.88-7.84 (m, 2H, Ar-H), 7.49-7.40 (m, 3H, Ar-H); 13C NMR (100 MHz, 
CDCl3) δ 140.5 (C), 132.3 (C), 130.8 (CH), 128.5 (CH), 127.1 (CH) ppm; HRMS (ESI) 
calculated for [M+H]+ 156.0211, C7H7ClNO found: 156.0219. 
N-hydroxy 4-methylbenzimidoyl chloride (211b) 
 
Following general procedure 4.3.2: 4-methylbenzaldehyde oxime (1.35 g, 10 mmol) gave the 
product 211a (1.15 g, 68 % yield) as a white solid; 1H NMR (400 MHz, CDCl3) δ 8.57 (s, 1H, 
OH), 7.76 (d, J = 8.28 Hz, 2H, Ar-H); 7.25 (d, J = 8.03 Hz, 2H, Ar-H), 2.43 (s, 3H, CH3);  13C 
NMR (100 MHz, CDCl3) δ 141.2 (C), 140.5 (C), 129.5 (C), 129.2 (CH), 127.1 (CH), 21.3 
(CH3) ppm. 
 
165 | P a g e  
 
N, 4-dihydroxybenzimidoyl chloride (211c) 
 
Following general procedure 4.3.2: 4-hydroxybenzaldehyde oxime (1.37 g, 10 mmol) gave 
the product 211a (0.87 g, 51 % yield) as a brown syrup; 1H NMR (400 MHz, MeOD) 7.67-
7.64 (m, 2H, Ar-H), 7.25 Hz (d, J = 8.03 Hz, 2H, Ar-H), 2.43 (s, 3H, CH3);  13C NMR (100 
MHz, MeOD): δ 160.4 (C), 138.5 (C), 129.6 (CH), 125.7 (C), 116.1 (CH) ppm. 
N-hydroxy-4-methoxybenzimidoyl chloride (211d) 
 
Following general procedure 4.3.2: 4-methoxybenzaldehyde oxime (1.51 g, 10 mmol) gave 
the product 211a (1.55 g, 84 % yield) as a yellow solid; M. p. 84-86 °C; 1H NMR (400 MHz, 
CDCl3): 8.82 (s, 1H, OH), 7.78 (d, J = 9.0 Hz, 2H, Ar-H); 6.93 (d, J = 9.0 Hz, 2H, Ar-H), 3.85 
(s, 3H, CH3);  13C NMR (100 MHz, CDCl3): δ 161.5 (C), 140.0 (C), 128.7 (CH), 124.8 (C), 
113.8 (CH), 55.4 (CH3) ppm. 
4-chloro-N-hydroxybenzimidoyl chloride (211e) 
 
Following general procedure 4.3.2: 4-chlorobenzaldehyde oxime (1.55 g, 10 mmol) gave the 
product 211a (1.29 g, 68 % yield) as a white solid; M. p. 88-89 °C; 1H NMR (400 MHz, 
CDCl3): 8.85 (s, 1H, OH), 7.76 (d, J = 8.9 Hz, 2H, Ar-H); 7.38 (d, J = 8.9 Hz, 2H, Ar-H);  13C 
NMR (100 MHz, CDCl3): δ 139.6 (C), 137.0 (C), 130.7 (C), 128.7 (CH), 128.3 (CH) ppm. 
4-fluoro-N-hydroxybenzimidoyl chloride (211f) 
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Following general procedure 4.3.2: 4-fluorobenzaldehyde oxime (1.4 g, 10 mmol) gave the 
product 211a (1.36 g, 79 % yield) as a white solid; M. p. 70-72°C; 1H NMR (400 MHz, CDCl3): 
7.85-7.81 (m, 2H, Ar-H); 7.14-7.08 (m, 2H, Ar-H);  13C NMR (100 MHz, CDCl3): δ 164.2 (C, 
d, J = 251.7 Hz), 139.6 (C), 129.2 (CH, d, J = 8.78 Hz), 128.4 (C, d, J = 2.93 Hz), 115.6 (CH, 
d, J = 21.96 Hz) ppm 
4-nitro-N-hydroxybenzimidoyl chloride (211g) 
 
Following general procedure 4.3.2: 4-nitrobenzaldehyde oxime (1.66 g, 10 mmol) gave the 
product 211a (1.44 g, 72 % yield) as a yellow solid; M. p. 123-124 °C; 1H NMR (400 MHz, 
CDCl3): 8.28 (d, J = 9.16 Hz, 2H, Ar-H), 8.19 (s, 1H, OH),  8.05 (d, J = 9.16 Hz, 2H, Ar-H);  
13C NMR (100 MHz, CDCl3): δ 148.9 (C), 138.1 (C), 133.1 (C), 128.0 (CH), 123.7 (CH) ppm.  
N-hydroxy-2,6-dimethylbenzimidoyl chloride (211h) 
 
Following general procedure 4.3.2: 2,6-dimethylbenzaldehyde oxime (1.5 g, 10 mmol) gave 
the product 211a (0.95 g, 52 % yield) as a yellow solid; 1H NMR (400 MHz, CDCl3): 8.28 (d, 
J = 9.16 Hz, 2H, Ar-H), 8.19 (s, 1H, OH),  8.05 (d, J = 9.16 Hz, 2H, Ar-H);  13C NMR (100 
MHz, CDCl3): δ 148.9 (C), 138.1 (C), 133.1 (C), 128.0 (CH), 123.7 (CH) ppm. 
N-hydroxythiophene-3-carbimidoyl chloride (211i) 
 
Following general procedure 4.3.2: thiophene carbaldehyde oxime (1.27 g, 10 mmol) gave 
the product 211a (1.4 g, 87 % yield) as a yellow solid; mixture of isomers (57:43); 1H NMR 
(400 MHz, CDCl3): δ 7.79-7.78 (m, 1H, major), 7.43 (d, J = 5.0 Hz, 1H, minor), 7.33 (m, 1H, 
major), 7.10 (d, J = 5.5 Hz, 1H, major); 13C NMR (100 MHz, CDCl3): δ  136.0 (C), 134.4 (C), 
131.6 (C), 127.3 (CH) 126.6 (CH), 125.2 (CH), 124.2 (CH), 123.9 (CH) ppm 
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4.4  Synthesis of 1,2,4-oxadiazol-5(4H)-imine 
 
4.4 General procedure for the synthesis of 1,2,4 –oxadiazol-5(4H)-imine 
 
Hydroximoyl chloride (1 equiv., 0.64 mmol) and N-aryl-N-tosyl cyanamide (1.25 equiv., 0.80 
mmol) were taken in an oven dried 10 mL round bottom flask equipped with a magnetic stirrer 
bar. The substrates were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 
minutes. The reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 3 equiv., 
1.92 mmol, 1.92 mL) was added through a syringe pump at the rate of 1.92 mL/hour. After the 
addition, the flask was removed from the ice-bath, and the volatile components were removed 
under vacuum. The organic residue from the reaction mixture was dissolved in 10 mL ethyl 
acetate, and washed with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried 
over anhydrous Na2SO4 and solvents removed under reduced pressure and purified by column 
chromatography.  
3,4-Diphenyl-1,2,4-oxadiazol-5(4H)-imine (214) 
 
 
 
N-Hydroxybenzimidoyl chloride 6a (100 mg, 0.64 mmol) and N-phenyl-N-tosyl cyanamide 2a 
(218 mg, 0.80 mmol) were taken in an oven dried 10 mL round bottom flask equipped with a 
magnetic stirrer bar under argon. The substrates were dissolved in anhydrous THF (0.5 mL) 
and allowed to stir for 5 minutes. The reaction mixture was cooled to 0 oC (ice-bath) and TBAF 
(1M in THF, 1.92 mL, 1.92 mmol) was added through a syringe pump at the rate of 1.92 
mL/hour. After the addition, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 10 mL ethyl acetate, and washed with water (2 x 5 mL) and brine (1 x 5 mL). The 
organic fraction was dried over anhydrous Na2SO4 and solvents removed under reduced 
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pressure and purified by column chromatography on silica gel using Pet Ether: EtOAc (9:1 to 
7:3) to afford the product 1a (120 mg, 79% yield) as a white solid, 79% yield; M. p. 146-
147 °C; Rf 0.35 (1:1 Pet Ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.41-7.32 (m, 4H, Ar-
H), 7.30-7.24 (m, 4H, Ar-H), 7.20-7.19 (m, 1H, Ar-H), 7.18-7.15 (m, 1H, Ar-H), 5.54 (brs, 1H, 
NH) ppm; 13C NMR (100 MHz, CDCl3) : δ 160.8 (C), 157.2 (C), 133.3 (C), 131.6 (CH), 129.9 
(CH), 129.2 (CH), 128.8 (CH), 128.3 (CH), 127.5 (CH), 123.2 (C),; IR: ῦ (cm-1)  3288, 1692, 
1589, 1498; HRMS (ESI) calculated for C14H12N3O [M+H]+ 238.0975, found: 238.0982. 
4-Phenyl-3-(p-tolyl)-1,2,4-oxadiazol-5(4H)-imine (220) 
 
 
 
 
N-Hydroxy 4-methylbenzimidoyl chloride 6b (100 mg, 0.59 mmol) and N-phenyl-N-tosyl 
cyanamide 2a (200 mg, 0.73 mmol) were taken in an oven dried 10 mL round bottom flask 
equipped with a magnetic stirrer bar under argon. The substrates were dissolved in anhydrous 
THF (0.5 mL) and allowed to stir for 5 minutes. The reaction mixture was cooled to 0 oC 
(icebath) and TBAF (1M in THF, 1.77 mL, 1.77 mmol) was added through a syringe pump at 
the rate of 1.77 mL/hour. After the addition, the flask was removed from the ice-bath, and the 
volatile components were removed under vacuum. The organic residue from the reaction 
mixture was dissolved in 10 mL ethyl acetate, and washed with water (2 x 5 mL) and brine (1 
x 5 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure and purified by column chromatography on silica gel using Pet Ether:EtOAc 
(9:1 to 7:3) to afford the product 1b (111 mg, 75% yield) as a white solid, 75% yield; M. p. 
165-166 °C; Rf 0.35 (1:1 Pet Ether:EtOAc); 1H NMR (400 MHz, CDCl3): δ  7.49-7.42 (m, 3H, 
Ar-H), 7.30-7.23 (m, 4H, Ar-H), 7.16-7.14 (m, 2H, Ar-H), 2.36 (s, 3H, CH3) ppm ; 13C NMR 
(100 MHz, CDCl3) : δ  160.8 (C), 157.1 (C), 142.0 (C), 133.3 (C), 129.8 (CH), 129.4 (CH), 
129.1 (CH), 128.1 (CH), 127.5 (CH), 120.1 (C), 21.4 (CH3) ppm; IR: ῦ (cm-1) 3177, 1678, 
1584, 1430; HRMS (ESI) calculated for C15H14N3O [M+H]+ 252.1131, found: 252.1119. 
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3-(4-Methoxyphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (219) 
 
Following general procedure 4.4: N-Hydroxy-4-methoxybenzimidoyl chloride 6c (100 mg, 
0.54 mmol) and N-phenyl-N-tosyl cyanamide 2a (183 mg, 0.67 mmol) were taken in an oven 
dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.61 mL, 1.61 mmol) 
was added through a syringe pump at the rate of 1.61 mL/hour. After the addition, the flask 
was removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 20 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure. The resulting residue was purified by 
column chromatography on silica gel using Pet Ether:EtOAc (8:2 to 2:8) to afford the product 
1c (121 mg, 84% yield) as a white solid, 84% yield; M. p. 131-133 °C Rf 0.28 (1:1 Pet Ether: 
EtOAc); 1H NMR (500 MHz, CDCl3): δ  7.45-7.44 (m, 3H, Ar-H), 7.27-7.25 (m, 4H, Ar-H), 
6.83-6.81 (m, 2H, Ar-H), 5.59 (brs, 1H, NH), 3.79 (s, 3H, OCH3) ppm; 13C NMR (125 MHz, 
CDCl3) : δ 161.9 (C), 160.8 (C), 156.8 (C), 133.4 (C), 129.8 (CH), 127.6 (CH), 115.1 (C), 
114.2 (CH), 55.3 (OCH3) ppm; IR: ῦ (cm-1) 3296, 2852, 1675, 1606, 1586; HRMS (ESI) 
calculated for C15H14N3O2 [M+H]+ 268.1081, found: 268.1091. 
3-(4-Chlorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (223) 
 
Following general procedure 4.4: 4-Chloro-N-hydroxybenzimidoyl chloride 6d (100 mg, 
0.52 mmol) and N-phenyl-N-tosyl cyanamide 2a (179 mg, 0.65 mmol) were taken in an oven 
dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.60 mL, 1.60 mmol) 
was added through a syringe pump at the rate of 1.60 mL/hour. After the addition, the flask 
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was removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (9:1 to 6:4) to afford the product 1d (95 mg, 67% yield) as  
a white solid, 67% yield; M. p. 153-155 °C; Rf 0.41 (1:1 Pet Ether: EtOAc); 1H NMR (400 
MHz, CDCl3): δ 6.20-6.18 (m, 3H, Ar-H), 6.06-5.98 (m, 6H, Ar-H), 4.35 (brs, 1H, NH) ppm; 
13C NMR (100 MHz, CDCl3) : δ  160.4 (C), 156.2 (C), 137.8 (C), 132.9 (C), 129.9 (CH), 129.4 
(CH), 129.3 (CH), 129.1 (CH), 127.4 (CH), 121.5 (C) ppm; IR: ῦ (cm-1) 3170, 2922, 2852, 
1679, 1581; HRMS (ESI) calculated for C14H11ClN3O [M+H]+ 272.0585, found: 272.0580. 
3-(4-Fluorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (222)  
 
Following general procedure 4.4: 4-Fluoro-N-hydroxybenzimidoyl chloride 6e (100 mg, 0.57 
mmol) and N-phenyl-N-tosyl cyanamide 2a (196 mg, 0.72 mmol) were taken in an oven dried 
10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The substrates 
were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The reaction 
mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.75 mL, 1.75 mmol) was added 
through a syringe pump at the rate of 1.75 mL/hour. After the addition, the flask was removed 
from the ice-bath, and the volatile components were removed under vacuum. The organic 
residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed with water 
(2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous Na2SO4 and 
solvents removed under reduced pressure and purified by column chromatography on silica gel 
using Pet Ether:EtOAc (9:1 to 7:3) to afford the product 1e (92 mg, 63% yield) as a white solid, 
63% yield; M. p. 127-131 °C; Rf 0.38 (1:1 Pet Ether:EtOAc); 1H NMR (400 MHz, CDCl3): δ 
7.39-7.31 (m, 3H, Ar-H), 7.27-7.23 (m, 2H, Ar-H), 7.18-7.15 (m, 2H, Ar-H), 6.95-6.90 (m, 
2H, Ar-H), 5.47 (s, 1H, NH ) ppm;  13C NMR (100 MHz, CDCl3) : δ 164.2 (C, d, J = 253 Hz), 
160.5 (C), 156.1 (C), 132.9 (C), 130.3 (CH, d, J = 8.7 Hz), 129.8 (CH), 129.3 (CH), 127.4 
(CH), 119.1 (C, d, J = 3.3 Hz), 116.0 (CH, d, J = 22.3 Hz) ppm; IR: ῦ (cm-1) 3286, 1691, 1433; 
HRMS (ESI) calculated for C14H11FN3O [M+H]+ 256.0881, found: 256.0895.  
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3-(4-Nitrophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (224) 
 
Following general procedure 4.4: 4-Nitro-N-hydroxybenzimidoyl chloride 6f (100 mg, 0.50 
mmol) and N-phenyl-N-tosyl cyanamide 2a (169 mg, 0.62 mmol) were taken in an oven dried 
10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The substrates 
were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The reaction 
mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.5 mL, 1.5 mmol) was added 
through a syringe pump at the rate of 1.5 mL/hour. After the addition, the flask was removed 
from the ice-bath, and the volatile components were removed under vacuum. The organic 
residue from the reaction mixture was dissolved in 30 mL ethyl acetate, and washed with water 
(2 x 10 mL). The aqueous fractions were re-extracted with ethyl acetate (2 x 10 mL), and the 
organic fractions were combined and washed with brine (1 x 5 mL). The organic fractions were 
then dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue 
obtained was purified by column chromatography on silica gel using Pet Ether:EtOAc (8:2 to 
2:8) to afford the product 1f (49 mg, 35% yield) as a brown solid, 35% yield; M. p. 148-149 °C; 
Rf 0.30 (1:1 Pet Ether: EtOAc);  1H NMR (500 MHz, CDCl3): δ 8.32-8.15 (m, 3H, Ar-H), 7.59-
7.49 (m, 6H, Ar-H) ppm; 13C NMR (125 MHz, CDCl3) : δ  155.7 (C), 155.4 (C), 149.4 (C), 
132.6 (C), 131.3 (C), 130.2 (CH), 130.1 (CH), 129.8 (CH), 129.2 (CH), 129.2 (CH), 127.3 
(CH), 126.7 (CH), 124.1 (CH), 123.9 (CH) ppm;   IR: ῦ (cm-1) 3315, 1681, 1537, 1433; HRMS 
(ESI) calculated for C14H11N4O3 [M+H]+ 283.0826, found: 283.0821. 
3-(2, 6-Dimethylphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (221) 
 
Following general procedure 4.4: N-Hydroxy-2,6-dimethylbenzimidoyl chloride 6g (100 mg, 
0.54 mmol) and N-phenyl-N-tosyl cyanamide 2a (185 mg, 0.68 mmol) were taken in an oven 
dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.60 mL, 1.60 mmol) 
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was added through a syringe pump at the rate of 1.60 mL/hour. After the addition, the flask 
was removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (9:1 to 1:1) to afford the product 1g (105 mg, 73% yield) 
as a white solid, 73% yield; M. p. 128-132 °C; Rf 0.51 (1:1 Pet Ether: EtOAc); 1H NMR (400 
MHz, CDCl3): δ 7.30-7.20 (m, 4H, Ar-H), 7.17-7.15 (m, 2H, Ar-H), 7.02-7.00 (m, 2H, Ar-H), 
2.24 (s, 6H, 2 x CH3) ppm; 13C NMR (100 MHz, CDCl3) : δ 159.9 (C), 156.5 (C), 137.8 (2 x 
C), 132.3 (C), 130.9 (CH), 129.2 (CH), 128.4 (CH), 127.6 (CH), 125.5 (CH), 122.6 (C), 19.6 
(2 x CH3) ppm;    IR: ῦ (cm-1) 3315, 1682, 1497; HRMS (ESI+) calculated for C16H16N3O 
[M+H]+ 266.1288, found: 266.1283. 
4-Phenyl-3-(thiophen-3-yl)-1,2,4-oxadiazol-5(4H)-imine (225) 
 
Following general procedure 4.4: N-Hydroxythiophene-3-carbimidoyl chloride 6h (100 mg, 
0.62 mmol) and N-phenyl-N-tosyl cyanamide 2a (210 mg, 0.77 mmol) were taken in an oven 
dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (icebath) and TBAF (1M in THF, 1.9 mL, 1.9 mmol) was 
added through a syringe pump at the rate of 1.9 mL/hour. After the addition, the flask was 
removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhyd rous 
Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (9:1 to 4:6) to afford the product 1h (80 mg, 54% yield) 
yield as a  yellow solid, 54% yield; M. p. 131-132 °C; Rf 0.30 (1:1 Pet Ether: EtOAc); 1H NMR 
(400 MHz, CDCl3): δ 7.54-7.49 (m, 3H, Ar-H), 7.36- 7.34 (m, 2H, Ar-H), 7.31-7.29 (m, 1H, 
HetAr-H), 7.14-7.13 (m, 2H, HetAr-H), 5.27 (brs, 1H, NH) ppm; 13C NMR (100 MHz, 
CDCl3) : δ 160.8 (C), 153.2 (C), 133.0 (C), 130.1 (CH), 129.9 (CH), 128.1 (CH), 128.0 (CH), 
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126.7 (CH), 126.1 (CH), 123.3 (C) ppm;  IR: ῦ (cm-1) 3303, 3102, 2923, 1679, 1538, 1438; 
HRMS (ESI) calculated for C12H10N3OS [M+H]+ 244.0539, found: 244.0546. 
4-(4-Methoxyphenyl)-3-phenyl-1,2,4-oxadiazol-5(4H)-imine (226) 
 
Following general procedure 4.4: N-Hydroxybenzimidoyl chloride 6a (20 mg, 0.13 mmol) 
and N-(4-Methoxyphenyl) N-toluenesulfonyl cyanamide 2b (50 mg, 0.16 mmol) were taken in 
an oven dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.3 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 0.4 mL, 0.4 mmol) was 
added through a syringe pump at the rate of 0.4 mL/hour. After the addition, the flask was 
removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (8:2 to 4:6) to afford the product 1i (23 mg, 68% yield) as 
a yellow solid, 68% yield; M. p. 126-128 °C; Rf 0.31 (1:1 Pet Ether: EtOAc); 1H NMR (400 
MHz, CDCl3): δ 7.48-7.43 (m, 1H, Ar-H), 7.38-7.32 (m, 4H, Ar-H), 7.20-7.16 (m, 2H, Ar-H), 
6.96-6.92 (m, 2H, Ar-H), 3.82 (s, 1H, OCH3) ppm; 13C NMR (100 MHz, CDCl3) : δ 161.3 (C), 
159.9 (C), 157.1 (C), 131.5 (CH), 128.9 (CH), 128.8 (CH), 128.2 (CH), 125.6 (C), 123.2 (C), 
115.2 (CH), 55.5 (OCH3) ppm; IR: ῦ (cm-1) 3301, 2923, 2852, 1679, 1512; HRMS (ESI+) 
calculated for C15H14N3O2 [M+H]+ 268.1081, found: 268.1090. 
3,4-bis (4-Methoxyphenyl)-1,2,4-oxadiazol-5(4H)-imine (227) 
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Following general procedure 4.4: N-Hydroxy-4-methoxybenzimidoyl chloride 6c (25 mg, 
0.13 mmol) and N-(4-Methoxyphenyl) N-toluenesulfonyl cyanamide 2b (50 mg, 0.16 mmol) 
were taken in an oven dried 10 mL round bottom flask equipped with a magnetic stirrer bar 
under argon. The substrates were dissolved in anhydrous THF (0.3 mL) and allowed to stir for 
5 minutes. The reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 0.4 mL, 
0.4 mmol) was added through a syringe pump at the rate of 0.4 mL/hour. After the addition, 
the flask was removed from the ice-bath, and the volatile components were removed under 
vacuum. The organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, 
and washed with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over 
anhydrous Na2SO4 and solvents removed under reduced pressure and purified by column 
chromatography on silica gel using Pet Ether:EtOAc (8:2 to 2:8) to afford the product 1j (25 
mg, 62% yield) as a yellow solid, 62% yield; M. p. 125-127 °C; Rf 0.20 (1:1 Pet Ether: EtOAc); 
1H NMR (400 MHz, CDCl3): δ 7.30-7.28 (m, 2H, Ar-H), 7.20-7.16 (m, 2H, Ar-H), 6.97-6.93 
(m, 2H, Ar-H), 6.85-6.81 (m, 2H, Ar-H), 3.83 (s, 3H, OCH3), 3.80 (s, 3H, OCH3) ppm;  13C 
NMR (100 MHz, CDCl3): δ  161.9 (2 x C), 159.9 (C), 156.9 (C), 129.8 (CH), 128.9 (CH), 
125.9 (C), 115.2 (C), 115.1 (CH), 114.2 (CH), 55.5 (OCH3), 55.3 (OCH3);  IR: ῦ (cm-1) 3331, 
3245, 2926, 1676, 1606, 1511; HRMS (ESI+) calculated for C16H16N3O3  [M+H]+ 298.1186, 
found: 298.1178. 
4-(4-Fluorophenyl)-3-phenyl-1,2,4-oxadiazol-5(4H)-imine (228) 
 
Following general procedure 4.4: N-Hydroxybenzimidoyl chloride 6a (25 mg, 0.13 mmol) 
and N-(4-Fluorophenyl) N-toluenesulfonyl cyanamide 2c (50 mg, 0.17 mmol) were taken in an 
oven dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.3 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 0.41 mL, 0.41 mmol) 
was added through a syringe pump at the rate of 0.41 mL/hour. After the addition, the flask 
was removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
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Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (9:1 to 1:1) to afford the product 1k (30 mg, 89% yield) as 
a white solid, 89% yield; M. p. 101-103 °C; Rf 0.50 (1:1 Pet Ether: EtOAc); 1H NMR (500 
MHz, CDCl3): δ 7.49-7.46 (m, 1H, Ar-H), 7.37-7.32 (m, 4H, Ar-H), 7.26-7.24 (m, 2H, Ar-H), 
7.14-7.11 (m, 2H, Ar-H), 5.70 (brs, 1H, NH) ppm; 13C NMR (125 MHz, CDCl3): δ 162.4 (C, 
d, J = 250 Hz), 160.1 (C), 157.0 (C), 131.7 (CH), 129.4 (CH, d, J = 9.1 Hz), 129.2 (C, d, J = 
2.7 Hz), 128.9 (CH), 128.3 (CH), 122.9 (C), 117.0 (CH, d, J = 22.7 Hz) ppm;   IR: ῦ (cm-1) 
3343, 2923, 1686, 1509; HRMS (ESI) calculated for C14H11 FN3O [M+H]+ 256.0881, found: 
256.0885. 
4-(4-fluorophenyl)-3-(4-methoxyphenyl)-1,2,4-oxadiazol-5(4H)-imine (229) 
 
Following general procedure 4.4: N-Hydroxy-4-methoxybenzimidoyl chloride 6c (21 mg, 
0.13 mmol) and N-(4-Fluorophenyl) N-toluenesulfonyl cyanamide 2b (50 mg, 0.17 mmol) 
were taken in an oven dried 10 mL round bottom flask equipped with a magnetic stirrer bar 
under argon. The substrates were dissolved in anhydrous THF (0.3 mL) and allowed to stir for 
5 minutes. The reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 0.4 mL, 
0.4 mmol) was added through a syringe pump at the rate of 0.4 mL/hour. After the addition, 
the flask was removed from the ice-bath, and the volatile components were removed under 
vacuum. The organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, 
and washed with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over 
anhydrous Na2SO4 and solvents removed under reduced pressure and purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1 to 6:4) to afford the product 1l (36 
mg, 96 % yield) as a yellow solid, 96 % yield; M. p. 117-120 °C; Rf 0.51 (1:1 Pet Ether: 
EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.29-7.26 (m, 4H, Ar-H), 7.17-7.13 (m, 2H, Ar-H), 
6.89-6.84 (m, 2H, Ar-H), 3.82 (s, 3H, OCH3) ppm; 13C NMR (100 MHz, CDCl3): δ 162.4 (C, 
d, J = 250 Hz), 162.1 (C), 160.7 (C),156.8 (C), 129.8 (CH), 129.56 (CH, d, J = 8.7 Hz),  129.4 
(C, d, J =2.9 Hz), 116.9 (CH, d, J = 23.4 Hz), 114.8 (C), 114.3 (CH), 55.3 (OCH3) ppm;   IR: 
ῦ (cm-1) 3313, 2921, 2850, 1684, 1603, 1513; HRMS (ESI+) calculated for C15H13 FN3O2 
[M+H]+ 286.0986, found: 286.0984. 
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3-(4-toluenesulfonyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-imine (230) 
 
Following general procedure 4.4: N-Hydroxy-4-hydroxybenzimidoyl chloride 6c (21 mg, 
0.13 mmol) and N-phenyl-N-tosyl cyanamide 2b (50 mg, 0.17 mmol) were taken in an oven 
dried 10 mL round bottom flask equipped with a magnetic stirrer bar under argon. The 
substrates were dissolved in anhydrous THF (0.3 mL) and allowed to stir for 5 minutes. The 
reaction mixture was cooled to 0 oC (ice-bath) and TBAF (1M in THF, 0.4 mL, 0.4 mmol) was 
added through a syringe pump at the rate of 0.4 mL/hour. After the addition, the flask was 
removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 10 mL ethyl acetate, and washed 
with water (2 x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure and purified by column chromatography 
on silica gel using Pet Ether:EtOAc (9:1 to 6:4) to afford the product 1l (36 mg, 43 % yield) as 
a pale yellow solid, 43% yield; M. p. 138-139 °C; Rf 0.21 (1:1 Pet Ether: EtOAc);  1H NMR 
(500 MHz, CDCl3): δ 7.66 (d, J = 7.9 Hz, 2H, Ar-H), 7.44 (brs, 3H, Ar-H), 7.30-7.27 (m, 4H, 
Ar-H), 7.23-7.19 (m, 2h, Ar-H), 6.97 (d, J = 8.4 Hz, 2H, Ar-H) ppm; 13C NMR (125 MHz, 
CDCl3) : δ  160.2 (C), 156.1 (C), 151.7 (C), 145.8 (C), 132.9 (C), 131.9 (C), 129.9 (CH), 129.7 
(CH), 128.4 (CH), 127.4 (CH), 122.9 (CH), 121.9 (C), 21.7 (CH3) ppm;   IR: ῦ (cm-1) 3315, 
1681, 1537, 1433, 1371, 1156; HRMS (ESI) calculated for C21H18N3O4S [M+H]+ 408.1013, 
found: 408.1034. 
3-Phenyl-4-propyl-1,2,4-oxadiazol-5(4H)-imine (253) 
 
Following general procedure 4.4: N-Hydroxybenzimidoyl chloride 6a (100 mg, 0.64 mmol) 
and N-propyl cyanamide 2d (67 mg, 0.80 mmol) were taken in an oven dried 10 mL round 
bottom flask equipped with a magnetic stirrer bar under argon. The substrates were dissolved 
in anhydrous THF (0.5 mL) and allowed to stir for 5 minutes. The reaction mixture was cooled 
to 0 oC (ice-bath) and TBAF (1M in THF, 1.92 mL, 1.92 mmol) was added through a syringe 
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pump at the rate of 1.92 mL/hour. After the addition, the flask was removed from the ice-bath, 
and the volatile components were removed under vacuum. The organic residue from the 
reaction mixture was purified by column chromatography on neutralized silica gel using Pet 
Ether:EtOAc (8:2) to afford the product 1m (45 mg, 35% yield) as a  yellow oil, 35 % yield; 
Rf  0.45 (2:3 Pet ether: EtOAc);  1H NMR (500 MHz, CDCl3): δ 7.60-7.56 (m, 5H, Ar-H), 3.60 
(brt, J = 6.7 Hz, 2H, CH2), 1.71-1.67 (m, 2H, CH2), 0.84 (brt, J = 7.0 Hz, 3H, CH3); 13C NMR 
(125 MHz, CDCl3): δ 158.8 (C), 131.7 (CH), 129.3 (CH), 128.4 (CH), 123.6 (C), 44.9 (CH2), 
21.1 (CH2), 10.8 (CH3) ; IR ῦ (cm -1): 2951, 2832, 1689, 1493, 1452;  HRMS (ESI) calculated 
for C11H14 N3O [M+H]+ 204.1151, found: 204.1131. 
2-(N,N-Diethylamino)ethyl isothiocyanate (266)9 
 
 
 
Diethylethylenediamine (265, 4.3 mmol) in acetone (4 mL) was cooled to -10 °C in a dry 
ice/acetone bath. Carbon disulfide (1.1 equiv., 4.73 mmol) in acetone (4 mL) was added 
dropwise via an addition funnel over 15 min. Then, over 45 min, the temperature was allowed 
to slowly rise to 10 °C. The reaction mixture was then cooled to -15 °C. Over 45 min, a solution 
of HgCl2 (1.0 equiv, 4.3 mmol) in acetone (12 mL) was added, keeping the temperature below 
-10 °C. After warming to 0 °C over 15 min, Et3N (2.2 equiv, 9.46 mmol) was added slowly by 
syringe. Finally, the reaction mixture was refluxed for 1 h, becoming black. Upon cooling, the 
salts were filtered through Celite, and washed subsequently with acetone (1 × 50 mL) and ether 
(2 × 50 mL). The filtrate was treated with Na2SO4. Solvent was removed by rotary evaporation. 
To the residue was added ether (75 mL), and this was filtered. The filtrate was concentrated to 
yield 266 as a colourless oil in 61 % yield; 1H NMR (500 MHz, CDCl3): δ 3.52 (t, J = 6.6 Hz, 
2H, CH2), 2.75 (t, J = 6.6 Hz, 2H, CH2), 2.58 (q, J = 7.2 Hz, 4H, 2 x CH2), 1.04 (t, J = 7.2 Hz, 
6H, 2 x CH3). 13C NMR (125 MHz, CDCl3): δ 131.4 (C), 52.5 (CH2), 47.4 (CH2), 44.0 (CH2), 
12.1 (CH3) ppm; IR: ῦ (cm-1) 2968, 2809, 2082, 1445. 
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2-(N,N-Diethylamino)ethyl cyanamide (241) 
 
25% aqueous NH3 (0.8 mL) was added drop wise to 2-(N,N-Diethylamino)ethyl isothiocyana te 
(266, 0.63 mmol) in ethyl acetate (1 mL) to give a thiourea product. After stirring for 10 
minutes at room temperature the excess of NH3 was removed in a rotary evaporator whereby 
the solvent ethylacetate was also simultaneously removed leaving behind the aqueous layer. 
To the crude reaction mixture was then further added ethyl acetate (1 mL) and triethylamine 
(0.11 ml, 1.14 mmol). To the resultant solution, iodine (144 mg, 0.57 mmol) was added in 
small pinches, during which precipitation of elemental sulfur was observed. Completion of the 
reaction was confirmed by TLC. The precipitated sulfur was filtered, washed with ethyl acetate 
(2 x 5 mL). The organic layer was washed with water (2 x 5 mL) and dried over anhydrous 
Na2SO4, concentrated under reduced pressure and purified over a short column of silica gel 
eluting it with hexane: ethyl acetate (97:3) to give the pure product in 15 % yield; colourless 
oil; 1H NMR (500 MHz, CDCl3): δ 3.15 (t, J = 5.7 Hz, 2H, CH2), 2.68 (br s, 1H, NH), 2.59 (t, 
J = 5.7 Hz, 2H, CH2), 2.52 (q, J = 7.2 Hz, 4H, 2 x CH2), 1.01 (t, J = 7.2 Hz, 6H, 2 x CH3). 13C 
NMR (125 MHz, CDCl3): δ 116.7 (CN), 51.2 (CH2), 46.5 (CH2), 43.6 (CH2), 11.8 (CH3) ppm; 
IR: ῦ (cm-1) 2964, 2216 
4.5  Synthesis of 1,2,4-oxadiazol-5-ones from 1,2,4-oxadiazol-5(4H)-imines 
1,2,4-oxadiazol-5(4H)- imine (1 equiv., 0.42 mmol) was taken in an oven-dried round bottom 
flask, and dissolved in 1 mL methanol. 0.6 mL of conc. HCl was added to the reaction mixture 
and refluxed for 3-5 hours. After the complete conversion of the starting material (TLC), 
methanol was removed under vacuum and the residue was dissolved in ethyl acetate (20 mL), 
and neutralised with sat. (aq) NaHCO3. The ethyl acetate fraction was further washed with 
water (2 x 10 mL) and brine (1 x 10 mL), dried over anhydrous Na2SO4. The organic fraction 
was removed under vacuum and the residue purified by column chromatography. 
  
179 | P a g e  
 
3,4-Diphenyl-1,2,4-oxadiazol-5(4H)-one (216) 
 
Following general procedure 4.5: 3,4-Diphenyl-1,2,4-oxadiazol-5(4H)-imine 1a (230 mg, 
0.97 mmol) was taken in an oven-dried round bottom flask, and dissolved in 1.5 mL methano l. 
1.4 mL of concd. HCl was added to the reaction mixture and refluxed for 5 hours. The reaction 
mixture was cooled to room temperature, methanol was removed under vacuum and the residue 
was dissolved in ethyl acetate (30 mL), and neutralized with sat. (aq) NaHCO3 solution. The 
ethyl acetate fraction was separated and further washed with water (2 x 10 mL), brine (1 x 10 
mL) and dried over anhydrous Na2SO4. The volatile solvent was removed under vacuum and 
the residue purified by column chromatography on silica gel using Pet Ether:EtOAc (9:1) to 
afford the product 4a (220 mg, 95% yield) as a white solid, 95% yield; M. p. 168-169 °C (Lit-  
166-167 oC)4; Rf 0.33 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.52-7.48 (m, 
1H, Ar-H), 7.47-7.44 (m, 3H, Ar-H), 7.38-7.35 (m, 4H, Ar-H), 7.25-7.23 (m, 2H, Ar-H) ppm; 
13C NMR (100 MHz, CDCl3):  δ  158.3 (C), 157.5 (C), 132.0 (C), 131.9 (CH), 129.8 (CH), 
129.5 (CH), 128.9 (CH), 128.2 (CH), 126.8 (CH), 123.0 (C); IR: ῦ (cm-1) 3065, 2922, 2852, 
1770, 1553; HRMS (ESI+) calculated for C14H11N2O2 [M+H]+ 239.0815, found: 239.0820. 
3-(4-Methoxyphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-one (231) 
 
Following general procedure 4.5: 3-(4-Methoxyphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-
imine 1c (45 mg, 0.17 mmol) was taken in an oven-dried round bottom flask, and dissolved in 
0.5 mL methanol. 0.3 mL of concd. HCl was added to the reaction mixture and refluxed for 4 
hours. The reaction mixture was cooled to room temperature, methanol was removed under 
vacuum and the residue was dissolved in ethyl acetate (20 mL), and neutralized with sat. (aq) 
NaHCO3 solution. The ethyl acetate fraction was separated and further washed with water (2 x 
10 mL), brine (1 x 10 mL) and dried over anhydrous Na2SO4. The volatile solvent was removed 
under vacuum and the residue purified by column chromatography on silica gel using Pet 
180 | P a g e  
 
Ether:EtOAc (9:1) to afford the product 4c (37 mg, 86% yield) as a white solid, 86 % yield; M. 
p. 160-162 °C; Rf 0.15 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.50-7.47 (m, 
3H, Ar-H), 7.33-7.29 (m, 2H, Ar-H), 7.28-7.25 (m, 2H, Ar-H), 6.90-6.86 (m, 2H, Ar-H), 3.84 
(s, 3H, OCH3) ppm;  13C NMR (100 MHz, CDCl3): δ 162.4 (C), 158.4 (C), 157.2 (C), 132.1 
(C),129.7 (2 x CH), 129.5 (CH), 126.9 (CH), 114.9 (C), 114.4 (CH), 55.4 (OCH3) ppm;  IR: ῦ 
(cm-1) 3002, 2934, 2836, 1770, 1585,; HRMS (ESI) calculated for C15H13N2O3 [M+H]+ 
269.0921, found: 269.0911. 
3-(2,6-Dimethylphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-one (232) 
 
Following general procedure 4.5: 3-(2,6-Dimethylphenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-
imine 1g (80 mg, 0.30 mmol) was taken in an oven-dried round bottom flask, and dissolved in 
1.0 mL methanol. 0.6 mL of conc. HCl was added to the reaction mixture and refluxed for 6 
hours. The reaction mixture was cooled to room temperature, methanol was removed under 
vacuum and the residue was dissolved in ethyl acetate (20 mL), and neutralized with sat. (aq) 
NaHCO3solution. The ethyl acetate fraction was further washed with water (2 x 10 mL), brine 
(1 x 10 mL) and dried over anhydrous Na2SO4. The volatile solvent was removed under vacuum 
and the residue purified by column chromatography on silica gel using Pet Ether:EtOAc (9:1) 
to afford the product 4g (72 mg, 91% yield) as awhite solid, 91 % yield; M. p. 137-138 °C; Rf 
0.38 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.36-7.33(m, 3H, Ar-H), 7.31-
7.29 (m, 1H, Ar-H), 7.15-7.13 (m, 2H, Ar-H), 7.10, (brs, 1H, Ar-H), 7.08 (brs, 1H, Ar-H), 2.26 
(s, 6H, 2 x CH3) ppm; 13C NMR (100 MHz, CDCl3): δ 157.9 (C), 157.3 (C), 138.1 (2 x C), 
131.4 (CH),129.4 (CH), 128.9 (CH), 127.9 (CH), 124.8 (CH), 122.7 (C), 19.8 (2 x CH3) ppm;  
IR: ῦ (cm-1) 2922, 2853, 1769, 1571; HRMS (ESI) calculated for C16H15N2O2 [M+H]+ 
267.1128, found: 267.1125. 
3-(4-Fluorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-one (233) 
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Following general procedure 4.5: 3-(4-Fluorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)- imine 
1e (73 mg, 0.28 mmol) was taken in an oven-dried round bottom flask, and dissolved in 1.0 
mL methanol. 0.6 mL of conc. HCl was added to the reaction mixture and refluxed for 6 hours. 
The reaction mixture was cooled to room temperature, methanol was removed under vacuum 
and the residue was dissolved in ethyl acetate (20 mL), and neutralized with sat. (aq) NaHCO3 
solution. The ethyl acetate fraction was separated and further washed with water (2 x 10 mL) 
and brine (1 x 10 mL), dried over anhydrous Na2SO4. The volatile solvent was removed under 
vacuum and the residue purified by column chromatography on silica gel using Pet 
Ether:EtOAc (9:1) to afford the product 4e (66 mg, 90% yield) as a white solid, 90 % yield; M. 
p. 166-167 °C; Rf 0.28 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.49-7.46 (m, 
3H, Ar-H), 7.40-7.35 (m, 2H, Ar-H), 7.25-7.21 (m, 2H, Ar-H), 7.10-7.04 (m, 2H, Ar-H) ppm;   
13C NMR (100 MHz, CDCl3): δ  164.6 (C, d, J = 254.5 Hz), 158.2 (C), 156.6 (C), 131.8 (C), 
130.45 (CH, d, J = 8.43 Hz), 129.9 (2 x CH), 129.7 (CH), 126.9 (CH), 119.16 (C, d, J = 3.8 
Hz), 116.4 (CH, d, J = 23 Hz) ppm;    IR: ῦ (cm-1) 2924, 1769, 1605, 1513; HRMS (ESI) 
calculated for C14H10 FN2O2 [M+H]+ 257.0721, found: 257.0722. 
3-(4-Chlorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-one (234) 
 
Following general procedure 4.5: 3-(4-Chlorophenyl)-4-phenyl-1,2,4-oxadiazol-5(4H)-
imine 1d (73 mg, 0.27 mmol) was taken in an oven-dried round bottom flask, and dissolved in 
1 mL methanol. 0.6 mL of conc. HCl was added to the reaction mixture and refluxed for 3 
hours. The reaction mixture was cooled to room temperature, methanol was removed under 
vacuum and the residue was dissolved in ethyl acetate (20 mL), and neutralized with sat. (aq) 
NaHCO3 solution. The ethyl acetate fraction was separated and further washed with water (2 x 
10 mL), brine (1 x 10 mL) and dried over anhydrous Na2SO4. The volatile solvent was removed 
under vacuum and the residue purified by column chromatography on silica gel using Pet 
Ether:EtOAc (9.5:0.5) to afford the product 4d (69 mg, 95% yield) as a white solid, 95 % yield; 
M. p. 182-183 °C; Rf 0.33 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ  7.50-7.46 
(m, 3H, Ar-H), 7.37-7.34 (m, 2H, Ar-H), 7.32-7.28 (m, 2H, Ar-H), 7.21-7.24 (m, 2H, Ar-H) 
ppm;  13C NMR (100 MHz, CDCl3): δ  158.0 (C), 156.6 (C), 138.4 (C), 131.7 (C),129.9 (CH), 
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129.7 (CH), 129.4 (CH), 129.3 (CH), 126.8 (CH), 121.4 (C);  IR: ῦ (cm-1) 2922, 2853, 1770, 
1583; HRMS (ESI) calculated for C14H10ClN2O2 [M+H]+ 273.0425, found: 273.0427. 
4-Phenyl-3-(thiophen-3-yl)-1,2,4-oxadiazol-5(4H)-one (235) 
 
Following general procedure 4.5: 4-Phenyl-3-(thiophen-3-yl)-1,2,4-oxadiazol-5(4H)- imine 
1h (45 mg, 0.18 mmol) was taken in an oven-dried round bottom flask, and dissolved in 0.5 
mL methanol. 0.3 mL of conc. HCl was added to the reaction mixture and refluxed for 5 hours. 
The reaction mixture was cooled to room temperature, methanol was removed under vacuum 
and the residue was dissolved in ethyl acetate (20 mL), and neutralized with sat. (aq) NaHCO3 
solution. The ethyl acetate fraction was separated and further washed with water (2 x 10 mL) 
and brine (1 x 10 mL), dried over anhydrous Na2SO4. The volatile solvent was removed under 
vacuum and the residue purified by column chromatography on silica gel using Pet 
Ether:EtOAc (9.5:0.5) to afford the product 4h (40 mg, 89% yield) as a white solid, 89 % yield; 
M. p. 170-171 °C; Rf 0.23 (9:1 Pet ether: EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.56-7.52 
(m, 3H, Ar-H), 7.36-7.33 (m, 3H, Ar-H), 7.22 (dd, J = 2.9, 1.3 Hz, 1H, HetAr-H), 7.17 (dd, J 
= 5.2, 1.3 Hz, 1H, HetAr-H) ppm;  13C NMR (100 MHz, CDCl3): δ 158.2 (C), 153.7 (C), 131.8 
(C), 130.2 (CH),130.1 (CH), 128.5 (CH), 127.5 (CH), 127.1 (CH), 125.9 (CH), 123.3 (C) ppm;  
IR: ῦ (cm-1) 3119, 2922, 1764, 1581, 1453; HRMS (ESI) calculated for C12H9N2O2S [M+H]+ 
245.0379, found: 245.0377. 
4.6 Synthesis of N-Phenylbenzimidamide (236)9 
 
 
1,2,4-Oxadiazol-5-one was taken in a 10 mL oven dried round bottom flask (1 equiv, 0.25 
mmol) and dissolved in 0.8 mL ethyl acetate followed by addition of glacial acetic acid (1 
equiv, 0.25 mmol). Pd/C catalyst was added and mixture stirred under a hydrogen atmosphere 
(1.1 atm) at room temperature for 20 hours. The reaction mixture was diluted with ethyl acetate 
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(10 mL), and filtered through celite. The filtrate was neutralised with aq. NaHCO3, and washed 
with water (2x 5 mL) and brine (1 x 5 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvent removed under vacuum. The residue was purified by silica gel column 
chromatography (DCM-methanol) to give N-Phenylbenzimidamide10 in 94% yield; yellow 
solid; M. p. 110-111 oC (lit- 110 – 111.2 oC)7; 1H NMR (500 MHz, CDCl3): δ 7.86 (brs, 2H, 
Ar-H), 7.50-7.43 (m, 3H, Ar-H), 7.38-7.35 (m, 2H, Ar-H), 7.09-7.06 (m, 1H. Ar-H), 7.0 (brd, 
J = 7.93 Hz, 2H, Ar-H), 4.86 (brs, 2H). 13C NMR (125 MHz, CDCl3): δ 135.2 (C), 130.8 (CH), 
129.5 (CH), 128.6 (CH), 126.9 (CH), 127.3 (C), 123.3 (CH), 121.8 (CH) ppm; IR: ῦ (cm-1) 
3318, 3058, 1619, 1571, 1475, 1433; HRMS (ESI) calculated for C13H12N2Na [M+Na]+ 
219.0893, found: 219.0882. 
4-methoxy-N-phenylbenzimidamide (237) 
 
Following procedure 4.6: white solid, 91% yield; M. p. 144-146 oC (lit- 144-147 °C)7; 1H 
NMR (500 MHz, CDCl3): δ 7.70 (brs, 2H, Ar-H), 7.37-7.29 (m, 2H, Ar-H), 7.14 (t, d = 7.2 Hz, 
1H, Ar-H), 7.01 (d, d = 6.4 Hz, 2H, Ar-H), 6.93 (d, J = 7.9 Hz, 2H, Ar-H), 3.85 (s, 3H, OCH3). 
13C NMR (125 MHz, CDCl3): δ 129.6 (CH), 114.2 (CH), 55.5 (OCH3) ppm; IR: ῦ (cm-1) 3318, 
3058, 1619, 1571, 1475, 1433; HRMS (ESI) calculated for C14H15N2O [M+H]+ 227.1179, 
found: 227.1190. 
2,4-dimethyl-N-phenylbenzimidamide (238) 
 
Following procedure 4.6: brown solid, 89% yield; M. p. 125-127 oC; 1H NMR (500 MHz, 
CDCl3): δ 7.37-7.27 (m, 3H, Ar-H), 7.20-6.99 (m, 5H, Ar-H), 6.85-6.78 (br m, 1H, Ar-H), 
2.45-2.22 (m, 6H, CH3). 13C NMR (125 MHz, CDCl3): δ 135.3 (CH), 131.2 (CH), 129.1 (CH), 
128.3 (CH), 127.6 (CH), 122.0 (CH), 19.4 (CH3) ppm; IR: ῦ (cm-1) 3318, 3058, 1619, 1571, 
1475, 1433; HRMS (ESI) calculated for C15H17N2 [M+H]+ 225.1386, found: 225.1391. 
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4.7 Experimental for Ch-3 - Synthesis of acyl hydrazides:  
4.7.1 Method A: Synthesis of acyl hydrazides starting from acyl chlorides12 
N’-Phenylbenzohydrazide12 (300) 
 
To a stirred solution of 2.16 g (20 mmol) phenylhydrazine in 20 mL dichloromethane was 
slowly added pyridine (1.58 g, 20 mmol) under the ice bath. Then, to this, well-stirred reaction 
mixture was added dropwise a solution of benzoyl chloride (2.8 g, 20 mmol) in 
dichloromethane (5 mL) over a period of 2 h. Upon completion of addition, ice bath was taken 
away, and the stirring was continued for another 3 h at the room temperature. A solid was 
collected by filtration, washed with water, dried, and recrystallised with ethanol to give 3.6 g 
of compound 300 (yield 85%) ; δH (500 MHz, MeOD) 7.95-7.91 (m, 2 H, Ar-H), 7.61-7.55 (m, 
1 H, Ar-H), 7.53-7.47 (m, 2 H, Ar-H), 7.20-7.10 (m, 2 H, Ar-H), 6.80 (d, J = 7.8 Hz, 2 H, Ar-
H), 6.72 (t, J = 7.3 Hz, 1 H,  Ar-H); δC (100 MHz, MeOD) 166.3 (C), 149.5 (C), 133.0 (C), 
131.5 (CH), 128.7 (CH), 128.4 (CH), 127.2 (CH), 118.6 (CH), 112.3 (CH); IR: ῦ (cm-1) (neat) 
3298, 3090, 1629, 1594, 1554, 1488. 
N’-phenylcyclopropanehydrazide (309) 13 
 
Following method A: Cyclopropylcarbonyl chloride (2.5 g, 23.9 mmol) and phenyl hydrazine 
(2.58 g, 23.9 mmol) were reacted to afford the product 309 (2.19 g, 52 % yield) as a pale-
yellow solid; δH (500 MHz, CDCl3) 7.39 (s, 1 H, NH), 7.30-7.21 (m, 2 H, Ar-H), 6.96-6.83 (m, 
3 H, Ar-H), 6.11 (s, 1 H, NH), 1.49-1.44 (m, 1 H, CH), 1.07-1.03 (m, 2 H, CH2), 0.86-0.78 (m, 
2 H, CH2); δC (125 MHz, CDCl3) 173.9 (C=O), 148.1 (C), 129.2 (CH), 121.2 (CH), 113.6 (CH), 
112.6 (CH), 12.8 (CH), 7.5 (CH2); IR: ῦ (cm-1) (neat) 3298, 3090, 1629, 1594, 1554, 1488 
4.7.2 Method B: Synthesis of acyl hydrazides from carboxylic acids14 
In a 50 ml round bottom flask, phenylhydrazine (1.0 equiv), 2-flourobenzoic acid (1.42 g, 10.1 
mmol, 1.0 equiv) and EDC.HCl (1.3 equiv) were dissolved in MeCN (10 mL) and stirred 
vigorously at ambient temperature. Immediately afterwards, DIPEA (2.0 equiv) was added in 
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a single portion and the reaction mixture was monitored by HPLC and LCMS until completion. 
Once finished, 100 mL of 1 M HCl (ice-cold) were added slowly at 0 oC. Afterwards, the 
organic components were extracted by ethyl acetate (3x 100 mL). The organic layer was 
washed with 1 M HCl (100 mL), 100 ml NaHCO3 (sat.) (3x 100 mL), brine (3x 100 mL) and 
water (60 mL). The combined organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated on a rotator evaporated at 40 oC (100 mBar). The white solid was further purified 
by gradient elution flash column chromatography on silica gel using ethyl acetate/cyclohexane 
as solvent system (0-50 %, over 60 min), giving N-phenyl-4- fluorobenzohydrazide (302) as 
a white solid (1.82 g, 7.90 mmol, 79 % yield). 
N’-Phenyl-2-fluorobenzohydrazide (302) 
 
Yellow solid, 79% yield; 1H NMR (500 MHz, MeOD): δ 7.75 (td, J = 7.5, 1.6 Hz, 1H, Ar-H), 
7.60-7.55 (m, 1H, Ar-H), 7.33-7.19 (m, 4H, Ar-H), 6.91 (d, J = 7.6 Hz, 2H, Ar-H), 6.83 (t, J = 
7.4 Hz, 1H, Ar-H) ppm; 13C NMR (120 MHz, MeOD) : δ 167.2 (C=O), 145.5 (C, d, J = 250.7 
Hz), 149.9 (C), 134.4 (CH, d, J = 8.2 Hz), 131.5 (CH), 130.0 (CH), 125.8 (d, J = 4 Hz, CH), 
123.1 (d, J = 14.5 Hz, C), 121.2 (CH), 117.3 (d, J = 22.7 Hz, CH), 114.2 (CH) ppm; IR: ῦ (cm-
1)  3265, 1637, 1613. 
N’-Phenyl-4-methoxybenzohydrazide (301)14 
 
Following Method B: 4-methoxybenzoic acid (2.5 g, 16.4 mmol) and phenyl hydrazine (1.77 
g, 16.4 mmol) were reacted to afford the product 301 (3.42 g, 86 % yield) as a light yellow 
solid; δH (500 MHz, MeOD) 7.89-7.86 (m, 2 H, Ar-H), 7.20-7.17 (m, 2H, Ar-H), 7.04-7.01 (m, 
2H, Ar-H)), 6.88-6.86 (m, 2H, Ar-H), 6.81 (t, J = 7.3 Hz, 1H, Ar-H), 3.86 (3 H, s, CH3); δC 
(125 MHz, MeOD) 169.9 (C=O), 164.3 (C), 150.3 (C), 130.3 (CH), 130.0 (CH), 126.1 (C), 
121.1 (CH), 114.9 (CH), 114.2 (CH), 55.6 (CH3); IR: ῦ (cm-1): 3291, 1634, 1600. 
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N’-Phenyl-4-trifluoromethylbenzohydrazide (303) 
 
Following method B: 4-trifluoromethoxybenzoic acid (1.0 g, 5.26 mmol) and phenyl 
hydrazine (0.57 g, 5.26 mmol) were reacted to afford the product 301 (1.25 g, 85 % yield) as a 
orange solid; δH (500 MHz, MeOD) 8.07 (d, J = 8.1 Hz, 2 H, Ar-H), 7.83 (d, J = 8.1 Hz, 2H, 
Ar-H), 7.21 (t, J = 7.9 Hz, 2H, Ar-H), 6.89 (d, J = 8.2 Hz, 2H, Ar-H), 6.84 (t, J = 7.3 Hz, 1H, 
Ar-H); δC (125 MHz, MeOD) 168.8 (C=O), 150.0 (C), 134.4 (J = 32.7 Hz, C), 130.0 (CH), 
129.3 (CH), 126.7 (q, J = 3.6 Hz, CH), 125.9 (C), 121.2 (CH), 114.2 (CH); υmax/cm-1 (neat) 
3236, 1642, 1487 
N’-Phenyl-4-nitrobenzohydrazide (304)14 
 
Following method B: 4-nitrobenzoic acid (3.0 g, 17.9 mmol) and phenyl hydrazine (1.94 g, 
17.9 mmol) were reacted to afford the product 301 (3.74 g, 81 % yield) as a light yellow solid; 
δH (500 MHz, MeOD) 8.36 (d, J = 8.8 Hz, 2 H, Ar-H), 8.11 (d, J = 8.7 Hz, 2H, Ar-H), 7.21 (t, 
J = 7.9 Hz 2H, Ar-H)), 6.89 (d, J = 7.9 Hz, 2H, Ar-H), 6.83 (t, J = 7.3 Hz, 1H, Ar-H); δC (125 
MHz, MeOD) 168.2 (C=O), 151.3 (C), 149.9 (C), 140.0 (C), 130.0 (CH), 129.9 (CH), 124.8 
(CH), 121.3 (CH), 114.2 (CH); υmax/cm-1 (neat) 3280, 1637, 1596, 1511, 1495, 1341 
N’-(2-methylphenyl) benzohydrazide (305) 
 
Following method B: Benzoic acid (2.0 g, 16.3 mmol) and 2-methylphenyl hydrazine (2.0 g, 
16.3 mmol) were reacted to afford the product 301 (1.92 g, 52 % yield) as a white solid; δH 
(500 MHz, DMSO-d6) 10.39 (s, 1 H, NH), 7.94 (d, J = 8.5 Hz, 1 H, Ar-H), 7.51 (t, J = 7.4 Hz, 
2 H, Ar-H), 7.25 (s, 1 H, NH), 7.04-7.0 (m, 2H, Ar-H), 6.73-6.67 (m, 2 H, Ar-H), 2.22 (s, 3 H, 
CH3); δC (125 MHz, DMSO-d6) 166.2 (C=O), 146.8 (C), 133.0 (C), 131.6 (CH), 130.0 (CH), 
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128.5 (CH), 127.2 (CH), 126.4 (CH), 122.0 (C), 118.7 (CH), 111.1 (CH), 17.2 (CH3); υmax/cm-
1 (neat) 3277, 1643, 1604 
N’-(2-trifluoromethylphenyl) benzohydrazide (306)15 
 
Following method B: Benzoic acid (2.0 g, 16.3 mmol) and 2-trifluoromethylphenyl hydrazine 
(2.9 g, 16.3 mmol) were reacted to afford the product 301 (3.76 g, 82 % yield) as a orange 
solid; δH (500 MHz, MeOD) 7.93 (d, J = 7.3 Hz, 2 H, Ar-H), 7.60 (t, J = 7.4 Hz, 1H, Ar-H), 
7.53-7.50 (m, 3H, Ar-H), 7.44 (t, J = 7.8 Hz, 1H, Ar-H), 7.09 (d, J = 8.4 Hz, 1H, Ar-H), 6.94 
(t, J = 7.5 Hz, 1H, Ar-H); δC (125 MHz, MeOD) 170.0 (C=O), 147.6 (C), 134.3 (C), 133.8 
(CH), 133.3 (CH), 129.7 (CH), 128.5 (C), 127.3 (q, J = 5.5 Hz, C), 125.1 (C), 120.3 (CH), 
115.2 (q, J = 30 Hz, C), 114.4 (CH); υmax/cm-1 (neat) 3236, 1642, 1487  
N’-(4-methoxyphenyl) benzohydrazide (307)14 
 
Following method B: Benzoic acid (2.0 g, 16.3 mmol) and 2-methoxyphenyl hydrazine (2.26 
g, 16.3 mmol) were reacted to afford the product 301 (1.86 g, 47 % yield) as a off-white solid; 
δH (500 MHz, MeOD) 7.89-7.87 (m, 2 H, Ar-H), 7.53-7.45 (m, 2 H, Ar-H), 6.88-6.86 (m, 3 H, 
Ar-H), 6.78 (d, J = 8.8 Hz, 1H, Ar-H), 3.67 (s, 3 H, CH3); δC (125 MHz, MeOD) 167.9 (C=O), 
155.0 (C), 141.4 (C), 132.2 (CH), 132.1 (CH), 128.7 (C), 127.3 (CH), 116.0 (CH), 114.6 (CH), 
55.6 (OCH3); υmax/cm-1 (neat) 3289, 1623, 1598 
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N’-Phenylthiophene-2-carbohydrazide (308)16 
 
Following method B: 2-Thiophenecarboxylic acid (2.0 g, 15.6 mmol) and phenyl hydrazine 
(1.68 g, 15.6 mmol) were reacted to afford the product 301 (3.27 g, 96 % yield) as a yellow 
solid; δH (500 MHz, MeOD) 7.80 (d, J = 3.2 Hz, 1 H, Ar-H), 7.72 (d, J = 4.9 Hz, 1H, Ar-H), 
7.20-7.16 (m, 3H, Ar-H), 6.86 (d, J = 7.8 Hz, 2H, Ar-H), 6.81 (t, J = 7.3 Hz, 1H, Ar-H); δC 
(125 MHz, MeOD) 161.3 (C=O), 149.3 (C), 137.8 (C), 131.3 (CH), 128.7 (CH), 128.5 (CH), 
128.1 (CH), 118.7 (CH), 112.2 (CH); υmax/cm-1 (neat) 3306, 1592, 1534 
N’-Phenyl-3-(1-tert-butoxycarbonylamino-2-methyl-butyl) carbohydrazide (310) 
 
Following method B: 1-tert-butoxycarbonylamino-2-methyl-butyl carboxylic acid (0.8 g, 3.4 
mmol) and phenyl hydrazine (0.37 g, 3.4 mmol) were reacted to afford the product 310 (0.75 
g, 68 % yield) as a light orange solid; d.r. ratio: 4:1; [α]D – 37.34o;  δH (500 MHz, MeOD) 7.14 
(t, J = 7.5 Hz, 2 H, Ar-H), 6.84-6.77 (m, 3H, Ar-H), 3.95 (d, J = 7.9 Hz 1H, CH), 1.86-1.79 (br 
m, 1H, CH), 1.64-1.56 (m, 1H, CH), 1.47 (s, 9H, CH3), 1.25-1.17 (m, 1H, CH), 0.98 (d, J = 6.7 
Hz, 3H, CH3), 0.93 (t, J = 7.4 Hz, 3H, CH3); δC (125 MHz, MeOD) 174.5 (C=O), 157.9 (C=O), 
149.8 (C), 129.8 (CH), 121.0 (CH), 114.2 (CH), 80.6 (C), 59.4 (CH), 37.8 (CH), 28.7 (CH), 
26.0 (CH2), 16.0 (CH), 11.3 (CH) ; υmax/cm-1 (neat) 3319, 3266, 2962, 1685, 1657, 1521,  
4.8 Synthesis of hydrazonyl chlorides 
4.8.1 Chlorination of acyl hydrazides17 
Carbon tetrachloride (1.46 mL, 15 mmol) was added to a stirred suspension of compound  
benzoyl phenylhydrazine (3.18 g, 15 mmol) and Ph3P (4.91 g, 18.75 mmol) in acetonitrile (40 
mL). Upon completion of addition, the reaction mixture was stirred at room temperature for 48 
hours, and then the solution was cooled, crystallization was initiated by scratching, and the 
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crude product was filtered off. It was further recrystallised or purified by silica-gel column 
chromatography. 
N-Phenyl-benzencarbohydrazonyl chloride (70)18 
 
Following general procedure 4.8.1: Benzoylphenylhydrazine (3.18 g, 15 mmol) gave the 
product 70 (2.07 g, 60 % yield) as a buff solid; δH (500 MHz, CDCl3) 8.06 (s, 1 H, NH), 7.96-
7.93 (m, 2 H, Ar-H), 7.44-7.36 (m, 3 H, Ar-H), 7.33 (t, J = 8.5 Hz, 2 H, Ar-H), 7.21-7.18 (m, 
2 H, Ar-H), 6.96 (t, J = 7.3 Hz, 1 H, Ar-H); δC (125 MHz, CDCl3) 143.4 (C), 134.5 (C), 129.4 
(CH), 129.2 (CH), 128.4 (CH), 126.4 (CH), 124.7 (C), 121.2 (CH), 113.5 (CH); υmax/cm-1 (neat) 
3305, 1596, 1502 
N-Phenyl-4-methoxybenzenecarbohydrazonoyl chloride (290)19 
 
Following general procedure 4.8.1: N’-Phenyl-4-methoxybenzohydrazide (2 g, 8.25 mmol) 
gave the product 70 (1.7 g, 79 % yield) as a Buff solid; δH (500 MHz, CDCl3) 7.95 (s, 1 H, 
NH), 7.89-7.86 (m, 2 H, Ar-H), 7.32 (app t, J = 7.8 Hz, 2 H, Ar-H), 7.17 (d, J = 7.3 Hz, 2 H, 
Ar-H), 6.96-6.92 (m, 3 H, Ar-H), 3.87 (s, 3 H, OCH3); δC (125 MHz, CDCl3) 160.5 (C), 143.6 
(C), 129.3 (CH), 127.9 (CH), 127.1 (C), 124.7 (C), 120.8 (CH), 113.8 (CH), 113.3 (CH), 55.4 
(OCH3); υmax/cm-1 (neat) 3313, 1599, 1500 
N-Phenyl-2-fluorobenzenecarbohydrazonoyl chloride (291)20 
 
Following general procedure 4.8.1: N’-Phenyl-2-fluorobenzohydrazide (1.0 g, 4.3 mmol) 
gave the product 70 (0.87 g, 81 % yield) as a yellow solid; δH (500 MHz, CDCl3) 8.13 (s, 1 H, 
NH), 7.73 (td,  J = 7.8, 1.7 Hz, 1 H, Ar-H), 7.39-7.35 (m, 1 H, Ar-H), 7.34-7.31 (m, 2 H, Ar-
H), 7.23-7.14 (m, 4 H, Ar-H), 6.96 (t, J = 7.3 Hz, 1 H, Ar-H); δC (125 MHz, CDCl3) 159.7 (C, 
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J = 257.0 Hz), 143.1 (C), 130.6 (CH, J = 9.1 Hz), 130.2 (CH), 129.4 (CH), 123.9 (CH, J = 3.6 
Hz), 123.1 (C, J = 9.1 Hz), 121.3 (CH), 118.7 (C, J = 5.4 Hz), 116.5 (CH, J = 21.8 Hz), 113.5 
(CH); υmax/cm-1 (neat) 3302, 1579, 1499, 1239, 1132 
N-Phenyl-4-trifluoromethylbenzenecarbohydrazonoyl chloride (292) 
 
Following general procedure 4.8.1: N’-Phenyl-4-trifluoromethylbenzohydrazide (1.0 g, 3.5 
mmol) gave the product 70 (0.53 g, 50 % yield) as a yellow solid; δH (500 MHz, CDCl3) 8.15 
(s, 1 H, NH), 8.04 (d,  J = 8.2 Hz, 2 H, Ar-H), 7.67 (d, J = 8.2 Hz, 2 H, Ar-H), 7.35 (app t, J = 
7.5 Hz, 2 H, Ar-H), 7.23-7.18 (m, 2 H, Ar-H), 7.0 (t, J = 7.3 Hz, 1 H, Ar-H); δC (125 MHz, 
CDCl3) 142.8 (C), 137.7 (C), 130.7 (q, J = 32.7 Hz, C), 129.5 (CH), 126.4 (CH), 125.4 (CH, J 
= 3.6 Hz), 123.0 (C), 122.9 (C), 121.7 (CH); υmax/cm-1 (neat) 3307, 1600, 1572, 1559 
N-Phenyl-4-nitrobenzenecarbohydrazonoyl chloride (293)21 
 
Following general procedure 4.8.1: N’-Phenyl-4-nitrobenzohydrazide (2.0 g, 7.7 mmol) gave 
the product 70 (1.62 g, 76 % yield) as a orange solid; δH (500 MHz, CDCl3) 7.95 (s, 1 H, NH), 
7.89-7.86 (m, 2 H, Ar-H), 7.32 (app t, J = 7.8 Hz, 2 H, Ar-H), 7.17 (d, J = 7.3 Hz, 2 H, Ar-H), 
6.96-6.92 (m, 3 H, Ar-H), 3.87 (s, 3 H, CH3); δC (125 MHz, CDCl3) 160.5 (C), 143.6 (C), 129.3 
(CH), 127.9 (CH), 127.1 (C), 124.7 (C), 120.8 (CH), 113.8 (CH), 113.3 (CH), 55.4 (CH3); 
υmax/cm-1 (neat) 3315, 1603, 1547, 1503, 1334 
N-Phenyl-thiophene-2-carbohydrazonoyl chloride  (297)19 
 
Following general procedure 4.8.1: N’-Phenylthiophene-2-carbohydrazide (2.0 g, 9.16 
mmol) gave the product 70 (1.56 g, 25 % yield) as a yellow-brown solid; δH (500 MHz, CDCl3) 
7.89 (s, 1 H, NH), 8.04 (dd,  J = 3.8, 1.2 Hz, 1 H, Ar-H), 7.35-7.30 (m, 3 H, Ar-H), 7.17-7.14 
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(m, 2 H, Ar-H), 7.04 (dd, J = 3.6, 1.4 Hz, 1 H, Ar-H), 6.96 (t, J = 7.3 Hz, 1 H, Ar-H); δC (125 
MHz, CDCl3) 143.0 (C), 138.7 (C), 129.3 (CH), 127.2 (CH), 127.0 (CH), 126.9 (CH), 121.2 
(CH), 119.6 (C), 113.4 (CH); υmax/cm-1 (neat) 3312, 1597, 1499 
N-(2-Trifluoromethylphenyl)benzenecarbohydrazonoyl chloride  (295) 
 
Following general procedure 4.8.1: N’-(2-trifluoromethylphenyl) benzohydrazide (2.0 g, 7.1 
mmol) gave the product 70 (1.51 g, 71 % yield) as a orange-brown solid; δH (500 MHz, CDCl3) 
8.67 (s, 1 H, NH), 7.96 (dd,  J = 8.2, 2.0 Hz, 2 H, Ar-H), 7.77 (d, J = 8.4 Hz, 1 H, Ar-H), 7.56-
7.51 (m, 2 H, Ar-H), 7.46-7.41 (m, 3 H, Ar-H), 7.0 (t, J = 7.5 Hz, 1 H, Ar-H); δC (125 MHz, 
CDCl3) 140.9 (C), 134.0 (C), 133.3 (CH), 129.8 (CH), 128.5 (CH), 127.7 (C), 126.7 (CH), 
126.3 (CH, J = 5.5 Hz), 124.6 (C, J = 272.5 Hz), 120.1 (CH), 115.2 (CH), 113.3 (C, J = 30.9 
Hz) ; υmax/cm-1 (neat) 3375, 1610, 1584, 1518, 1313, 1095. 
N-phenyl- (1-tertbutoxycarbonylamino-2-methylbutyl)- carbohydrazonoyl chloride 
(299) 
 
Following general procedure 4.8.1: N’-Phenyl-3-(1-tert-butoxycarbonylamino-2-methyl-
butyl) carbohydrazide (0.5 g, 1.55 mmol) gave the product 70 (0.39 g, 74 % yield) as a light 
orange solid; mixture of isomers (80:20), [α]D + 19.94o; δH (500 MHz, CDCl3) 7.69 (s, 1 H, 
NH), 7.26 (t, J = 7.7 Hz, 2 H, Ar-H, major), 7.19 (t, J = 7.8 Hz, minor), 7.05 (d, J = 7.8 Hz, 
2H, Ar-H, major), 6.89 (d, J = 7.9 Hz, 1H, Ar-H, major), 6.82 (d, J = 7.8 Hz, minor), 4.90 (d, 
J = 8.8 Hz, 1 H, CH), 1.84 (br s, 1 H, CH), 1.63-1.54 (m, 1 H, CH2), 1.45 (s, 9H, CH3), 1.20-
1.16 (m, 1 H, CH2), 0.98-0.87 (m, 6 H, 2 x CH3); δC (125 MHz, CDCl3) 155.2 (C=O), 147.8 
(C), 143.5 (C), 129.2 (CH), 120.8 (CH), 113.2 (CH), 79.8 (C), 60.8 (CH), 37.6 (CH), 28.3 
(CH3), 24.5 (CH2), 15.7 (CH3), 11.3 (CH3) ; υmax/cm-1 (neat) 3319, 3266, 2962, 1685, 1657, 
1521 
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N-(4-methoxyphenyl) benzenecarbohydrazonoyl chloride (296)21 
 
Following general procedure 4.8.1: N’-(4-methoxyphenyl) benzohydrazide (1.0 g, 4.1 mmol) 
gave the product 70 (0.78 g, 73 % yield) as a yellow-brown solid; δH (500 MHz, CDCl3) 7.94-
7.91 (m, 3 H, 2 Ar-H, 1 NH), 7.43-7.35 (m, 3 H, Ar-H), 7.14 (d, J = 8.8 Hz, 2 H, Ar-H), 6.90 
(d, J = 9.0 Hz, 2 H, Ar-H), 3.81 (s, 3 H, OCH3); δC (125 MHz, CDCl3) 154.4 (C), 137.4 (C), 
134.5 (C), 128.9 (CH), 128.3 (CH), 126.2 (CH), 123.8 (C), 114.7 (CH), 114.5 (CH), 55.6 
(OCH3); υmax/cm-1 (neat) 3325, 1592, 1495 
N-(2-methylphenyl) benzenecarbohydrazonoyl chloride20 
 
Following general procedure 4.8.1: N’-(2-methylphenyl) benzohydrazide (1.0 g, 4.4 mmol) 
gave the product 70 (0.6 g, 56 % yield) as a yellow solid; δH (500 MHz, CDCl3) 7.97-7.93 (m, 
3 H, 2 Ar-H, 1 NH), 7.53 (d, J = 8.1 Hz, 1 H, Ar-H), 7.42-7.34 (m, 3 H, Ar-H), 7.24-7.21 (m, 
1 H, Ar-H), 7.12 (d, J = 7.5 Hz, 2 H, Ar-H), 6.87 (td, J = 7.5, 0.9 Hz, 1 H, Ar-H), 2.30 (s, 3 H, 
CH3); δC (125 MHz, CDCl3) 141.2 (C), 134.5 (C), 130.5 (CH), 129.2 (CH), 128.4 (CH), 127.3 
(CH), 126.4 (CH), 125.5 (C), 121.1 (C), 120.8 (CH), 113.3 (CH), 16.8 (CH3); υmax/cm-1 (neat) 
3313, 1599, 1500 
N-Phenyl-cyclopropanecarbohydrazonoyl chloride (298)13 
 
Following general procedure 4.8.1: N’-phenylcyclopropanehydrazide (1.0 g, 5.7 mmol) gave 
the product 70 (0.87 g, 79 % yield) as a pale-yellow solid; δH (500 MHz, CDCl3) 7.55 (s, 1 H, 
NH), 7.26-7.23 (m, 2 H, Ar-H), 7.03-7.01 (m, 2 H, Ar-H), 6.87 (t, J = 7.3 Hz, 1 H, Ar-H), 1.99-
1.94 (m, 1 H, CH), 1.01-0.98 (m, 1 H, CH2), 0.87-0.83 (m, 2 H, CH2); δC (125 MHz, CDCl3) 
143.9 (C), 129.2 (CH), 120.4 (CH), 112.9 (CH), 18.1 (CH), 6.4 (CH2); υmax/cm-1 (neat) 3315, 
3050, 1599, 1497. 
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4.8.2. Chlorination of aryl hydrazones23 
Aromatic aldehydes 311 (1.00 mmol) and tertbutylcarbazate/phenyl hydrazine (1.00 mmol) are 
placed in a 50 ml round bottomed flask where condensation between 311 and hydrazine 
derivative takes place instantaneously to form the carbo-tert-butoxyhydrazones 312. In the case 
of solid aldehydes, 5.0 ml of methanol is required to add to the mixture and heated slightly on 
a water bath to furnish the condensation. Subsequently, N-chlorosuccinamide (1.00 mmol) is 
added to the dry DMF (10 ml) solution of compound 312 (1.00 mmol) at cold condition 
(temperature around 0 oC) and then stirred for 3 hour at room temperature. The progress of the 
reaction is monitored by TLC analysis. In cases of 313 and 314, heating at 50 oC (overnight) 
was required to drive the reaction to completion. After completion of the reaction, the reaction 
mixture is poured into ice-cold water and the solid residue is filtered out, which is washed 
several times with distilled water, dried in open air and then crystallized from acetone. 
 N-(tert-butoxycarbonyl)-benzenecarbohydrazonyl chloride (313)23 
 
Following general procedure 4.8.2: N-(tert-butoxycarbonyl)-phenylhydrazone (2.0 g, 9.5 
mmol) gave the product 70 (1.76 g, 73 % yield) as a white solid; δH (500 MHz, CDCl3) 8.30 
(s, 1 H, NH), 7.95 (app d, J = 8.0 Hz, 2 H, Ar-H), 7.44-7.39 (m, 3 H, Ar-H), 1.57 (s, 9 H, 3 x 
CH3); δC (125 MHz, CDCl3) 151.6 (C), 142. 1 (C), 133.4 (C), 130.5 (CH), 128.4 (CH), 127.4 
(CH), 82.3 (C), 28.2 (CH3); υmax/cm-1 (neat) 3161, 2981, 1741, 1716, 1505 
N-(tert-butoxycarbonyl)-2,4-dimethoxybenzenecarbohydrazonyl chloride (314) 
 
Following general procedure 4.8.2: N-(tert-butoxycarbonyl)-2,4-dimethoxyphenylhydrazone 
(3.0 g, 10.7 mmol) gave the product 70 (1.35 g, 40 % yield) as a white solid; δH (500 MHz, 
CDCl3) 8.13-7.99 (m, 2 H, Ar-H), 7.83 (s, 1 H, NH), 6.44 (s, 1 H, Ar-H), 3.93 (s, 3 H, OCH3), 
3.86 (s, 3 H, OCH3),  1.54 (s, 9 H, 3 x CH3); δC (125 MHz, CDCl3) 157.4 (C), 157.0 (C), 152.4 
(C), 127.6 (CH), 115.8 (C), 115.1 (C), 95.9 (CH), 81.3 (C), 56.2 (OCH3), 56.0 (OCH3), 28.3 
(CH3); υmax/cm-1 (neat) 3208, 2977, 1690, 1603, 1540 
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N-(tert-butoxycarbonyl)-furancarbohydrazonyl chloride (315) 
 
Following general procedure 4.8.2: N-(tert-butoxycarbonyl)- furanylhydrazone (2.0 g, 9.5 
mmol) gave the product 70 (1.46 g, 63 % yield) as a pale yellow solid; δH (500 MHz, CDCl3) 
7.97 (s, 1 H, NH), 7.73 (s, 1 H, HetAr-H), 7.30 (app d, J = 1.8 Hz, 1 H, HetAr-H), 6.89 (s, 1 
H, HetAr-H), 1.53 (s, 9 H, 3 x CH3); δC (125 MHz, CDCl3) 142.6 (CH), 137.4 (C), 134.7 (C), 
116.6 (C), 109.8 (CH), 81.6 (C), 28.2 (CH3); υmax/cm-1 (neat) 3187, 2986, 1721, 1532 
N-Phenyl-pyridyl-2-carbohydrazonoyl chloride (316) 
 
Following general procedure 4.8.2: N-phenyl-2-pyridylhydrazone (2.0 g, 10.1 mmol) gave 
the product 70 (2.79 g, 84 % yield) as a brown solid; δH (500 MHz, CDCl3) 8.68-8.65 (m, 1 H, 
HetAr-H), 8.28 (s, 1 H, NH), 8.07 (d, J = 8.1 Hz, 1 H, HetAr-H), 7.76-7.71 (m, 1 H, HetAr-H), 
7.33 (t, J = 7.5 Hz, 2 H, Ar-H), 7.28-7.25 (m, 1 H, HetAr-H), 7.21 (app d, J = 8.5 Hz, 2 H, Ar-
H), 6.98 (t, J = 7.3 Hz, 1 H, Ar-H); δC (125 MHz, CDCl3) 151.3 (C), 149.1 (CH), 142.8 (C), 
136.3 (CH), 129.4 (CH), 125.2 (C), 123.4 (CH), 121.7 (CH), 121.1 (CH), 113.6 (CH); υmax/cm-
1 (neat) 3313, 1599, 1500 
4.8.3 Japp-Klingemann synthesis24 
A solution of aniline derivative (20 mmol) in dilute HCl (1:1, 15 mL) was cooled to 0 oC, and 
a solution of NaNO2 (1.1 equiv.) in H2O (19 mL) was added drop wise over 10 min under 
vigorous stirring. The addition was controlled in such a way to keep the internal solution 
temperature at 0 oC. The resulting ice-cold solution of diazonium compound was added drop 
wise to a cold solution of ethyl-2-chloroacetoacetate (1.0 equiv.) and NaAOc (1.5 equiv.) in 
H2O/EtOH (9:1, 111 mL). It is important to keep the diazonium solution at 0 oC during the 
addition. After complete addition, the mixture was stirred for 4 h, then poured into 150 mL of 
water, and the precipitate was filtered off. The crude was dried, furnishing the desired product. 
 
 
195 | P a g e  
 
Ethyl 2-chloro-2-(2-phenylhydrazono)acetate (321a)19 
 
Following general procedure 4.8.3: Aniline (1.86 g, 20 mmol) and 2-chloro-3-oxobutanoate 
(3.29 g, 20 mmol) were reacted to afford the product 70 (4.12 g, 91 % yield) as a pale-brown 
solid; δH (500 MHz, CDCl3) 8.30 (s, 1 H, NH), 7.30-7.27 (m, 2 H, Ar-H), 7.21-7.17 (m, 2 H, 
Ar-H), 7.01-6.98 (m, 1 H, Ar-H), 4.36-4.32 (m, 2 H, Ar-H), 1.35 (t, J = 7 Hz, 3 H, CH3); δC 
(125 MHz, CDCl3) 159.7 (C), 141.5 (C), 129.4 (CH), 123.1 (CH), 116.0 (C), 114.4 (CH), 62.7 
(CH2), 14.2 (CH3); υmax/cm-1 (neat) 3278, 2982, 1712, 1548 
Ethyl 2-chloro-2-(2-(2-chlorophenyl)hydrazono)acetate (321b)25 
 
Following general procedure 4.8.3: 2-chloroaniline (2.55 g, 20 mmol) and 2-chloro-3-
oxobutanoate (3.29 g, 20 mmol) were reacted to afford the product 70 (4.54 g, 87 % yield) as 
a pale-yellow solid; δH (500 MHz, CDCl3) 8.33 (s, 1 H, NH), 7.64 (dd, 8.2, 1.4 Hz, 1 H, Ar-
H), 7.35 (dd, J = 7.9, 1.2 Hz, 1 H, Ar-H), 7.31-7.27 (m, 1 H, Ar-H), 6.98 (td, J  = 7.9, 1.4 Hz, 
1 H, Ar-H), 4.41 (q, J = 7.2 Hz, 2 H, CH2), 1.42 (t, J = 7.2 Hz, 3 H, CH3); δC (125 MHz, CDCl3) 
159.4 (C), 137.8 (C), 129.4 (CH), 128.1 (CH), 123.2 (CH), 119.1 (C), 118.5 (C), 115.7 (CH), 
62.9 (CH2), 14.2 (CH3); υmax/cm-1 (neat) 3312, 1720, 1557, 1504 
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Ethyl 2-chloro-2-(2-(4-bromophenyl)hydrazono)acetate (321c)26 
 
Following general procedure 4.8.3: 4-bromoaniline (3.4 g, 20 mmol) and 2-chloro-3-
oxobutanoate (3.29 g, 20 mmol) were reacted to afford the product 70 (5.79 g, 96 % yield) as 
a pale-yellow solid; δH (500 MHz, CDCl3) 8.31 (s, 1 H, NH), 7.46-7.43 (m, 2 H, Ar-H), 7.14-
7.10 (m, 2 H, Ar-H), 4.40 (q, J = 7.2 Hz, 2 H, CH2), 1.41 (t, J = 7.2 Hz, 3 H, CH3); δC (125 
MHz, CDCl3) 159.5 (C), 140.7 (C), 132.4 (CH), 116.9 (C), 116.0 (CH), 115.5 (C), 62.9 (CH2), 
14.2 (CH3); υmax/cm-1 (neat) 3248, 1705, 1554, 1508, 1483 
4.9 Synthesis of 1,2,4-triazol-3-imine 
4.9.1 Optimisation studies: 
All optimization studies towards 1,2,4-triazole-3-imine were performed on 0.21 mmol of 
hydrazonyl chloride (70). The conversation rate for nitrile imine formation from 70 (Table 3.1) 
was calculated by GC-MS (dimer formation was observed at 11.58 min).  
Where the ratio of 285:286 is mentioned (Table 3.2, 3.4, 3.5, 3.6), it is calculated from the 
crude NMR. A characteristic peak at 8.10 ppm (2 protons) is observed for 285, whereas a peak 
at 8.20 ppm is representative for 286. Where ratio of 285:286:284 is specified, it is calculated 
from the GC-MS spectra of the crude reaction mixture.  
4.9.2 General procedure for the synthesis of 1,2,4-triazol-3-imine 
In an oven dried 5 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 0.59 mmol) and N-aryl-N-tosyl cyanamide (1.25 equiv, 0.27 mmol) in anhydrous 
CH3CN (0.5 M, 1 mL). The reaction mixture was introduced to an ice-bath, followed by 
addition of 18-crown-6 (2.75 equiv, 59 mmol) in a single portion under vigorous stirring 
conditions. After 10 minutes, hydrazonoyl chloride (1 equiv, 0.21 mmol) was added which 
formed a paste like suspension. After 5 min, the flask was removed from the ice-bath, and the 
volatile components were removed under vacuum. The organic residue from the reaction 
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mixture was dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). 
The organic fraction was dried over anhydrous Na2SO4 and solvents removed under reduced 
pressure. The purification was carried out using a short column packed with silica gel (7 cm 
height) with gradient elution of Pet Ether: EtOAc (9.5:0.5 to 1:1) followed by Pet Ether: 
EtOAc: NH3 (1:1:0.1 to 0:1:0.2) to afford the 1,2,4-triazol-3-imine product. 
 
2,4,5-Triphenyl-1H-1,2,4-triazol-3-imine (285) 
 
 
In an oven dried 5 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 90 mg, 0.59 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 74 mg, 0.27 
mmol) in anhydrous CH3CN (0.5 M, 1 mL). The reaction mixture was introduced to an ice-
bath, followed by addition of 18C6 (2.75 equiv, 157 mg, 59 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenylbenzenecarbohydrazonoyl chloride 6a 
(1 equiv, 50 mg, 0.21 mmol) was added which formed a paste like suspension. After 5 min, the 
flask was removed from the ice-bath, and the volatile components were removed under 
vacuum. The organic residue from the reaction mixture was dissolved in 20 mL ethyl acetate, 
and washed with sat. aqueous KCl (3 x 4 mL). The organic fraction was dried over anhydrous 
Na2SO4 and solvents removed under reduced pressure. The purification was carried out using 
a short column packed with silica gel (7 cm height) with gradient elution of Pet Ether: EtOAc 
(9.5:0.5 to 1:1) followed by Pet Ether:EtOAc:NH3 (1:1:0.1 to 0:1:0.2) to afford the product 1a 
(60 mg, 89% yield) as a light brown solid, 89% yield; M. p. 182-183 °C; Rf 0.35 (0.2% NH3 in 
EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.12 (d, J = 7.9 Hz, 2H, Ar-H), 7.54-7.46 (m, 5H, Ar-
H), 7.39-7.34 (m, 3H, Ar-H), 7.32-7.22 (m, 5H, Ar-H), 5.16 (brs, 1H, NH) ppm; 13C NMR (120 
MHz, CDCl3) : δ 153. 5 (C), 145.5 (C), 138.8 (C), 134.1 (C), 130.3 (CH), 130.0 (CH), 129.4 
(CH), 129.0 (CH), 128.5 (CH), 128.3 (CH), 127.8 (CH), 126.3 (C), 124.9 (CH), 120.0 (CH) 
ppm; IR: ῦ (cm-1)  3315, 3064, 2961, 1629, 1590, 1488, 1448, 1382, 1312, 1242; HRMS (ESI) 
calculated for C20H17N4 [M+H]+ 313. 1457 found 313.1446. 
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5-(4-methoxyphenyl)-4-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (322) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 160 mg, 1.05 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 130 mg, 
0.48 mmol) in anhydrous CH3CN (3 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 278 mg, 1.05 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-4-methoxybenzenecarbohydrazonoyl 
chloride 6b (1 equiv, 100 mg, 0.38 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 
to 3:7:0.05) to afford the product 2a (112 mg, 86% yield) as a light orange-brown solid, 86% 
yield; M. p. 147-148 °C; Rf 0.39 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ  8.13 
(d, J = 7.8 Hz, 2H, Ar-H), 7.55-7.45 (m, 5H, Ar-H), 7.33-7.30 (m, 4H, Ar-H), 7.22 (t, J = 7.4 
Hz, 1H, Ar-H), 6.81-6.78 (m, 2H, Ar-H), 4.72 (brs, 1H, NH), 3.79 (s, 3H, OCH3) ppm ; 13C 
NMR (125 MHz, CDCl3) : δ  160.9 (C), 153. 6 (C), 145.4 (C), 139.0 (C), 134.2 (C), 130.2 
(CH), 129.4(CH), 129.3 (CH), 128.9 (CH), 128.5 (CH), 124.7 (CH), 119.9 (CH), 118.7 (C), 
113.9 (CH), 55.3 (OCH3) ppm; IR: ῦ (cm-1) 3327, 2930, 1634, 1609, 1595, 1500, 1432, 1307, 
1253, 1022; HRMS (ESI) calculated for C21H19N4O [M+H]+ 343.1553 found- 343.1552. 
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5-(4-trifluoromethylphenyl)-4-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 140 mg, 0.92 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 113 mg, 
0.42 mmol) in anhydrous CH3CN (3 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 240 mg, 0.92 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-4-
trifluoromethylbenzenecarbohydrazonoyl chloride 6b (1 equiv, 100 mg, 0.33 mmol) was added 
which turned the reaction mixture into a paste like suspension. After 10 min, the flask was 
removed from the ice-bath, and the volatile components were removed under vacuum. The 
organic residue from the reaction mixture was dissolved in 20 mL ethyl acetate, and washed 
with sat. aqueous KCl (3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and 
solvents removed under reduced pressure. The purification was carried out using a short 
column packed with silica gel (7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 
to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 to 3:7:0.05) to afford the product 2a (103 
mg, 81% yield) as a light brown solid. M. p. 144-146 °C Rf 0.61 (0.3% NH3 in EtOAc); 1H 
NMR (500 MHz, CDCl3): 8.12 (d, J = 8.1 Hz, 2H, Ar-H), 7.58-7.47 (m, 9H, Ar-H), 7.34-7.32 
(m, 2H, Ar-H), 7.27-7.24 (m, 1H, Ar-H), 4.92 (brs, 1H, NH) ppm; 13C NMR (125 MHz, 
CDCl3) : δ 153. 4 (C), 144.1 (C), 138.7 (C), 133.8 (C), 131.7 (C, q, 2J = 32.7 Hz), 130.5 (CH), 
129.8 (CH), 129.0 (CH), 128.3 (CH), 128.0 (CH), 125.5 (CH, q, 3J = 3.69 Hz), 125.2 (CH), 
123.6 (C, d, 1J = 272.48 Hz), 120.0 (CH) ppm; 19F NMR (470.6 MHz, CDCl3) δ -63.03 ppm; 
IR: ῦ (cm-1) 3312, 3063, 2921, 1652, 1617, 1595, 1491, 1429, 1390, 1324 (CF3 stretch), 1155, 
1107; HRMS (ESI) calculated for C21H16 F3N4 [M+H]+ 381.1322, found- 381.1329. 
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5-(4-nitrophenyl)-4-phenyl-2-phenyl-1H-1,2,4-triazol-3(4H)-imine (323) 
 
In an oven dried 25 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 450 mg, 2.99 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 370 mg, 
1.36 mmol) in anhydrous CH3CN (6 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 790 mg, 2.99 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-4-nitrobenzenecarbohydrazonoyl 
chloride 6b (1 equiv, 300 mg, 1.09 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 35 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 8 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 
to 1:9:0.1) to afford the product 2d (296 mg, 76 % yield) as a bright yellow solid, 76 % yield; 
M. p. 201-203 °C; Rf 0.7 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.16-8.12 (m, 
4H, Ar-H), 7.62-7.56 (m, 5H, Ar-H), 7.51 (t, J = 7.63 Hz, 2H, Ar-H), 7.36-7.34 (m, 2H, Ar-
H), 7.28 (t, J = 7.32 Hz, 1H, Ar-H), 5.05 (brs, 1H, NH) ppm; 13C NMR (125 MHz, CDCl3) : δ  
153. 3 (C), 148.2 (C), 143.4 (C), 138.5 (C), 133.7 (C), 132.2 (C), 130.7 (CH), 130.0 (CH), 
129.1 (CH), 128.3 (CH), 128.2 (CH), 125.5 (CH), 123.7 (C), 120.1 (CH) ppm; IR: ῦ (cm-1) 
3318, 3058, 2935, 1641, 1593, 1548, 1491, 1455, 1337, 1235; HRMS (ESI) calculated for 
C20H16N5O2 [M+H]+  358.1299, found 358.1298. 
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5-(2-fluorophenyl)-4-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (325) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 168 mg, 1.10 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 136 mg, 
0.50 mmol) in anhydrous CH3CN (3 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 290 mg, 1.10 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-2-fluorobenzenecarbohydrazonoyl 
chloride 6b (1 equiv, 100 mg, 0.40 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 25 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 
to 2:8:0.05) to afford the product 2d (132 mg, 81 % yield) as a grey solid, 81 % yield; M. p. 
132-133 °C; Rf 0.55 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.10 (d, J = 7.93 
Hz, 2H, Ar-H), 7.52-7.37 (m, 7H, Ar-H), 7.26-7.16 (m, 4H, Ar-H), 6.97 (t, J = 9.0 Hz, 1H, Ar-
H), 5.0 (brs, 1H, NH) ppm;  13C NMR (125 MHz, CDCl3) : δ 160.0 (C, d, J = 252.5 Hz), 152.9 
(C), 142.4 (C), 138.8 (C), 133.6 (C), 132.5 (CH, d, J = 8.18 Hz), 131.2 (CH, d, J = 1.82 Hz), 
129.8 (CH), 129.0 (CH, d, J = 2.72 Hz), 127.4 (CH), 125.0 (CH), 124.4 (CH, d, J = 3.63 Hz), 
120.0 (CH), 116.1 (CH, d, J = 20.89 Hz), 115.0 (C, d, J = 14.53 Hz) ppm; 19F NMR (470.6 
MHz, CDCl3) δ -110.53 ppm; IR: ῦ (cm-1) 3313, 3061, 2928, 1644, 1621, 1594, 1492, 1453, 
1381, 1322, 1221, 1145; HRMS (ESI) calculated for C20H16 FN4 [M+H]+ 331.1354, found 
331.1359. 
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5-(thiophen-2-yl)-4-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (333) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 176 mg, 1.16 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 143 mg, 
0.53 mmol) in anhydrous CH3CN (3 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 300 mg, 1.16 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-2-thiophenecarbohydrazonoyl 
chloride 6b (1 equiv, 100 mg, 0.42 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 25 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 
to 1:9:0.1) to afford the product 2d (114 mg, 85 % yield) as a brown solid, 85 % yield; M. p. 
146-147 °C; Rf 0.53 (0.2% NH3 in EtOAc);  1H NMR (500 MHz, CDCl3): δ 8.12 (d, J = 7.93 
Hz, 2H, Ar-H), 7.63-7.58 (m, 3H, Ar-H), 7.49-7.42 (m, 4H, Ar-H), 7.33 (dd, J = 5.04 Hz, J = 
1.07 Hz, 1H, Ar-H), 7.22 (t, J = 7.42 Hz, 1H, Ar-H), 6.90-6.89 (m, 1H, Ar-H), 6.75 (dd, J = 
3.81 Hz, J = 1.07 Hz, 1H, Ar-H), 4.40 (brs, 1H, NH) ppm; 13C NMR (125 MHz, CDCl3) : δ  
153. 5 (C), 141.3 (C), 138.8 (C), 133.4 (C), 130.5 (CH), 130.3 (CH), 129.3 (CH), 128.9 (CH), 
128.0 (C), 127.9 (CH), 127.3 (CH), 124.9 (CH), 119.9 (CH) ppm;   IR: ῦ (cm-1) 3318, 3065, 
2926, 1630, 1593, 1491, 1448, 1405, 1303, 1232; HRMS (ESI) calculated for C18H14N4NaS 
[M+Na]+ 341.0831, found 341.0851. 
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2-(2-methylphenyl)-4-phenyl-5-phenyl-2H-1,2,4-triazol-3(4H)-imine (327) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 170 mg, 1.12 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 139 mg, 
0.51 mmol) in anhydrous CH3CN (3 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 290 mg, 1.12 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-2-methylphenyl-3-phenylcarbohydrazonoyl 
chloride 6g (1 equiv, 100 mg, 0.41 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 25 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (6:4:0.05 
to 1:9:0.1) to afford the product 2d (59 mg, 44 % yield) as a buff-coloured solid, 44 % yield; 
M. p. 145-146 °C; Rf 0.48 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.52-7.41 
(m, 4H, Ar-H), 7.36-7.32 (m, 8H, Ar-H), 7.27-7.24 (m, 2H, Ar-H), 4.48 (brs, 1H, NH), 2.41 (s, 
3H, CH3) ppm; 13C NMR (125 MHz, CDCl3) : δ 154.5 (C), 145.9 (C), 136.2 (C), 136.1 (C), 
134.9 (C), 131.5 (CH), 129.9 (CH), 129.8 (CH), 129.0 (CH), 128.8 (CH), 128.4 (CH), 128.1 
(CH), 127.8 (CH), 127.7 (CH), 127.0 (CH), 126.6 (C), 18.2 (CH3) ppm;  IR: ῦ (cm-1) 3332, 
3098, 2924, 1633, 1594, 1549, 1494, 1444, 1421, 1319; HRMS (ESI+) calculated for C21H19N4 
[M+H]+ 327.1604 found- 327.1633. 
2-(2-trifluoromethylphenyl)-4-phenyl-5-phenyl-2H-1,2,4-triazol-3(4H)-imine (326) 
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In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 69 mg, 0.46 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 57 mg, 0.21 
mmol) in anhydrous CH3CN (1.5 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 121 mg, 0.46 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-2-trifluoromethylphenyl-3-
phenylcarbohydrazonoyl chloride 6h (1 equiv, 50 mg, 0.17 mmol) was added which turned the 
reaction mixture into a paste like suspension. After 10 min, the flask was removed from the 
ice-bath, and the volatile components were removed under vacuum. The organic residue from 
the reaction mixture was dissolved in 25 mL ethyl acetate, and washed with sat. aqueous KCl 
(3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure. The purification was carried out using a short column packed with silica gel 
(7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet 
Ether:EtOAc:NH3 (6:4:0.05 to 0:1:0.01) to afford the product 2h (28 mg, 44 % yield) as a white 
solid, 44 % yield; M. p. 99-100 °C; Rf 0.33 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): 
δ 7,.86 (d, J = 7.78 Hz, 1H, Ar-H), 7.75-7.70 (m, 2H, Ar-H), 7.60-7.57 (m, 1H, Ar-H), 7.51-
7.43 (m, 3H, Ar-H), 7.36-7.33 (m, 5H, Ar-H), 7.28-7.25 (m, 2H, Ar-H),  3.99 (brs, 1H, NH) 
ppm; 13C NMR (125 MHz, CDCl3) : δ 155.1 (C), 146.2 (C), 135.3 (C), 134.5 (C), 133.1 (CH), 
130.6 (CH), 130.0 (CH, d, J = 2.72 Hz), 129.2 (CH, d, J = 29.97 Hz), 128.8 (C, d, J = 31.8 
Hz), 128.4 (CH), 128.1 (CH), 128.0 (CH, q, 3J = 5.45 Hz), 127.8 (CH), 126.2 (C), 123.14 (C, 
d, 1J = 274.29 Hz) ppm; 19F NMR (470.6 MHz, CDCl3) δ -60.26 ppm; IR: ῦ (cm-1) 3320, 3056, 
1643, 1605, 1497, 1456, 1414, 1314, 1131; HRMS (ESI) calculated for C21H16 F3N4 [M+H]+ 
381.1322, found 381. 1328. 
 
2-(4-methoxyphenyl)-4-phenyl-5-phenyl-2H-1,2,4-triazol-3(4H)-imine (328) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 80 mg, 0.53 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 65 mg, 0.24 
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mmol) in anhydrous CH3CN (2.4 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 139 mg, 0.53 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-4-methoxyphenyl-3-
phenylcarbohydrazonoyl chloride 6hi (1 equiv, 50 mg, 0.19 mmol) was added which turned 
the reaction mixture into a paste like suspension. After 10 min, the flask was removed from the 
ice-bath, and the volatile components were removed under vacuum. The organic residue from 
the reaction mixture was dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl 
(3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure. The purification was carried out using a short column packed with silica gel 
(7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet 
Ether:EtOAc:NH3 (1:1:0.02 to 0:1:0.01) to afford the product 2h (54 mg, 83 % yield) as a white 
solid, 83 % yield; M. p. 164-165 °C; Rf 0.26 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, 
CDCl3): δ 7.93 (d, J = 8.54 Hz, 2H, Ar-H), 7.52-7.45 (m, 3H, Ar-H), 7.37-7.25 (m, 7H, Ar-H), 
7.0 (d, J = 8.7 Hz, 2H, Ar-H), 4.53 (brs, 1H, NH), 3.84 (s, 3H, OCH3) ppm; 13C NMR (125 
MHz, CDCl3) : δ 157.2 (C), 153. 7 (C), 145.3 (C), 134.3 (C), 132.0 (C), 130.2 (CH), 129.9 
(CH), 129.2 (CH), 128.4 (CH), 128.3 (CH), 127.8 (CH), 126.4 (C), 122.4 (CH), 114.2 (CH), 
55.5 (OCH3) ppm; IR: ῦ (cm-1) 3319, 2920, 2847, 1624, 1592, 1511, 1494, 1446, 1416, 1300, 
1242, 1142; HRMS (ESI+) calculated for C21H19N4O [M+H]+ 343.1553 found 343.1557. 
4-(4-fluorophenyl)-5-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (329) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 90 mg, 0.59 mmol) and N-(4-Fluorophenyl)-N-tosyl cyanamide 2c (1.25 equiv, 82 
mg, 0.27 mmol) in anhydrous CH3CN (2.5 mL). The reaction mixture was introduced to an 
ice-bath, followed by addition of 18C6 (2.75 equiv, 157 mg, 0.59 mmol) in a single portion 
under vigorous stirring conditions. After 10 minutes, N-Phenylbenzenecarbohydrazonoyl 
chloride 6a (1 equiv, 50 mg, 0.21 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
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components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (1:1:0.02 
to 0:1:0.01) to afford the product 2j (31 mg, 44 % yield) as a pale yellow solid, 44 % yield; M. 
p. 169-170 °C; Rf 0.24 (0.1% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.07 (d, J = 7.93 
Hz, 2H, Ar-H), 7.48 (t, J = 8.24 Hz, 2H, Ar-H), 7.40-7.38 (m, 3H, Ar-H), 7.33-7.30 (m, 4H, 
Ar-H), 7.25-7.19 (m, 3H, Ar-H), 4.96 (brs, 1H, NH) ppm; 13C NMR (125 MHz, CDCl3): δ  
162.6 (C, d, J = 250.68 Hz), 153.5 (C), 145.5 (C), 138.7 (C), 130.3 (CH, d, J = 8.17 Hz), 130.1 
(CH), 130.1 (C, d, J = 3.63 Hz), 129.1 (CH), 128.6 (CH), 127.8 (CH), 126.1 (C), 125.2 (CH), 
120.1 (CH), 117.3 (CH, d, J = 23.61 Hz); 19F NMR (470.6 MHz, CDCl3) δ -110.54 ppm; IR: ῦ 
(cm-1) 3312, 3065, 2928, 1645, 1594, 1504, 1411, 1322, 1218, 1143; HRMS (ESI+) calculated 
for C20H16 FN4 [M+H]+ 331.1354, found 331.1362. 
 
 
4-(4-methoxyphenyl)-5-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (330) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 90 mg, 0.59 mmol) and N-(4-methoxyphenyl)-N-tosyl cyanamide 2b (1.25 equiv, 
78 mg, 0.27 mmol) in anhydrous CH3CN (2.5 mL). The reaction mixture was introduced to an 
ice-bath, followed by addition of 18C6 (2.75 equiv, 157 mg, 0.59 mmol) in a single portion 
under vigorous stirring conditions. After 10 minutes, N-Phenylbenzenecarbohydrazonoyl 
chloride 6a (1 equiv, 50 mg, 0.21 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
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fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (1:1:0.02 
to 0:1:0.01) to afford the product 2j (45 mg, 61 % yield) as a light-brown solid, 61 % yield; M. 
p. 177-178 °C; Rf 0.51 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.14 (d, J = 7.78 
Hz, 2H, Ar-H), 7.47-7.34 (m, 5H, Ar-H), 7.30-7.19 (m, 5H, Ar-H), 7.01 (d, J = 8.7 Hz, 2H, Ar-
H), 4.30 (brs, 1H, NH), 3.86 (s, 3H, OCH3) ppm; 13C NMR (125 MHz, CDCl3): δ 160.1 (C), 
153. 9 (C), 145.7 (C), 139.0 (C), 129.9 (CH), 129.7 (CH), 128.9 (CH), 128.4 (CH), 127.8 (CH), 
126.4 (2 x C), 124.7 (CH), 119.8 (CH), 115.5 (CH), 55.5 (OCH3) ppm;  IR: ῦ (cm-1) 3311, 
2929, 1635, 1608, 1595, 1498, 1450, 1322, 1246; HRMS (ESI) calculated for C21H19N4O 
[M+H]+ 343.1553, found 343.1564. 
4-(4-methoxyphenyl)-5-(2-fluorophenyl)-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (331) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 84 mg, 0.55 mmol) and N-(4-methoxypheny)l-N-tosyl cyanamide 2b (1.25 equiv, 
76 mg, 0.25 mmol) in anhydrous CH3CN (2.5 mL). The reaction mixture was introduced to an 
ice-bath, followed by addition of 18C6 (2.75 equiv, 146 mg, 0.55 mmol) in a single portion 
under vigorous stirring conditions. After 10 minutes, N-Phenyl-2-
fluorobenzenecarbohydrazonoyl chloride 6b (1 equiv, 50 mg, 0.20 mmol) was added which 
turned the reaction mixture into a paste like suspension. After 10 min, the flask was removed 
from the ice-bath, and the volatile components were removed under vacuum. The organic 
residue from the reaction mixture was dissolved in 20 mL ethyl acetate, and washed with sat. 
aqueous KCl (3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents 
removed under reduced pressure. The purification was carried out using a short column packed 
with silica gel (7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed 
by Pet Ether:EtOAc:NH3 (1:1:0.02 to 0:1:0.01) to afford the product 2l (51 mg, 71 % yield) as 
a light-brown solid, 71 % yield; M. p. 149-150 °C; Rf 0.62 (0.1% NH3 in EtOAc); 1H NMR 
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(500 MHz, CDCl3): δ 8.12 (d, J = 7.93 Hz, 2H, Ar-H), 7.52-7.45 (m, 1H, Ar-H) or dt, 7.23-
7.16 (m, 4H, Ar-H), 7.0 (t, J = 9.15 Hz, 1H, Ar-H), 6.93 (d, J = 8.85 Hz, 2H, Ar-H),  4.98 (brs, 
1H, NH), 3.82 (s, 3H, OCH3) ppm; 13C NMR (125 MHz, CDCl3): δ 160.0 (C, d, J = 253.4 Hz), 
159.8 (C), 153.4 (C), 142.7 (C), 138.9 (C), 132.4 (CH, d, J = 8.17 Hz), 131.3 (CH, d, J = 1.82 
Hz), 128.9 (CH), 125.9 (C), 124.9 (CH), 124.4 (CH, d, J = 3.63 Hz), 119.8 (CH), 116.1 (CH, 
d, J = 20.89 Hz), 115.1 (C), 115.0 (CH), 55.4 (OCH3) ppm; 19F NMR (470.6 MHz, CDCl3) δ -
110.43 ppm; IR: ῦ (cm-1) 3305, 2962, 1647, 1623, 1591, 1490, 1457, 1384, 1321, 1224; HRMS 
(ESI+) calculated for C21H18 FN4 O [M+H]+ 361.1459, found 361.1468. 
 
4-(4-fluorophenyl)-5-(4-methoxyphenyl)-2-phenyl-2H-1,2,4-triazol-3(4H)-imine (332) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 80 mg, 0.53 mmol) and N-(4-fluoropheny)l-N-tosyl cyanamide 2c (1.25 equiv, 69 
mg, 0.24 mmol) in anhydrous CH3CN (2.5 mL). The reaction mixture was introduced to an 
ice-bath, followed by addition of 18C6 (2.75 equiv, 139 mg, 0.53 mmol) in a single portion 
under vigorous stirring conditions. After 10 minutes, N-Phenyl-4-
methoxyphenylcarbohydrazonoyl chloride 6b (1 equiv, 50 mg, 0.19 mmol) was added which 
turned the reaction mixture into a paste like suspension. After 10 min, the flask was removed 
from the ice-bath, and the volatile components were removed under vacuum. The organic 
residue from the reaction mixture was dissolved in 20 mL ethyl acetate, and washed with sat. 
aqueous KCl (3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents 
removed under reduced pressure. The purification was carried out using a short column packed 
with silica gel (7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 7:3) followed 
by Pet Ether:EtOAc:NH3 (1:1:0.02 to 0:1:0.01) to afford the product 2l (54 mg, 78 % yield) as 
a white fluffy solid, 78 % yield; M. p. 127-129 °C; Rf 0.66 (0.2% NH3 in EtOAc); 1H NMR 
(500 MHz, CDCl3): δ 8.06 (d, J = 7.93 Hz, 2H, Ar-H), 7.48 (t, J  = 7.93 Hz, 2H, Ar-H), 7.33-
7.30 (m, 4H, Ar-H), 7.22 (q, J = 7.93 Hz, 3H, Ar-H), 6.82 (d, J = 8.85 Hz, 2H, Ar-H),  4.64 
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(brs, 1H, NH), 3.80 (s, 3H, OCH3) ppm; 13C NMR (125 MHz, CDCl3): δ 162.6 (C, d, J = 250.68 
Hz), 160.9 (C), 153.5 (C), 145.4 (C), 138.8 (C), 130.4 (CH, d, J = 9.08 Hz), 130.2 (C, d, J = 
2.72 Hz), 129.4 (CH), 129.0 (CH), 125.0 (CH), 120.1 (CH), 118.4 (C), 117.3 (CH, d, J = 22.71 
Hz), 114.0 (CH), 55.3 (OCH3) ppm; 19F NMR (470.6 MHz, CDCl3) δ -110.62 ppm; IR: ῦ (cm-
1) 3313, 2944, 1638, 1595, 1510, 1499, 1456, 1432, 1392, 1255, 1211; HRMS (ESI+) calculated 
for C21H18 FN4 O [M+H]+ 361.1459, found 361.1457. 
5-pyridyl-4-phenyl-1-phenyl-2H-1,2,4-triazol-3(4H)-imine (334) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 360 mg, 2.37 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 293 mg, 
1.08 mmol) in anhydrous CH3CN (6.5 mL). The reaction mixture was introduced to an ice-
bath, followed by addition of 18C6 (2.75 equiv, 627 mg, 2.37 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-pyridylcarbohydrazonoyl chloride 6l 
(1 equiv, 200 mg, 0.86 mmol) was added which turned the reaction mixture into a paste like 
suspension. After 10 min, the flask was removed from the ice-bath, and the volatile components 
were removed under vacuum. The organic residue from the reaction mixture was dissolved in 
50 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 7 mL). The organic fraction was 
dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The purifica t ion 
was carried out using a short column packed with silica gel (7 cm height) with a gradient elution 
of Pet Ether: EtOAc (9:1 to 1:1) followed by EtOAc:NH3 (1:0.02) to afford the product 2l (190 
mg, 70 % yield) as a buff-coloured solid, 70 % yield; M. p. 185-187 °C; Rf 0.69 (0.1% NH3 in 
EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.36 (d, J = 4.27 Hz, 1H, Ar-H), 8.17 (d, J = 7.93 Hz, 
2H, Ar-H), 7.82 (d, J = 7.93 Hz, 1H, Ar-H), 7.70 (t, J = 7.63 Hz, 1H, Ar-H), 7.51-7.46 (m, 5H, 
Ar-H), 7.36-7.31 (m, 2H, Ar-H), 7.24-7.21 (m, 2H, Ar-H), 5.01 (brs, 1H, NH) ppm; 13C NMR 
(125 MHz, CDCl3): δ 153.8 (C), 149.1 (CH), 146.0 (C), 144.4 (C), 138.8 (C), 136.4 (CH), 
134.6 (C), 129.7 (CH), 128.9 (CH), 128.2 (CH), 125.0 (CH), 124.1 (CH), 123.0 (CH), 120.0 
(CH) ppm; IR: ῦ (cm-1) 3318, 3057, 2921, 1633, 1586, 1489, 1477, 1389, 1242; HRMS (ESI+) 
calculated for C19H16N5 [M+H]+  314.1400, found 314.1402. 
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5-cyclopropyl-4-phenyl-1-phenyl-2H-1,2,4-triazol-3(4H)-imine (335) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 600 mg, 3.95 mmol) and N-phenyl-N-tosyl cyanamide 2c (1.25 equiv, 495 mg, 
1.80 mmol) in anhydrous CH3CN (8 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 1.04 g, 3.95 mmol) in a single portion under vigorous 
stirring conditions. After 10 minutes, N-Phenyl-cyclopropanecarbohydrazonoyl chloride 6b (1 
equiv, 280 mg, 1.44 mmol) was added which turned the reaction mixture into a paste like 
suspension. After 10 min, the flask was removed from the ice-bath, and the volatile components 
were removed under vacuum. The organic residue from the reaction mixture was dissolved in 
50 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 8 mL). The organic fraction was 
dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The purifica t ion 
was carried out using a short column packed with silica gel (7 cm height) with a gradient elution 
of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (1:1:0.02 to 0:1:0.01) to 
afford the product 2l (230 mg, 58 % yield) as a brown solid, 58 % yield; M. p. 110-111 °C; Rf 
0.27 (0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.00 (d, J = 7.93 Hz, 2H, Ar-H), 
7.61-7.58 (m, 2H, Ar-H), 7.53-7.50 (m, 1H, Ar-H), 7.46-7.41 (m, 4H, Ar-H), 7.17 (t, J = 7.4 
Hz, 1H, Ar-H), 4.63 (brs, 1H, NH), 1.45-1.40 (m, 1H, CH-cyclopropyl), 1.15-1.06 (m, 2H, 
CH2), 0.94-0.84 (m, 2H, CH2) ppm; 13C NMR (125 MHz, CDCl3): δ 153.3 (C), 148.7 (C), 
139.0 (C), 133.1 (C), 130.2 (CH), 129.3 (CH), 128.9 (CH), 128.2 (CH), 124.4 (CH), 119.6 
(CH), 7.22 (CH2), 6.42 (CH) ppm; IR: ῦ (cm-1) 3327, 3047, 1638, 1593, 1495, 1457, 1410, 
1230; HRMS (ESI+) calculated for C17H17N4 [M+H]+ 277.1448, found 277.1460. 
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3-imino-2,4-diphenyl-2H-1,2,4-triazole-5(4H)-carboxylic acid ethyl ester (337) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 92 mg, 0.60 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 75 mg, 0.27 
mmol) in anhydrous CH3CN (1.5 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 160 mg, 0.60 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, C-ethoxycarbonyl-N-phenylhydrazonoyl 
chloride 6b (1 equiv, 50 mg, 0.22 mmol) was added which turned the reaction mixture into a 
paste like suspension. After 10 min, the flask was removed from the ice-bath, and the volatile 
components were removed under vacuum. The organic residue from the reaction mixture was 
dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic 
fraction was dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The 
purification was carried out using a short column packed with silica gel (7 cm height) with a 
gradient elution of Pet Ether: EtOAc (9.5:0.5 to 1:9) to afford the product 2l (55 mg, 81 % 
yield) as a light brown solid, 81 % yield; M. p. 130-132 °C; Rf 0.44 (EtOAc); 1H NMR (500 
MHz, CDCl3): δ 8.06 (d, J = 7.93 Hz, 2H, Ar-H), 7.59-7.53 (m, 3H, Ar-H), 7.48 (t, J = 7.85 
Hz, 1H, Ar-H), 7.36 (d, J = 7.17 Hz, 1H, Ar-H), 7.30-7.27 (m, 1H, Ar-H), 4.29 (q, J = 7.12 Hz, 
2H, CH2), 4.00 (brs, 1H, NH), 1.26-1.23 (m, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ 
156.3 (C), 153.4 (C), 138.0 (C), 136.9 (C), 133.6 (C), 129.9 (CH), 129.7 (CH), 129.0 (CH), 
128.1 (CH), 126.2 (CH), 120.9 (CH), 62.4 (CH2), 13.8 (CH3) ppm; IR: ῦ (cm-1) 3305, 3274, 
3049, 2983, 1738, 1634, 1595, 1492, 1435, 1391, 1310, 1208; HRMS (ESI+) calculated for 
C17H17N4O2 [M+H]+ 309.1346, found 309.1340. 
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3-imino-2-(4-bromophenyl)-4-phenyl-2H-1,2,4-triazole-5(4H)-carboxylic acid ethyl ester 
(338) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 136 mg, 0.90 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 111 mg, 
0.41 mmol) in anhydrous CH3CN (2.5 mL). The reaction mixture was introduced to an ice-
bath, followed by addition of 18C6 (2.75 equiv, 238 mg, 0.90 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, C-ethoxycarbonyl-N-(4-
bromophenyl)hydrazonoyl chloride 6b (1 equiv, 100 mg, 0.33 mmol) was added which turned 
the reaction mixture into a paste like suspension. After 10 min, the flask was removed from the 
ice-bath, and the volatile components were removed under vacuum. The organic residue from 
the reaction mixture was dissolved in 20 mL ethyl acetate, and washed with sat. aqueous KCl 
(3 x 4 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure. The purification was carried out using a short column packed with silica gel 
(7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 7:3) to afford the product 2l 
(90 mg, 71 % yield) as a Pale-yellow solid, 71 % yield; M. p. 194-195 °C; Rf 0.36 (1:1 Pet 
Ether: EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.09 (d, J = 8.09 Hz, 2H, Ar-H), 7.59-7.53 (m, 
5H, Ar-H), 7.34 (d, J = 6.71 Hz, 2H, Ar-H), 5.10 (brs, 1H, NH), 4.28 (q, J = 7.12 Hz, 2H, CH2), 
1.24 (t, J = 7.12 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ 156.2 (C), 153.0 (C), 
137.4 (C), 137.0 (C), 133.4 (C), 131.9 (CH), 130.0 (CH), 129.9 (CH), 128.1 (CH), 121.6 (CH), 
118.8 (C), 62.4 (CH2), 13.8 (CH3) ppm; IR: ῦ (cm-1) 3310, 3099, 2977, 1726, 1645, 1588, 1552, 
1489, 1447, 1387, 1209; HRMS (ESI+) calculated for C17H16BrN4O2 [M+H]+ 387.0451, found 
387.0448. 
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3-imino-2-(2-chlorophenyl)-4-phenyl-2H-1,2,4-triazole-5(4H)-carboxylic acid ethyl ester 
(339) 
 
In an oven dried 25 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 480 mg, 3.16 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 390 mg, 
1.43 mmol) in anhydrous CH3CN (6 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 850 mg, 3.16 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, C-ethoxycarbonyl-N-(2-chlorophenyl) 
hydrazonoyl chloride 6b (1 equiv, 300 mg, 1.15 mmol) was added which turned the reaction 
mixture into a paste like suspension. After 10 min, the flask was removed from the ice-bath, 
and the volatile components were removed under vacuum. The organic residue from the 
reaction mixture was dissolved in 35 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 
8 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure. The purification was carried out using a short column packed with silica gel 
(7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 1:1) to afford the product 2l 
(230 mg, 60 % yield) as a pale yellow-orange solid, 60 % yield; M. p. 126-128 °C; Rf 0.42 
(0.2% NH3 in EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.62-7.50 (m, 5H, Ar-H), 7.44-7.40 (m, 
4H, Ar-H), 4.66 (brs, 1H, NH), 4.29 (q, J = 7.09 Hz, 2H, CH2), 1.25 (t, J = 7.09 Hz, 3H, CH3) 
ppm; 13C NMR (125 MHz, CDCl3): δ 156.3 (C), 153.8 (C), 137.8 (C), 134.2 (C), 134.0 (C), 
132.8 (C), 130.8 (CH), 130.1 (CH), 129.7 (CH), 129.5 (CH), 127.9 (CH), 62.4 (CH2), 13.9 
(CH3) ppm; IR: ῦ (cm-1) 3331, 3039, 2980, 1732, 1646, 1588, 1542, 1486, 1443, 1380, 1200; 
HRMS (ESI+) calculated for C17H16ClN4O2 [M+H]+ 343.0956, found 343.0961. 
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5-(1-tert-butoxycarbonylamino-2-methyl-butyl)-2,4-diphenyl-2H-1,2,4-triazol-3(4H)-
imine (340) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 61 mg, 0.40 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 50 mg, 0.18 
mmol) in anhydrous CH3CN (1 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 107 mg, 0.40 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-Phenyl-3-(1-tert-butoxycarbonyl-amino)-2-
butylpropanecarbohydrazonoyl chloride 6b (1 equiv, 50 mg, 0.15 mmol in 1.5 ml CH3CN) was 
added dropwise over a period of 5 minutes which turned the reaction mixture into a paste like 
suspension. After 10 min, the flask was removed from the ice-bath, and the volatile components 
were removed under vacuum. The organic residue from the reaction mixture was dissolved in 
20 mL ethyl acetate, and washed with sat. aqueous KCl (3 x 4 mL). The organic fraction was 
dried over anhydrous Na2SO4 and solvents removed under reduced pressure. The purifica t ion 
was carried out using a short column packed with silica gel (7 cm height) with a gradient elution 
of Pet Ether: EtOAc (9:1 to 7:3) followed by Pet Ether:EtOAc:NH3 (1:1:0.02 to 0:1:0.01) to 
afford the product 2l (37 mg, 61 % yield) as a dark-brown solid, 61 % yield; M. p. 61-62 °C; 
Rf 0.62 (0.2% NH3 in EtOAc); [α]D – 41.55o; 1H NMR (500 MHz, CDCl3): δ 8.01 (d, J = 7.93 
Hz, 2H, Ar-H), 7.60-7.57 (m, 2H, Ar-H), 7.54-7.51 (m, 1H, Ar-H), 7.45-7.40 (m, 4H, Ar-H), 
7.19 (t, J = 7.24 Hz, 1H, Ar-H), 4.99 (d, J = 9.31 Hz, 1H, NH{-boc}), 4.46 (t, J = 8.24 Hz, 
CH), 1.71-1.59 (m, 1H, CH), 1.53-1.43 (m, 9H, 3xCH3 & 1H, CH2), 1.09-0.98 (m, 1H, CH2), 
0.86 (m, 6H, 2xCH3) ppm; 13C NMR (125 MHz, CDCl3): δ 155.1 (C), 153.2 (C), 147.4 (C), 
138.8 (C), 132.5 (C), 130.4 (CH), 129.8 (CH), 128.9 (CH), 128.5 (CH), 124.8 (CH), 119.8 
(CH), 79.9 (C), 51.0 (CH), 38.3 (CH), 28.3 (CH3), 24.2 (CH2), 15.7 (CH), 11.3 (CH) ppm; IR: 
ῦ (cm-1) 3317, 2967, 2928, 1706, 1637, 1596, 1495, 1455, 1365, 1231, 1161; HRMS (ESI+) 
calculated for C24H32N5O2 [M+H]+ 422.2551, found 422.2577. 
 
 
215 | P a g e  
 
4,5-diphenyl-2H-1,2,4-triazol-3(4H)-imine (336) 
 
In an oven dried 10 mL round bottom flask cooled under nitrogen atmosphere, was taken CsF 
(2.75 equiv, 328 mg, 2.16 mmol) and N-phenyl-N-tosyl cyanamide 2a (1.25 equiv, 267 mg, 
0.98 mmol) in anhydrous CH3CN (6 mL). The reaction mixture was introduced to an ice-bath, 
followed by addition of 18C6 (2.75 equiv, 570 mg, 2.16 mmol) in a single portion under 
vigorous stirring conditions. After 10 minutes, N-(tert-butoxycarbonylamino )-
phenylhydrazonoyl chloride 6b (1 equiv, 200 mg, 0.78 mmol) was added which turned the 
reaction mixture into a paste like suspension. After 10 min, the flask was removed from the 
ice-bath, and the volatile components were removed under vacuum. The organic residue from 
the reaction mixture was dissolved in 50 mL ethyl acetate, and washed with sat. aqueous KCl 
(3 x 8 mL). The organic fraction was dried over anhydrous Na2SO4 and solvents removed under 
reduced pressure. The purification was carried out using a short column packed with silica gel 
(7 cm height) with a gradient elution of Pet Ether: EtOAc (9:1 to 1:9) followed by 
EtOAc:CH3CN:NH3 (9:1:0.2 to 7:3:0.5) to afford the product 2l (114 mg, 62 % yield) as a 
white crystalline solid, 62 % yield; M. p. 226-228 °C; Rf 0.2 (0.2% NH3 in EtOAc); 1H NMR 
(500 MHz, CDCl3): δ 7.55-7.50 (m, 3H, Ar-H), 7.38-7.36 (m, 2H, Ar-H), 7.31-7.23 (m, 5H, 
Ar-H), 4.51 (brs, 2H, NH) ppm; 13C NMR (125 MHz, CDCl3): δ 154.7 (C), 150.1 (C), 134.0 
(C), 130.4 (CH), 129.8 (CH), 129.1 (CH), 128.4 (CH), 127.7 (CH), 127.3 (CH), 127.3 (C) ppm; 
IR: ῦ (cm-1) 3427, 3058, 1639, 1594, 1562, 1497, 1484, 1355; HRMS (ESI+) calculated for 
C14H13N4 [M+H]+ 237.1135, found 237.1144. 
4.10 Synthesis of 1,2,4-triazol-3-one27 
1,2,4-triazol-3-imine (0.16 mmol) and sodium acetate (3.2 mmol) were taken in a 10 mL oven 
dried round bottom flask and dissolved in 2.6 mL 50% acetic acid solution. At 0-5 oC, sodium 
nitrite (4.00 mmol) was added portion-wise over a period of 3 minutes. After complete addition, 
the reaction mixture was allowed to stir at room temperature. After 6 hours, the reaction 
mixture was boiled for 10 minutes to expel the nitrous gases (visible as yellow fumes). The 
reaction mixture was then neutralised with sat. aqueous NaHCO3 and extracted with ethyl 
acetate (20 mL). The ethyl acetate fraction was separated, washed with brine (10 mL) and dried 
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over anhydrous Na2SO4. The volatile components were then removed under vacuum and the 
residue purified by column chromatography on silica gel using Pet Ether: EtOAc (8:2) to afford 
1,2,4-triazol-3-one products. 
2,4,5-triphenyl-2H-1,2,4-triazol-3(4H)-one (345)28 
 
1,3,4-Triphenyl-4,5-dihydro-1H-1,2,4-triazol-5- imine (50 mg, 0.16 mmol) and sodium acetate 
(262 mg, 3.2 mmol) were taken in a 10 mL oven dried round bottom flask and dissolved in 2.6 
mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (276 mg, 4.00 mmol) was added portion-
wise over a period of 3 minutes. After complete addition, the reaction mixture was allowed to 
stir at room temperature. After 6 hours, the reaction mixture was boiled for 10 minutes to expel 
the nitrous gases (visible as yellow fumes). The reaction mixture was then neutralized with sat. 
(aq) NaHCO3 and extracted with ethyl acetate (20 mL). The ethyl acetate fraction was 
separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. The volatile 
components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (8:2) to afford the product 4a (38 mg, 
76% yield) as a white solid, 76% yield; M. p. 214-215 °C [lit. 213-214]5; Rf 0.46 (4:1 Pet Ether: 
EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.14 (d, J = 8.09 Hz, 2H, Ar-H), 7.50-7.40 (m, 8H, 
Ar-H), 7.35-7.31 (m, 4H, Ar-H), 7.28-7.25 (m, 1H, Ar-H) ppm; 13C NMR (125 MHz, CDCl3):  
δ  151.8 (C), 145.2 (C), 137.8 (C), 133.5 (C), 130.3 (CH), 129.5 (CH), 129.0 (CH), 128.8 (CH), 
128.6 (CH), 128.0 (CH), 127.3 (CH), 126.4 (C), 125.5 (CH), 118.9 (CH); IR: ῦ (cm-1) 2920, 
2852, 1700, 1574, 1490, 1373; HRMS (ESI+) calculated for C20H16N3O [M+H]+ 314.1288, 
found 314.1297. 
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5-(4-Methoxyphenyl)-4-phenyl-2-phenyl-2H-1,2,4-triazol-3(4H)-one (347)29 
 
3-(4-methoxyphenyl)-1,4-diphenyl-1H-1,2,4-triazol-5-imine (100 mg, 0.29 mmol) and sodium 
acetate (480mg, 5.84 mmol) were taken in a 25 mL oven dried round bottom flask and dissolved 
in 5 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (500 mg, 7.3 mmol) was added 
portion-wise over a period of 3 minutes. After complete addition, the reaction mixture was 
allowed to stir at room temperature. After 4 hours, the reaction mixture was boiled for 10 
minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was then 
neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (30 mL). The ethyl acetate 
fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. The 
volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (8:2) to afford the product 4a (84 mg, 
84 % yield) as a white solid, 84 % yield; M. p. 178-179 °C [lit. 173-174 °C]; Rf 0.32 (4:1 Pet 
Ether: EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.12 (d, J = 7.63 Hz, 2H, Ar-H), 7.47-7.40 (m, 
5H, Ar-H), 7.34 (d, J = 8.85 Hz, 2H, Ar-H), 7.30 (d, J = 6.87 Hz, 2H, Ar-H), 7.25-7.22 (m, 1H, 
Ar-h), 6.82 (d, J = 9.0 Hz, 2H, Ar-H), 3.79 (s, 3H, OCH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ 161.0 (C), 151.8 (C), 145.1 (C), 137.9 (C), 133.6 (C), 129.5 (CH), 129.5 (CH), 128.9 (CH), 
128.8 (CH), 127.4 (CH), 125.3 (CH), 118.8 (CH), 118.6 (C), 114.0 (CH), 55.3 (OCH3) ppm; 
IR: ῦ (cm-1) 2928, 1701, 1597, 1511, 1493, 1373, 1255; HRMS (ESI) calculated for 
C21H18N3O2 [M+H]+ 344.1394, found 344.1395. 
5-(4-nitrophenyl)-4-phenyyl-2-phenyl-2H-1,2,4-triazol-3(4H)-one (346)30 
 
3-(4-nitrophenyl)-1,4-diphenyl-1H-1,2,4-triazol-5-imine (150 mg, 0.42 mmol) and sodium 
acetate (688 mg, 5.84 mmol) were taken in a 25 mL oven dried round bottom flask and 
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dissolved in 7 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (720 mg, 10.5 mmol) 
was added portion-wise over a period of 5 minutes. After complete addition, the reaction 
mixture was allowed to stir at room temperature. After 4 hours, the reaction mixture was boiled 
for 10 minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was 
then neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (35 mL). The ethyl 
acetate fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. 
The volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (8:2) to afford the product 4a (133 mg, 
89 % yield) as a yellow solid, 89 % yield; M. p. 199-201 °C; Rf 0.35 (4:1 Pet Ether:EtOAc); 
1H NMR (500 MHz, CDCl3): δ  8.19 (d, J = 8.85 Hz, 2H, Ar-H), 8.12 (d, J = 7.78 Hz, 2H, Ar-
H), 7.63 (d, J = 9.0 Hz, 2H, Ar-H), 7.55-7.48 (m, 5H, Ar-H), 7.33-7.29 (m, 3H, Ar-H) ppm;  
13C NMR (125 MHz, CDCl3): δ 151.6 (C), 148.5 (C), 143.0 (C), 137.5 (C), 133.0 (C), 132.3 
(C), 130.0 (CH), 129.5 (CH), 129.1 (CH), 128.6 (CH), 127.3 (CH), 126.1 (CH), 123.8 (CH), 
119.0 (CH); IR: ῦ (cm-1) 1713, 1594, 1547, 1510, 1494, 1342; HRMS (ESI) calculated for 
C20H14N4NaO3 [M+Na]+ 381.0958, found 381.0949. 
2-(4-Methoxyphenyl)-5-phenyl-4-phenyl-2H-1,2,4-triazol-3(4H)-one (350) 
 
1-(4-methoxyphenyl)-3,4-diphenyl-1H-1,2,4-triazol-5-imine (78 mg, 0.23 mmol) and sodium 
acetate (370 mg, 4.55 mmol) were taken in a 25 mL oven dried round bottom flask and 
dissolved in 3.8 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (390 mg, 5.69 mmol) 
was added portion-wise over a period of 5 minutes. After complete addition, the reaction 
mixture was allowed to stir at room temperature. After 4 hours, the reaction mixture was boiled 
for 10 minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was 
then neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (25 mL). The ethyl 
acetate fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. 
The volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (8:2) to afford the product 4a (57 mg, 
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73 % yield) as a white solid, 73 % yield; M. p. 198-199 °C; Rf 0.32 (4:1 Pet Ether: EtOAc); 1H 
NMR (500 MHz, CDCl3): 8.01 (d, J = 8.85 Hz, 2H, Ar-H), 7.47-7.39 (m, 6H, Ar-H), 7.34-7.30 
(m, 4H, Ar-H), 7.00 (d, J = 8.85 Hz, 2H, Ar-H), 3.85 (s, 3H, OCH3) ppm;  13C NMR (125 MHz, 
CDCl3): δ  157.4 (C), 151.7 (C), 144.8 (C), 133.5 (C), 131.2 (C), 130.2 (CH), 129.5 (CH), 
128.7 (CH), 128.5 (CH), 128.0 (CH), 127.3 (CH), 126.4 (C), 120.7 (CH), 114.1 (CH), 55.5 
(OCH3) ppm;  IR: ῦ (cm-1) 3047, 2920, 2849, 1695, 1593, 1512, 1498, 1448, 1379, 1254; 
HRMS (ESI) calculated for C21H18N3O2 [M+H]+ 344.1394, found 344.1391. 
2-(2-Methylphenyl)-5-phenyl-4-phenyl-2H-1,2,4-triazol-3(4H)-one (349) 
 
1-(4-methoxyphenyl)-3,4-diphenyl-1H-1,2,4-triazol-5-imine (88 mg, 0.27 mmol) and sodium 
acetate (440 mg, 5.39 mmol) were taken in a 25 mL oven dried round bottom flask and 
dissolved in 4.5 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (460 mg, 6.74 mmol) 
was added portion-wise over a period of 5 minutes. After complete addition, the reaction 
mixture was allowed to stir at room temperature. After 6 hours, the reaction mixture was boiled 
for 10 minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was 
then neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (25 mL). The ethyl 
acetate fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. 
The volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1 to 7:3) to afford the product 4a (72 
mg, 82 % yield) as a white solid, 82 % yield; M. p. 145-146 °C; Rf 0.28 (4:1 Pet Ether: EtOAc); 
1H NMR (500 MHz, CDCl3): δ 7.54-7.52 (m, 1H, Ar-H), 7.48-7.39 (m, 6H, Ar-H), 7.35-7.31 
(m, 7H, Ar-H), 2.45 (s, 3H, CH3) ppm;  13C NMR (125 MHz, CDCl3): δ  152.4 (C), 145.4 (C), 
135.5 (C), 135.2 (C), 133.7 (C), 131.2 (CH), 130.1 (CH), 129.5 (CH), 128.8 (CH), 128.7 (CH), 
128.5 (CH), 127.9 (CH), 127.2 (CH), 127.0 (CH), 126.6 (CH), 126.5 (C), 18.4 (CH3) ppm;  IR: 
ῦ (cm-1) 3051, 1710, 1590, 1493, 1444, 1409, 1366, 1320; HRMS (ESI) calculated for 
C21H18N3O [M+H]+ 328.1444, found 328.1451. 
5-(thiophen-2-yl)-5-phenyl-4-phenyl-2H-1,2,4-triazol-3(4H)-one (351) 
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3-(thiophen-2-yl)-1,4-diphenyl-1H-1,2,4-triazol-5-imine (150 mg, 0.47 mmol) and sodium 
acetate (770 mg, 9.42 mmol) were taken in a 25 mL oven dried round bottom flask and 
dissolved in 8 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (812 mg, 11.78 mmol) 
was added portion-wise over a period of 5 minutes. After complete addition, the reaction 
mixture was allowed to stir at room temperature. After 6 hours, the reaction mixture was boiled 
for 10 minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was 
then neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (35 mL). The ethyl 
acetate fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. 
The volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1 to 7:3) to afford the product 4a (125 
mg, 88 % yield) as a white solid, 88 % yield; M. p. 196-197 °C; Rf 0.39 (4:1 Pet ether: EtOAc); 
1H NMR (500 MHz, CDCl3): δ 8.10 (d, J = 8.09 Hz, 2H, Ar-H), 7.54-7.53 (m, 3H, Ar-H), 7.46 
(t, J = 7.85 Hz, 2H, Ar-H), 7.42-7.40 (m, 2H, Ar-H), 7.36 (d, J = 4.88 Hz, 1H, HetAr-H), 7.26-
7.23 (m, 1H, Ar-h), 6.91 (t, J = 4.35 Hz, 1H, HetAr-H), 6.81 (d, J = 3.36 Hz, 1H, HetAr-H) 
ppm;  13C NMR (125 MHz, CDCl3): δ 151.7 (C), 141.0 (C), 137.7 (C), 132.9 (C), 129.8 (CH), 
129.0 (CH), 128.4 (CH), 128.3 (CH), 127.9 (C), 127.4 (CH), 125.5 (CH), 118.8 (CH) ppm;  IR: 
ῦ (cm-1) 3102, 2046, 1698, 1591, 1491, 1453, 1374, 1303; HRMS (ESI) calculated for 
C18H14N3OS [M+H]+ 320.0852, found 320.0850. 
5-Pyridyl-5-phenyl-4-phenyl-2H-1,2,4-triazol-3(4H)-one (352) 
 
3-pyridyl-1,4-diphenyl-1H-1,2,4-triazol-5-imine (140 mg, 0.45 mmol) and sodium acetate 
(730 mg, 8.94 mmol) were taken in a 25 mL oven dried round bottom flask and dissolved in 
7.3 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (770 mg, 11.18 mmol) was added 
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portion-wise over a period of 5 minutes. After complete addition, the reaction mixture was 
allowed to stir at room temperature. After 6 hours, the reaction mixture was boiled for 10 
minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was then 
neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (35 mL). The ethyl acetate 
fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. The 
volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1 to 7:3) to afford the product 4a (110 
mg, 79 % yield) as a pale-yellow solid, 79 % yield; M. p. 205-206 °C; Rf 0.25 (4:1 Pet 
ether:EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.37 (d, J = 4.12 Hz, 1H, HetAr-H), 8.06 (d, J = 
8.09 Hz, 2H, Ar-H), 7.72-7.65 (m, 2H, HetAr-H), 7.41-7.31 (m, 5H, Ar-H), 7.24-7.17 (m, 4H, 
Ar-H and HetAr-H) ppm;  13C NMR (125 MHz, CDCl3): δ 151.9 (C), 149.4 (CH), 146.1 (C), 
144.1 (C), 137.7 (C), 136.6 (CH), 134.0 (C), 129.0 (CH), 129.0 (CH), 128.4 (CH), 127.2 (C), 
125.7 (CH), 124.4 (CH), 123.3 (CH), 119.0 (CH) ppm;  IR: ῦ (cm-1) 3050, 2927, 1703, 1595, 
1489, 1452, 1372, 1157; HRMS (ESI) calculated for C19H15N4O [M+H]+ 315.1240, found 
315.1244. 
5-(cyclopropyl)-5-phenyl-4-phenyl-2H-1,2,4-triazol-3(4H)-one (353) 
 
3-cyclopropyl-1,4-diphenyl-1H-1,2,4-triazol-5-imine (120 mg, 0.43 mmol) and sodium acetate 
(712 mg, 8.68 mmol) were taken in a 25 mL oven dried round bottom flask and dissolved in 
7.2 mL 50% acetic acid solution. At 0-5 oC, sodium nitrite (748 mg, 10.85 mmol) was added 
portion-wise over a period of 5 minutes. After complete addition, the reaction mixture was 
allowed to stir at room temperature. After 6 hours, the reaction mixture was boiled for 10 
minutes to expel the nitrous gases (visible as yellow fumes). The reaction mixture was then 
neutralized with sat. (aq) NaHCO3 and extracted with ethyl acetate (35 mL). The ethyl acetate 
fraction was separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. The 
volatile components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1) to afford the product 4a (87 mg, 
73 % yield) as a light-orange solid, 73 % yield; M. p. 91-92 °C; Rf 0.43 (4:1 Pet ether: EtOAc); 
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1H NMR (500 MHz, CDCl3): δ 8.01 (d, J = 7.78 Hz, 2H, Ar-H), 7.57-7.41 (m, 7H, Ar-H), 7.21 
(t, J = 7.4 Hz, 1H, Ar-H), 1.62-1.56 (m, 1H, cyclopropyl-H), 1.20-1.17 (m, 2H, cyclopropyl-
H), 0.99-0.96 (m, 2H, cyclopropyl-H) ppm; 13C NMR (125 MHz, CDCl3): δ 151.6 (C), 148.3 
(C), 138.0 (C), 132.8 (C), 129.6 (CH), 128.9 (CH), 128.8 (CH), 127.1 (CH), 125.1 (CH), 118.6 
(CH), 7.54 (CH2), 6.85 (CH) ppm;  IR: ῦ (cm-1) 3018, 1709, 1594, 1577, 1492, 1463, 1375, 
1261; HRMS (ESI) calculated for C17H16N3O [M+H]+ 278.1288, found 278.1293. 
4,5-Diphenyl-2H-1,2,4-triazol-3(4H)-one (354) 
 
3,4-diphenyl-1H-1,2,4-triazol-5-imine (50 mg, 0.21 mmol) and sodium acetate (347 mg, 4.23 
mmol) were taken in a 10 mL oven dried round bottom flask and dissolved in 3.5 mL 50% 
acetic acid solution. At 0-5 oC, sodium nitrite (365 mg, 5.29 mmol) was added portion-wise 
over a period of 5 minutes. After complete addition, the reaction mixture was allowed to stir at 
room temperature. After 6 hours, the reaction mixture was boiled for 10 minutes to expel the 
nitrous gases (visible as yellow fumes). The reaction mixture was then neutralized with sat. 
(aq) NaHCO3 and extracted with ethyl acetate (25 mL). The ethyl acetate fraction was 
separated, washed with brine (10 mL) and dried over anhydrous Na2SO4. The volatile 
components were then removed under vacuum and the residue purified by column 
chromatography on silica gel using Pet Ether:EtOAc (9:1 to 1:1) to afford the product 4a (35 
mg, 70 % yield) as a white solid, 70 % yield; M. p. 252-253 °C; Rf 0.19 (3:2 Pet Ether: EtOAc); 
1H NMR (500 MHz, CDCl3): δ 9.67 (brs, 1H, NH), 7.48-7.37 (m, 4H, Ar-H), 7.34-7.26 (m, 
6H, Ar-H) ppm; 13C NMR (125 MHz, CDCl3): δ 155.1 (C), 146.7 (C), 133.4 (C), 130.2 (CH), 
129.6 (CH), 128.8 (CH), 128.5 (CH), 127.9 (CH), 127.2 (CH), 126.6 (C) ppm;  IR: ῦ (cm-1) 
3153, 3051, 2931, 1689, 1593, 1550, 1496, 1445, 1416, 1331; HRMS (ESI) calculated for 
C14H11N3NaO [M+Na]+ 260.0794, found 260.0804. 
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3-anilino-2,4-diphenyl-1,2,4-triazole (286) 
 
brown solid,  M. p. 87-89 oC; 1H NMR (500 MHz, CDCl3): δ- 8.22-8.19 (m, 2H, Ar-H), 7.64-
7.58 (m, 6H, Ar-H), 7.52-7.40 (m, 4H, Ar-H), 7.36 (t, J = 8.4 Hz, 2H, Ar-H), 7.06 (t, J = 7.48 
Hz, 1H, Ar-H), 6.45 (brs, 1H, NH); 13C NMR (125 MHz, CDCl3): δ- 159.4 (C), 150.7 (C), 
138.9 (C), 136.3 (C), 130.7 (C), 130.1 (CH), 129.3 (CH), 129.2 (CH), 128.8 (CH), 128.4 (CH), 
126.4 (CH), 124.6 (CH), 122.5 (CH), 117.7 (CH); IR ῦ (cm-1): 2923, 2853, 1598, 1561, 1441; 
HRMS (ESI) calculated for C20H17N4 [M+H]+ 313.1448, found 313.1451. 
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4.12 Crystallographic data 
Table 4.1 Crystal data and structure refinement for 3,4-diphenyl-1,2,4-oxadiazol-5(4H)-one 
(216) 
 
Identification code  pasjmb 
Empirical formula  C14 H10 N2 O2 
Formula weight  238.24 
Temperature  120(2) K 
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Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions a = 15.2095(12) Å a= 90°. 
 b = 5.9093(4) Å b= 102.997(8)°. 
 c = 12.9247(11) Å g = 90°. 
Volume 1131.86(16) Å3 
Z 4 
Density (calculated) 1.398 Mg/m3 
Absorption coefficient 0.784 mm-1 
F(000) 496 
Crystal size 0.6815 x 0.5067 x 0.2868 mm3 
Theta range for data collection 5.972 to 74.991°. 
Index ranges -18<=h<=18, -7<=k<=7, -16<=l<=14 
Reflections collected 8812 
Independent reflections 2277 [R(int) = 0.0321] 
Completeness to theta = 67.684° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.845 and 0.705 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2277 / 0 / 163 
Goodness-of-fit on F2 1.026 
Final R indices [I>2sigma(I)] R1 = 0.0433, wR2 = 0.1158 
R indices (all data) R1 = 0.0464, wR2 = 0.1189 
Extinction coefficient n/a 
Largest diff. peak and hole 0.457 and -0.216 e.Å-3 
 
 
Table 4.2 Crystal data and structure refinement for 2,4,5-Triphenyl-1H-1,2,4-triazol-3(4H)-
imine (285) 
 
Identification code  EN_SB_660P 
Empirical formula  C20 H16 N4 
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Formula weight  312.37 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 19.1339(10) Å a= 90°. 
 b = 5.8057(3) Å b= 112.9259(17)°. 
 c = 15.2949(8) Å g = 90°. 
Volume 1564.84(14) Å3 
Z 4 
Density (calculated) 1.326 Mg/m3 
Absorption coefficient 0.639 mm-1 
F(000) 656 
Crystal size 0.224 x 0.094 x 0.075 mm3 
Theta range for data collection 2.507 to 72.356°. 
Index ranges -21<=h<=23, -6<=k<=7, -18<=l<=18 
Reflections collected 20654 
Independent reflections 3081 [R(int) = 0.0640] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7536 and 0.4278 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3081 / 0 / 220 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0621, wR2 = 0.1610 
R indices (all data) R1 = 0.0656, wR2 = 0.1660 
Extinction coefficient n/a 
Largest diff. peak and hole 0.366 and -0.382 e.Å-3 
 
 
Table 4.3 Crystal data and structure refinement for 3-anilino-2,4-diphenyl-1,2,4-triazole 
(286) 
Identification code  cu_EN_SB_821_B_0m 
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Empirical formula  C20 H16 N4 
Formula weight  312.37 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.3202(2) Å a= 90°. 
 b = 11.7029(3) Å b= 90°. 
 c = 18.2850(5) Å g = 90°. 
Volume 1566.43(7) Å3 
Z 4 
Density (calculated) 1.325 Mg/m3 
Absorption coefficient 0.639 mm-1 
F(000) 656 
Crystal size 0.267 x 0.147 x 0.089 mm3 
Theta range for data collection 4.486 to 72.124°. 
Index ranges -9<=h<=8, -14<=k<=14, -22<=l<=22 
Reflections collected 14411 
Independent reflections 3066 [R(int) = 0.0221] 
Completeness to theta = 67.679° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7536 and 0.6674 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3066 / 0 / 221 
Goodness-of-fit on F2 1.089 
Final R indices [I>2sigma(I)] R1 = 0.0258, wR2 = 0.0674 
R indices (all data) R1 = 0.0262, wR2 = 0.0678 
Absolute structure parameter 0.08(9) 
Extinction coefficient 0.0031(4) 
Largest diff. peak and hole 0.194 and -0.136 e.Å-3 
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Table 4.4 Crystal data and structure refinement for 2,4,5-triphenyl-2H-1,2,4-triazol-3(4H)-
one (345) 
 
Identification code  EN_SB_796_P 
Empirical formula  C20 H15 N3 O 
Formula weight  313.35 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 19.0316(7) Å a= 90°. 
 b = 5.6528(2) Å b= 111.7060(10)°. 
 c = 15.3092(5) Å g = 90°. 
Volume 1530.21(9) Å3 
Z 4 
Density (calculated) 1.360 Mg/m3 
Absorption coefficient 0.688 mm-1 
F(000) 656 
Crystal size 0.246 x 0.063 x 0.044 mm3 
Theta range for data collection 2.499 to 72.174°. 
Index ranges -23<=h<=23, -6<=k<=6, -18<=l<=18 
Reflections collected 26731 
Independent reflections 3002 [R(int) = 0.0261] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7536 and 0.6592 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3002 / 0 / 217 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0341, wR2 = 0.0856 
R indices (all data) R1 = 0.0361, wR2 = 0.0874 
Extinction coefficient n/a 
Largest diff. peak and hole 0.195 and -0.277 e.Å-3 
